var title_f9_62_10208="Wrist extension";
var content_f9_62_10208=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=EM%2F86704&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=EM%2F86704&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 524px\">",
"   <div class=\"ttl\">",
"    Wrist extension",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 504px; height: 336px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Blake Boggess, DO.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_62_10208=[""].join("\n");
var outline_f9_62_10208=null;
var title_f9_62_10209="Terlipressin: International drug information";
var content_f9_62_10209=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"drugTitle\">",
"   Terlipressin: International drug information",
"  </div>",
"  <div id=\"lexiTitleImg\">",
"   <img height=\"17\" src=\"./../images/lexiComp/Lexicomp_2012_71x17.myextg\" width=\"71\"/>",
"  </div>",
"  <div class=\"clear\">",
"  </div>",
"  <div id=\"drugCopy\">",
"   Copyright 1978-2013 Lexicomp, Inc. All rights reserved.",
"  </div>",
"  <div id=\"topicText\">",
"   For abbreviations and symbols that may be used in Lexicomp (",
"   <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\">",
"    show table",
"   </a>",
"   )",
"   <div class=\"list fbnlist drugH1Div drugBrandNames\" id=\"F4304048\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     International Brand Names",
"    </span>",
"    <ul>",
"     <li>",
"      Glipressina (IT);",
"     </li>",
"     <li>",
"      Glycylpressin (AR, AT, DE);",
"     </li>",
"     <li>",
"      Glypressin (BE, CH, DK, ES, GB, IE, LU, NL);",
"     </li>",
"     <li>",
"      Glypressine (FR);",
"     </li>",
"     <li>",
"      Remestyp (CZ)",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list synlist drugH1Div drugBrandNames\" id=\"F1980264\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Index Terms",
"    </span>",
"    <ul>",
"     <li>",
"      Triglycyl Lysine Vasopressin",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"list_set htclist drugH1Div drugBrandNames\" id=\"F1980282\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Pharmacologic Category",
"    </span>",
"    <ul>",
"     <li>",
"      <span class=\"list-set-name\">",
"       Hormone, Posterior Pituitary",
"      </span>",
"     </li>",
"    </ul>",
"   </div>",
"   <div class=\"block iuse drugH1Div\" id=\"F1980285\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Reported Use",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Treatment of acute esophageal variceal hemorrhage",
"    </p>",
"   </div>",
"   <div class=\"block idos drugH1Div\" id=\"F1980281\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Range",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Adults: I.V.: 2 mg followed by 1 or 2 mg every 4-6 hours until bleeding is controlled, for up to 72 hours",
"    </p>",
"   </div>",
"   <div class=\"block prod-avail drugH1Div\" id=\"F11821154\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Product Availability",
"    </span>",
"    <p style=\"text-indent:0em;display:inline\">",
"     Product available in various countries; not currently available in the U.S.",
"    </p>",
"   </div>",
"   <div class=\"block foc drugH1Div\" id=\"F1980284\" xmlns=\"file://www.w3.org/1999/xhtml\">",
"    <span class=\"drugH1\">",
"     Dosage Forms",
"    </span>",
"    <p style=\"text-indent:-2em;margin-left:2em;\">",
"     Injection, powder for reconstitution: 1 mg",
"    </p>",
"   </div>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 10437 Version 28.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1004-122.72.80.101-C15F01F966-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_62_10209=[""].join("\n");
var outline_f9_62_10209=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F4304048\">",
"      International Brand Names",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1980264\">",
"      Index Terms",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1980282\">",
"      Pharmacologic Category",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1980285\">",
"      Reported Use",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1980281\">",
"      Dosage Range",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F11821154\">",
"      Product Availability",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#F1980284\">",
"      Dosage Forms",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10437\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"DRUG_INT/10437|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?23/39/24183\" title=\"Lexicomp clinical abbreviations\">",
"      Lexicomp clinical abbreviations",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_62_10210="Facial sinus PI";
var content_f9_62_10210=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PI%2F75045&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PI%2F75045&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 544px\">",
"   <div class=\"ttl\">",
"    Sinuses of the face",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 524px; height: 514px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    This drawing shows the sinuses of the face.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_62_10210=[""].join("\n");
var outline_f9_62_10210=null;
var title_f9_62_10211="Geographic tongue - distal";
var content_f9_62_10211=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=DERM%2F79512&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=DERM%2F79512&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Geographic tongue",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Reproduced with permission from: www.visualdx.com. Copyright Logical Images, Inc.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_62_10211=[""].join("\n");
var outline_f9_62_10211=null;
var title_f9_62_10212="Meconium stained membranes";
var content_f9_62_10212=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=OBGYN%2F53101&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=OBGYN%2F53101&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 560px\">",
"   <div class=\"ttl\">",
"    Meconium stained fetal membranes",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 540px; height: 384px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Arrows point to meconium pigment in membranes.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Drucilla Roberts, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_62_10212=[""].join("\n");
var outline_f9_62_10212=null;
var title_f9_62_10213="First degree AV block II";
var content_f9_62_10213=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=CARD%2F75567&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=CARD%2F75567&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=4\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    First degree AV block II",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 331px; height: 123px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Electrocardiogram of lead II showing normal sinus rhythm, first degree atrioventricular block with a markedly prolonged PR interval of approximately 0.40 sec, and a widened QRS complex (0.16 sec) due to concurrent left bundle branch block.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton Arnsdorf, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal rhythm strip",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 432px; height: 165px; background-image: url(data:image/jpeg;base64,/9j/4AAQSkZJRgABAQAAAQABAAD/2wBDAAYEBQYFBAYGBQYHBwYIChAKCgkJChQODwwQFxQYGBcUFhYaHSUfGhsjHBYWICwgIyYnKSopGR8tMC0oMCUoKSj/2wBDAQcHBwoIChMKChMoGhYaKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCgoKCj/wAARCAClAbADASIAAhEBAxEB/8QAHwAAAQUBAQEBAQEAAAAAAAAAAAECAwQFBgcICQoL/8QAtRAAAgEDAwIEAwUFBAQAAAF9AQIDAAQRBRIhMUEGE1FhByJxFDKBkaEII0KxwRVS0fAkM2JyggkKFhcYGRolJicoKSo0NTY3ODk6Q0RFRkdISUpTVFVWV1hZWmNkZWZnaGlqc3R1dnd4eXqDhIWGh4iJipKTlJWWl5iZmqKjpKWmp6ipqrKztLW2t7i5usLDxMXGx8jJytLT1NXW19jZ2uHi4+Tl5ufo6erx8vP09fb3+Pn6/8QAHwEAAwEBAQEBAQEBAQAAAAAAAAECAwQFBgcICQoL/8QAtREAAgECBAQDBAcFBAQAAQJ3AAECAxEEBSExBhJBUQdhcRMiMoEIFEKRobHBCSMzUvAVYnLRChYkNOEl8RcYGRomJygpKjU2Nzg5OkNERUZHSElKU1RVVldYWVpjZGVmZ2hpanN0dXZ3eHl6goOEhYaHiImKkpOUlZaXmJmaoqOkpaanqKmqsrO0tba3uLm6wsPExcbHyMnK0tPU1dbX2Nna4uPk5ebn6Onq8vP09fb3+Pn6/9oADAMBAAIRAxEAPwD6P0tpjZX+Yfm+0SYXd15q/OZPPtMRg/Mc/N0+U1R0gH7Lfjzwc3EnzYHy1fmBEtoBL/Ec8fe+U0zrq29o/n37CW7P9tugY8L8uDnrxWXqTP8A8I4SIwW85OM/9NhWpCT9su/nGPl49OKyNQDf8I0AbgZ85PnwOf3wpPYqj/Ej6xNadpPt9oNny4bJz04p0Ly+Zd5iHD/J833vlFNnP+n2n7zAw3y+vHWktxiW8zcZy/t8vyigx+z8v1Gq8otLQrEu4uAwLdKp7pv+Eux5Y8v7GPmz/tmps4s7LF1t+dctkfNzVVsHxacXZXNoPlyP7xoZvTS970fcsM9x/Yt2WiXcPMwN3UZNTyvP9rscxpglt3PT5aoKpOj3m6/Y5MmDleOtW5wv2uw/0s8Fu6/N8tApRV38+/YsSNIWuwyKAIxt568Gs7TDOPD+nkInmbkyM8Y3Va3KJ77NzuHlrgFh8vDVR0rB8OWCi6KtuT5gwz96lccY2h849+zNMmT+2CFVdnkDJJ5+8aooZ/7P1f5I93my4GTyNoq1hf7YLfaWz5I+XcMH5jVBVVtP1YfbWXMsnO5ePlHtQEF+nfuN1Uz/AG3QMrHzMc9ePkrUtvtH2673rGE+XaRnnisfVEX7boJF82BLyCy/N8v0rTt9gv7o/bmbhflLrgcfShFVV+7j6Po/5iq7XC+H7M7I/M3R/KScdatzNc/21aqFi2+RKd3P95P/AK1ZnyN4esx/aDZzH829c9fpV2RY/wC2LY/b3/1EnG9fVPakOUbN/wDb3R9ihpIu/setjbDuNxLgZPpWmPtYFgNsPTnk8fLWTpCxm01kG+kANxJzvX0+laTJHmwH9oSDHT5154+lNbF1177/AMn2LFv5/wDad3kRfcj55/2qzNWNz/wik2Vi3ZHGT/fFXIFT+1Lv/TpM7I8jev8Ate1ZmqiM+FJv9NfqP41/vjjpQ9iaMf3sfWPRnQSm4FzDgRbcNk80im58y4ysOAfl688d6jlRPtcGbyQEbvl3rz+lIFjDXJN9JyefnX5ePpVHKlp8uz7j5ftJW1IEW/eM9cY2mq0f2n+35eIdnkDnnPWnFY/KtQL98bx829cn5T7VBGqHxBJi9kz5A+Xcvr9KTNYrR+j6PuTL9q/s254izvlx1/vmppjc+ZY4EWNx3df7jVXUJ/Ztzm8cjfJzvXj5z7U+dUMlj/psgy/GHXn5G9qAa1fz6PsTg3Hnzhli27BgjPPWs3RvtY8O22xYdwJ4Of75q4qL9puf9OkJKDguvHXnpVDRlT/hG7fdeyAZPzb15+c98U1uVFWh849H2Zpn7T/aa8RY8k5PPrUB+1fY9R3LD1fA55+WpTGn9ooftkgPlHC7l55+lVnVWtdTxeSfx8Bl4+X6UiY9Pl08yLU/tn2fSsCAf6RFnrxV1Bdf2vIcQ48hM9f7zVnakiG30n/Tpf8AXxYw68/pV1YgdYlxey/6hONy/wB5vajqaSXuff0fcb/p39mXu7yPMzJ646VamN359thYeSdx544qkY4jpt6DfylMvlt6+n0q1Msfn2ub2TOTtG9fm4+lNIzlv9/R9ippf2r+2dYyIvvR46/3Kuf6SbGDiHfvTPXGM1Q0tY/7a1kC6fdujz8y/wB36Va2xrp8GLtym9Pn3j19cUiqq99f9u9P7pcYXH2tDiPbsbPX1FVz9o+zX+RF959vXpjvUzKv2yPNy4bY3G4c8j2qqyIbPUP9KkA3Pkhhxx9KZlBbfL8xbIz/ANl6bxFnbHnr021dUXPnsT5WzaMdc5rOs0Q6XpYN1J0jx8w5+Xp0q6iD7Y4F1KW2jKZGB74xSWwVVq/n08yNjcnTyWEW/wBBnGM1FdfaP7csMCLb5UueueqU5kj/ALKbF1IU7uWGRz0zimXaKdd0/M7hvKlwMjn7ntQyofE/+3unkW4fO8+5z5ecjb19KkXz/s8ePL38Z64xUUSL513iZ8kjdyPl4/SkURiygBncJ8uG3DJ9KZi1f8PyJ/3/AJx/1fl4985rNsTcf2dc8RBvPlx1/vmtH5PtTfvm37RlMjGPXFZeniIaZebZ3K+fLubPIO80uppD4X6rp6mlMZvNtsbMFju/75PSljEv2iYnbt42/lTZQpltj5rZ3HbyOflNLEym5nUSEsu3I9OKZl0+X6mfrAuP7LQfu9/nJu9Mb60G+0fao/8AV+XtOfXNZmsLCNGj/fv5fnJh88n560W8n7XFulbzdh2jPUetI2l8C06y6eg0C58i53GMHLbMA/rSuJilpkpuDDd6dDUatAIbzErnlt+WPHHamOYDDYjzX2hhtO45PB6mgmzvt+HkeW6b8SrlLG/2fD7xQ6NO7OBbjA56E5q/L8T70yWZ/wCFe+K+vy/6MP7p6c11+lNqpstROLUsJ5No55NX5Dq3mWeRZ5JO4fNx8ppanTVgud3a69fI4/wp8RINX8aS6Je+HdZ0nUJ7f7Qn22EKHVRg9K6S/aL/AIRnmF9nnJ8pTn/XCuS1ddTT406BJi1/eWNzGG5xwobp1rpdQOq/8I7nFmT5qcfN/wA9RSu7MqFNKcLNbx6m3cOn9o2eYn3YfB2dBim28kHmX4W3lxv+ceWfm+UdKrTHVv7QswRZhcPkjd1xSwnWPMvTiy3B/lGG5+UUzH2a5d1t38xpmtxYWANpMV8xdi+UTg5qBpLceMMm2lMhsxz5R/vGnIdY+xWRxZFi65BDcfrUf/E1/wCEqxmy/wCPQc4b+8fekzeMUubVbS6kqSwHR71RZzgAyZBhPXmrlxJF9qss2svVsfuuny1QA1ddIuyWsush6N0596szjV/tVlk2Octn5W/u/WmRKKu9V16+RIZIftF7i1lyY1z+668NVLTJIf8AhHrH/RZiu5flEWT96rDDV/OvMtZbfLGPlb/a96z9JTWG8O2IjazByuMhs/e+tF9SoxXJ8S3j18mbHnxf2r/x7TFjCOfK6cms8TQ/YNWBs5yDJIceV/sirONW/tU82OPJGflb+8feqgXVRp+q4ay+/Ln5W/uj3pMmEUuq6dfMh1eWL7b4f/0Sbibj910+WtO3ng+33eLKcN8uT5PXisfVRq/2zQNz2Q/fdlb+735rVtxrH9oXWXsduF42t6fWhM0qRXs46rZ9X/N6FJJIToFmPsM/VOPJ96vSyw/21an7HNnyJefJ90rP26uugWgL2ecx4O1s9eO9XpV1b+2LU77LAhk42t6p7/ShMU0rvVfa6vsVNMkh+y6x/oku0TScGHGeKuNPDmwP2G4OOmIOny1m6b/azWms7WtA3nSDlW64+taKrqxFhmSzyBz8jf3frQnoOrFKb1X3vsT20sTancj7JKuUj5MXH8VZertCPCdwPssnBHAi77xzV+Aap/a13+8tNuyPA2t/te9ZWsJqn/CJzZktuozhTnG8e9DYqMV7WOq3j1ZvvNG15ADazZIb5jFwKXzIg1xm1lPPP7rrxUEqap9sg/fWmz5sjYf8aAmq5ux59qSfufIeOPrVXObljZarbu+/oK80LRWZ+xTYMg+XyeR8p5xUUckQ8QyD7NKD5A58rjrSGLVhDZAzWu8ON3yHptOe9RImpf8ACRy/vrfZ9nH8B/vfWk2axjG0veWz6vv6FhZYv7OuR9llI8yXjyuvzmpppIhJY/6LIfn4/d/d+RqqxxamNOuR51vkySlfkPHzn3qSSLU/MsMz2/Dnd8h5+Rvenclxjd+8uvV9vQmDx/abnFrL9wc+X168VQ0R4v8AhG7bNpIwBPyeXk/fNXgmo+fcbprcqUG0bD1596y9Fi1M+HLdUmt9+TyUP98+9F9Sopezeq3j1fZmz5kZv0H2eTPlnDeXwOelVi0Zs9TxbuD8/VOvy04x6j/aSET2+wRHcNh5OfrVd49R+yalmeDB34Gw8fL9aLkRitNV06vv6DdRMRt9J/0aT/XxY/d9PrV5Cg1iX9y3+oTnZ/tNWXqUWo/ZdJxcQ7hPFk7D/jV2OLUP7XlJuIMeQv8AyzP95velcuUVyfEuvfv6CM0f9mXv+iSdZPlMfXirUpjNxa4tn4J58v7vFUHg1UadeA3dvv8An58s+n1qaeHVfPtcXUGATu/de31p3JcY3+Jder7egzTDH/bWs/uGHMfOzr8tWd6DT4D9lkA3qPL2cjnrWbp0WonWtXxcwjmP/ln/ALP1q0ltqv2KISXcXmB1PEXbP1oTKqxjzK8l9nv29DRYqb2P9033G+bb05FVWK/YtSxCThn+UDluKJYNRN5GUuogmxs5j9x71TNvqZtdRAvIuXfb+66cfWhsyhCOnvLp37+hZsmU6VpR8huRHxj7vy9a0Vx9pceUQQo+fHB9qxbC31D+zNNzex4Cxk/uu2361fEGo/aGJvIzFt4Hlc5oWwVox5n7y69+/oOkI/s1j9mZf+meOTz1qK7bGv6ePKLfupvmHQcpUc9vqf8AZ7L9rjMvr5fvUNzBfnW7DF3Hjypc/uvdKTHTjG795fa79vQ1Im/f3X7o8Ef8C4pqSH7FAwt2JO0bOPl96rpBf+bc4vE5I25iHHFNW21MWsSi+jDDbuPk9qZHJH+ZdO/b0NDeftRXyTjbnzOMfSs/Tm3afdfuCuJ5Rt4+b5zzU32a+80n7au3A/5YiqFhbagLC6H21d5mk25iGPvml1HGMeV+8t138/I15mImth5ecsef7vymkiZvtNx+6wPl+bI+biqcttf+dbH7euAxz+5H9006K2vhcTk3ykHGP3I9KZPJG3xLbz7+hBq0rrpKk2xJMyjZuHHz1os8n2hP9Hz8p+fcOPasbU7TUf7NUG/Ut5q5/cj+/WgbXUPPQjUB5YU5HkjOaDSUYci95bvv5eRKJJDDc/6KVA3fxD5qY8k3lWh+ynO4fLvHy8Goja3/AJM+dQHO7b+5HFRyWeo7LUDUfmDDd+5HoaCVGHdf+TdippawfY9RzeyhftEnzeb0q/LHCZLMC9lxkkHzevymqOlSr9k1EGxnI8+Tjy15/Wr7yr5loBZTjkgZRePlPvQjarfnfz7djjNfjhPxV8Ln7VJkpdLxJ0Hkg10F+kQ8OH/TJMeanzebz/rRXPeKZlT4l+EWa1mUebcgHYvzEwdOtdFfyg+HSPsU2PNT5di/89R2zStuaQvzQ9Y9vM0JkhN/aYvJCcNgeb14pIY7fzrz/Tpfv8/vunyinTzAX9oBZTdG52Lxx9aIZV867/0Cbl+fkXn5R71Rz68vy8u5WSO3FhaD7fLjeuGM3J5qEJB/wlGPt02fsg/5bcfeNWElT7DaZ0+c4cYHlrxz9ah85P8AhKgPsUufsgP3F/vn3pM2jf3vR9iXy7cabdYvpSCJM5mzjrUtwkIurL/TJuS2D5vX5aY0q/2Zd4sZhgP1ReevvU9w6i5sv9DlPLY+QfL8v1pmbbv9/bsMdYPOu/8ATJOIhn970+9WbpYth4dsgb+ZQWXkTYP3q03lUz3i/Ypv9UvOxefve9ZelTIvhqwzYyt8yj7in+L60uppC/J849uzNPZB/amDey7vKHHm9eTVKOGA2GrD7bNjzJMnzv8AZFaQK/2r/wAej8w/e2jjk+9Uo3X7Bq3+iSf6yTjaOflHvQRCT/Lt3KWrRQC50IfbJiTPwfO5+7V+1jtv7Tu9uoTlgEyPO4FV9VdftWhYs3/13XaPl+X61ftX/wCJneA2MijC4baMEfnQtzScn7Nej7fzGakMB0C0Y3s+3Kc+b71flii/tm2H2ybcYZeBL7pVRJS3hy0P2OXO5Pl2jn5uvWtGVh/bFri3b/Uy/NgccpSRM2+Z/wDb3bsZGkRQNa6z/pkxX7RJn977VoNHCV07ddzD0Pm9flqrpD4h1oi0cYuJMDaPm4q+zhRp/wDorEHtx8vy0LYdaT9o/wDgfyhBFF/al2RcybvLjBHmf71ZOrJD/wAIfPm4kZcjrJzneK1oJX/te9AtXwEi+bjn71Z2qsw8Hzt9nIfj5eP74olswo3VSPrDsa1wkf2+2Bmk3YbAD0kCQ+belZ5TyN/z5x8vb0p11MYrqF5Igsaq7NIzABAB3NJZ3K3CXEsCJJGcFGRgyyDHUEVRy3fL8v1GusDW9lmaTy967G38k4OMmoUEf/CUSDzG8z7MPl3dt3pVovIILQi2BJcApn7vB5qshceJnHkjBth8+f8Aa6UmXC/vej6ruKEiTS7s+bJs8yXcd3Q7zUsqxCTTcyP9/wCT5uv7tv6UZkOm3P7kZ3yALnr8x5p1wziXTgIlPzn+L7v7tvagV3d/P8gXyxd3eJH3BBuG7pwazdF8g+FrYvK4iycNuwT+8NagaQ3FwPIX7g53/e6+1ZmiSTf8I1bkWwJyfk3dPnPtR1Ljf2fzj1XZmiyxDV4iZG8wwkKM8EZqNljNpqgVmOS+/J6fLU7tJ/aKAQgjyiS27pz06VCzym01DMSjBfA3fe+X6UGcb6fLr5lLVUh+y6NudwouItvzdfrWggX+3JTk7/s6cdsbmqlqbTfZtLPkKT9oi439P0q+hf8AtWXMY/1C87v9puOlIud/Z/f180VZRbjR78bm8r95k5Oc4qxcfZxLZ7iQ275OTzx3qKSSb+zL4+Qm4eZ8u/rx9KsTSTiS3H2dGyeT5n3ePpVEu/59V2M3SvIXXtb253Zi3df7tWT9k/s2HBbyQ64POc5qDTWmGt6wRCvWL+Pr8v0q0Zbj7HETaoG3r8vm+/0pI0q351/271X8pM/2f7ZGxH7zY2OD0yKpt9lNpqQb7u99/X0qa81AWl7bJcG3i87KRmScLvbj5QCOTUZkuBa3+LaMgM//AC168fSgzgnp8uq7kNp9kOlaUSOAI9vB67avqLT7UxA/e7Rnr0qpYzXK6VppW3jOUjBHm9Bt+lXhLc+aV+zJtx97zf06UJaBVvzP59V3KUqWP9mt8p8vv1znNR3gtP7d08uvzeVLjg/7FWpprtrNm+yxhv7vne/0qG5e6/texIt4z+7lz+96fc9qTLpt33/m6rsSwi08+6AUdRu4PpQFsfscOV/djbt4NPgkuvPuSbeMHIx+968fSnRyXQtoiLaMtgZXzen6UzN3vv26rsGLNbk8fvdvoelZlktiNPvPl+Xz5N3B/vmtfzLnzSPs8e3H3vN/pis+xkuvsNzm1jz50mB53X5z7UdSoN8r17dUWJ1sxNa5UZ3Hbwf7pojSy+0zkIN+Bk4PpUkkl15kOLaPG45Pm9OD7UqSXP2iYfZ02jGD5vXj6UyLu2/Tuu5kasLAaSpCfJ5y4GD/AH60HTT/ALTEDGN5U7eD0qtqsl2dMBa1jV/NX5RLn+P6VoNJd+emLaLbg5bzeR+lFjWTfIter+0vIqrBp5hudsfdt2Qaa8WnhLUCP5d4xwfQ1deS6CSYt4+Acfvev6VznjXxanhSw0y71K1ylzeRWoCS/dZ+B26UnoRGUm9//Jl2LulC9FpqJMkJP2iTHymtKUXRltCHhHPPynn5TWDpWn2Is9S/0q78sTvu/wBKk/xq/Lp1iZLLN1edfk/0uT+6fehXOisoc7/+R8vU5bxtHcf8J74OkMkIUX0gAwc5MNdLfi6Hh0/PDv8ANTnBx/rhXG+PLCyj8X+E5PtF0ZP7UWM5uX4DR8c54ro9Q0+xHhok3FyU85ety5/5ajtmp1sy6aheGvWPT18zoLhbr7daHfFtw2flPXFOhF15t388Odw2/KePlFUJ9NsxqFmPtF1uw23/AEp+mPrSQ6bYNLe/6Td/ew/+lSf3R71Wpz2hyrXp/L5+pMgvPsFn+8h3eYuTtPPNeZ2Oo3j/ALT+oWTXA8pNET93zt6hunrzXcf2bpn9nWG6e52+YoX/AEl/X614zpkFi/7VN+vmzGEweQp85slhChI3ZzjPapbehs6cXzNX6/Z/4J73suxpV3mSIsfMIO08DmrMwn+1WWWj6tu4PPy1hx6dpg0m9KyXBUGTOZn68+9WpbDThcWADzFWLbczOf4frTuyJQjd79fs+XqXytx9qvfnjwYl2jB4+9WVpsV23hWyRZYlfcvJXtuqRtM037Tfj97xEu796/8Ate9Z2m6XpjeFbJpBJ5ZZed7dd1J3uawUFHd7x+z5PzOnAm/tPJZNvkjIx7mqaCb7Bq2HTd5kuDjp8oqAaPpi6rjyn3mLP329T71WTStOGn6sdkhVZJM5duDtHvT1Moxp930+yu/qW9UEn2jQvnXiYbuOvymr1qbj+0rsM6FAEwAvTg1iajpunLPof7twWmG0bjz8tXYdF0ptRutsTGXC7xvbH86NRzVP2au3s+i/m9RqrP8A8I3ZgSoJNyfNt4xmr8wm/tm1+dAvky5G3rylc82j6T/wj1s3lyeXuTJ3N1zzVqbRtK/tm1Tyn5glON74PKe/1palyjTu9X9r7K7eo7SBdG11vEybxcSbTt6cVoLDcsmnEzLlcFvl6/LXP6Vpukraa0VtztWZxyWPatJ9N0t4dOZ4SAQMfe5+WhXsVWUOd2v/AOAr+X1NO3SX+17wmQbTHHgbf96srV0mPhC4BmG7I5C9vMFPttL0kavdgW2W8uM4IY/3qzdVstKPhCdhbKFBGDtOc7xQ9hUYx9rG194fZX+ZF8YpLi38Ca1LDPs/0KVMAddwC/1rK/Z5eeb4SaK8k2f9HVFGPu4GKX4x6bpP/CJyRtbhHleOJSoI+9Kg/wAay/gBp+mj4dvDNbiRoLmaFiyEnCsRxR1M1CPsd39y7+p6pIkohtB5/wA4cZbH3uDVdUf/AISRz5vH2YfLj/aqi+naI1pak2SbC6gfuznODUK6ZpP/AAkjqbKIj7MODHkdabFGELS1ez+yu/qa4jl/sy5HnfMXkwdvT5zUlwj+bp3708SHPHX921ZC6bo4066/0KIjfJnMX+2elPl07RhJp/8AoMQ+c7f3XX5G60C5I3er6/ZXb1NYJJ9quT5pwUGAB061l6EkzeF7cCch8t823/poaP7O0YX1yDYw52An91x36Vm6NpujHwxCz2MTAlufK+b/AFh70dTSMIez3e8fsrs/M6rY/wBsU+aeIyCMdeetVikgs9QzKTkvg46fLVM6do/9owr9ggz5R2/ueOv0qL+zdH+z6gRYQ9Xz+6/2e1PUxjCK6vp0Xf1LGpRy/Z9LxMeJ4snb1q6qv/a8n7w48hOMf7TVg6hp+jiDS9thAA08YH7nqPfiryaZpP8AbEiiwt8+Qp/1Ix95valqXKMeTd9ei7+pcaN/7OvVMxJPmfNjpxUtxFKZbbFwQFbkbR83FZLaXpDaXesNPg2DzP8Allz07VJcaboqyWwOnwctwBD7d+KepPLG+76/ZXb1JNMgmGt6wzTHaxj2/L/s1aEcps4R9pJO9fm2j16Vh6fZaQ2sarE1jAY4zGVUwjC5XnHHfFSDTtBFhEf7OgCeYv8Ayw5+9QrmtSEXJXv9n7K7ep5l+0xLcQX/AIEaCYgrqyNwBx0Gf1r2DyZfsmoA3J5Zudo4+UV4f+0Rp+mHUPDqW1jEnls077IQMgOg549zXrNtpmhSabeMumW4GCf9QP7o6cVOuooxjyLV/wDgK7+pqWkUh0rSv9JIwsZztHPy9K0PLl88/wCkHG37u0fnXO2mlaIdM0xjplsSRHz5Aznb34rQXTNFNyyjTbbdtyT5A/wqlexFWMLvV9fsrv6lp4pfsDD7Ux/2to9aZdJL/a9iv2gjMcv8I5+5VFtM0IWLFdMt9menkDPX6VHdaXow1mwX+zrbmOUgCAY/h9vrQ7hCML7v7X2V29TZiik+0XJ+0NyRxtHHFNWKQWkIF0R93DbRzVGLS9HNxdf8S224xn9wOePpSLpWjfYoGbTbbbhcfuBkfpT1ItC+76fZXb1NYRS+dn7ScY+5tH51m2Ucg067H2kk+fJ82Bx85p39n6R9r2f2db79u7d5A/wrP07T9JaxvD/Z8OBPIDmHn71LW5UIx5Xq+n2V5+ZuyxuJLbM5yGPYfN8ppIkf7XPm4Jxt+XA44qnNpuk+dbA6fbksx2/uRx8p9qItN0r7VcAWFvuAGT5I54+lPUztG2727Lv6jdWUnSh/pmB5q/Pgc/PV90YSxE3eOD8uB83vWHqOn6QNJVxp8IQyrgCEA/frTfTtL8+INYQFsHafJGAPypalyUVFavd9F5eZMqsY7g/bNwy2eB8teI/tS3jW/h3wwiXW8/2lHLjjnZzmvZV07S/JuCthAPvbv3I5/SvDv2lrCye00OK0s44ykU87BY8HaqUpXsVSjGU7K/3Lse1aS7C11E/ZGJ+0SfLlef1rQld/MsyLVsk88r8nyn3qnpUcq2upASgM08hU4+7V6VZPOsv3o4J3cfe+U1RnVa9o/n37HE/EdnGpeG3W2ZlTXLX5ht7gjFdDqTsPDZItmJ81Pkyv/PYe9c58WpXsdKh1SS4WO1sNTs7qUkcIit8zH86121G11DwiLiw1S2uYmlUrPEwZSPOFS3ua0rXh6x7m7cO39oWf+jtjD5OV44+tOtndpLzNqykPxkr83yj3rzbxj8R54vFMWj+CtPfxHqltGzXEcDgRwk8AO/TPtXMeHvjXfnXGi8U6JLoWlz3DWbX05+WG5VBlD7e9HMZqk3BPTbz7nsnmSfYLIiy5Mi5Usvy814JoVxL/AMNC/aTbjM2o3kIwR/AAvX/gNe6L5sulaZKl4pR5EbcAMMCeMV4A1r4gjvdP8V+GrL+17tNQvb0W6sF3RPPJzn6DNKT2OujFWnttLufQxkmOj3n+jKMeZxuGD19qnuHm+12H+jr1b+P7vy/SuW8C68fFPw/OrrJJA1wJd0T43RMCQVP4iuqnRvtVgPtB6tnp83y07nLJJSe3Xv2E3zm8vgYI8eUmDv6/e9qz9He4XwzZEW6Egj5d/wDtdelXwjfbL3/ST/ql44+X71cZq3jHQ/C/g+2k1bWo45htKwRsrSyHd91UHJpN2ZcUnG2m8e/ZncF5xqu0QoU8kZbf05PtVdGmFjqZMaE75MAP1+Ue1eV3njzx9f3bX3hrwVcNp6RBhHfSrFNMuT8yr/SruhfF7wtd6DfPq2rLo+ol5BJY3nyzRNgDbjHrRzEqnZLbp3PQNWeQXGiDykJM4yd3T5T7VpQPMb25UxIAAuG39f0rjLjxl4Zvv7BntvEmnSJ5oO4Tpz8p6+lacHirw+t/csfEunkEL8puEwOvvTTQppezXo+/8xf8y5Og2rCCPflMLv8Af6VdmM39q2uI4yfJlz859U9q5MeKdAGg2o/4SawyGT5vPTPX61cm8WeHRq1sT4m07Hkyf8vMeOqe9K6HJK7/AO3u/Yv6Z9oWDWMQxbjPIceYeePpVwPd+Xp5FvCTxn96fl+X/drl9F8TaJcDVYovEdi8slw4jCzpk8cYGeateKfEem+GNBtNS1PVGWCPaAsZDPKxHCqO5NNNWLqJOb2/HsdFC91/aVyPJh27EwfNP+1/s1kas91/wiM+YIu3AlJ/jH+zXleq/EH4iRTPqWmeDJ3sLgxxwwSuBOAc7WZR90Gt/wAIeN7Txb4DvImuja65aYS9sZCBJC3mDt3X3pNl0qaVSG28e5r/ABde8a00KBIYiZtUgXHmE5w4bH3faoPgp9rh0PX4PJiDQ6zdpgyEYO/p92rnxEjebxJ4LtVuG+fUTIcY4Cxsc/rXHWmseIPAHjLVbXWbAf8ACLarqzvDqUcqlonm5XevYE0dbmS5XSUVa9vPuexb7zybYmCAybhkeafQ/wCzUCNc/wBvv+6hx9nH/LQ/3v8Adp4hc2toPtj53D5xjng1Esbf8JC/+kt/x7j5eP71UyIqPvbbPv3JQ93/AGfOfJh3b5MDzDz8x/2adM935lhmGH/WHP70/wBxv9mq91NDa6Rdy3GoLFEpkJkdlAX5j3rzjxJ8TUu9VsdF+H4fxFrQJZjEwFvENhGXk6Z5zik2gjFSb0XXv2PTxJe/bLgLBAQEXH74+/8As1Q0KW7/AOEahZYYTJluPNIH+sP+zXlN5qHxb0G5Gq6hHYataAj7Vp2nqDMiHOCuepFS+GfjL4Rfw0kGo6vc6XfxOyzW1xCQ6HeT6YPWknrqbezjyWVt49+zPZGe6+3RjyYdpjOT5p4Of92ome6Ntf7ooRjdjEh5+X/drz5vjF4F+3xN/wAJQu0RkH92cfjxWpa/EPwfdWV28Xi7TWWQMVDXCKR8voeaq6MFC1tO3fudLqLXJt9N/dQ58+Mn96f/AImrqNN/akmY4wPJXkOf7ze1cVqXjvwm1vpoXxbpZKzxk4uUPHqeaux+PvCJ1Z2HivSSDCox9qjwfmb3pXQ5L3Nu/fujo5HujY3mIot3z4HmH0/3alnkvBJBiCDBb5v3x44/3a5NvHXhP+z7xV8W6WWbfg/akz0+tY3iv4jQy3umaV4EuLfX9cuWJWOCZTFEoHLyMOgp3QlG7tZde/Y7fTmuhrmrHyYcHyv+Wp/un/ZqZXvvsMP7i33714844xu/3a8O/wCEn+LGgXmv3GpaJp98lmkc9zJbyYBj5+VB3IGa9S8HeJNP8U+DrHVNO1LdFI67/mG6Jt3KN6EUJ9zapBcyen2e/Y4v4vzXNx4jmhEEDfZNGecjzCcZnTn7v+zXpemz3c2iyyeTCGZMgeaf7g/2a831XTpvE3xK8Y2Vpe4ZNGjskY42+YxL4P5rT/hn4o1GO+1vwb4xuLa116xiV4PKcbbiIp95c9SMDIqbi5VypadO/c9Ks5LsaVpeIockRg/vT02/7taINz53McPl44IkOc/981nWS50jSf37EERYbjn5a0lXFyT57E7fucfnVLYwrW5np379yFmuzbHMUPmZ/wCehxjP0qC6M/8AbVjtSPHlS5y5/wBj2oup4LbTXe4v1jQEgyO4GOema4PxL8WPBula7Zh9cW6liSRGisl84liVwDt4zwaG0OnH3tF/N37HosTTma4zHGCCNvznnj6URtci2i+SLfhc/Of8K888P/GLwRqt5cxf24LGdmwI79TAQQMcbuK7y2uLefTbdob5HQhCsiuDuzjH50XRDjbddu/YtFrj7QQI4vK29d5zn8qo6e901pdZSLcJ5AvznpuPtWgADctiU7tv3M/rWVpgjWwvR9pZh9okyc/d+Y0dRwtyvTt3NGZpvOtvkjwWO75z/dPtSxGb7TOGRNvGCGOen0ps5UTWpMuMMe/3vlNEUkZurg+eOi8buBxQRbTbp+pT1Q3LaVnbH5nmrn5jj749q0yZPMQBV2EHdzzn2rhfiB4z0Lwr4bV9S1DfK8gMMER3yzkPnCgV5/qvxl8UR6pbSweBL+LT0ja5kM0nzGDu2B0YelJyRs6Upxsl1f6HvDGXypchA3O3n8s14v8AGxLm81eG3McbmLRbuVvmOASuK9L8KeJNI8T6CdT0a/E9tOCx+bmM45BHYiuN1nTLbxB421K1jvjlNKFqGLZGZM9aHqtCsOuSd5Lby8jrNO1Gxa01LeszIZn3fu2zir0uo2O6x3RzYB/d/u24+U0ukG5EF+RFDv8AtD4G44P6VelNx5lr+7izn5vmPHynpxTKqyhzvT8fL0Mm5fSdRlv7a/tPtMUqqJI5oC6suOhBGK8v1f4ZfD19IluodKurV3lXcLeWaNT+8APyg7entXpmqeK9I0TVJrfWdV0uwkcK0a3FyI2fj0NZHinxZpGleHIv7R1PS7WSd0kiSa5C7180HIz1HepdrM0oNc8VZ2vHr/wB3h/SvC3hdrGz0DTPscOHJ2ROS3HVmPLH3OadrNn4b12w1ex1ax+02szfMrwFsHYPmHHBHY10c008l9p7wpA8TqzBw5PG3jHFFu1402oAxWw+cD755+RfamSpx5b67fzf3vQ+dNR8NeMfDXhyGLwl4ik1OxMirb2V5ZEvGCcYD+g616p4NstL8PPpGlGCWV7TSo4Xb7OTvcfebGO5zXWj7b/Z1hiK2JEqfxn1+lITe/8ACVj91bf8enXe398+1TY6faxtJLtL7X/APGdS8I63YP4ivPBuufYbG9nef7Bcab5io3fax+6D7Cp5NB8fXQ05LrxfBbs4IPkaIuY+OcEjk17Ju1D+y7vdFaD/AFmMO3Tn2qxO179qs/kts5bPzt/d+lPlIdZJ7d/teXoeD2fwu1H7bqsd5498RyQyqDJ5dpsZ+vGSTt4HbFdX4K8GeCdB8P2s8Hh/zr1mUyXVzbtNIzbuu5s4/wCA4Femg332u6/d22PLXHzt/te1UdGN8PDlpiO2LDHV2xjd9KFGz0D2sXG77x+15PyF+2ad/aQ/0GTd5QAP2Y8cn2rFm03wzdQ6pLc+H7WWVpJMvJp6sx4HcrXWKbz+0PmSDy/LGSHOep9qrA3f2XUcLAfnfHzH0+lVYwjOP5faOC1fwf4Ee60gnwpZKXmGdtgFDDb3wOasxeCPh+b24B8I2ZIC8fYeB9OK63VWuhPo2Y4M+eM/OePlPtV+I3v2yfMdvtwuDvbJ6+1Kxc5x5F6P7Xmebx+CfAX9hQOvhO0OWTLGy5PPPNWZfBPgD+1bdf8AhELPBikyPsHBOUxxj6/nXZg339kWwEdtkFP42x1+lWJmvP7VtsJb48mTq7eqe1Fgc43f/b32vI8qX4dfDu6i1c3HhVSRKwUxRSIUA6AbSMVa0f4d/D3SLvS7+z8My/aUIZWlE0oBx12uxGfwrvNKe+K6vlLUsLh8fO2On0q8jXhisTst8kAn52/u/ShIqpKKk9P/ACby9ChFd6b/AGnc/wCgyZ8uMf8AHqf9r2ryn4neA9G1/TE1vSBeaLrdscC4trYKso38+YABu+pNe0w/a/7QuCUg27Ex85z39qyNZ+2f8IjcgrBnHUMT/GPalJaDoTi6kV5x+0eZeBPCuraJ8QmufEN/d61pkUBFlJcWoDrI33zgD2/WvQfE+kaP4n0PV9Lv7OZYLhQpeODbIpA4ZTjgiulmN19tt/kg24bPzHPT6UK115t1tWDII25c+nfimo20MJ1VKzt07+Z4Y3w61/T4LR9I8c60FLhRHdaekwRccdepFJL8M7y414W91418TSRtb5naOFUZ8nouB8or3KN737NBlLffkZ+c4/lUC/af+Ejc7Ytv2YfxHP3vpS5EbRxHxej6nk1l8IPBMVvNcX9rrupeU74ivbiRkJDcHAxk/WvQLKz0LSU0yLStBjtIt5O2CzVP+WbdcDmt9jcnT7jKwht0mPmOMbj7UsxufN0/iL/WfN8x/wCebe1Oxk6qbb9evkZ0VxYG/uv+JdJ9xSf9HHPWsTS7fRn8ORvLoaSszMSTaKx/1h74rr4zcfbrj5YsbF2/MffrxWdoy3Q8OxoghEgZ/wCI4/1h9qLO5aqLk+cevkylJaaG9/CraBEd0bdbJOn5Vj/8Ix4PePUv+KM07cC3zf2ZF/d7ccV3DC4N7CQItgQ7uTnPtxURM5t9Q3CPq23k/wB3vTszKNSOmnbr5nB6l4V8HLaaXt8G6cu6ePONNiBPqDxzWhH4T8HDV3UeDdLH7hSB/ZkWB8zdttdFqf2j7NpefK3faIt2CcVfTf8A2rJ93Z5K8Z5zuakVOceTbv180cOfCfg86Vet/wAIZpowZMf8S2LI49ccVrWOk+HdImhfS/DNrZySEAvb2KRnp3IAzW4fO/s6+yY/M/ebeuOnercvm7oNuzG75859O1MiVRX279fI5yxubU61q27TpTjywf3AP8JrybxH8JNI1C5vNR0yfXtKhvWBmsrPEcLvn72O34V7ZY+cNd1X/VlSIivJz0PWi4+3DTUw0HneYuDzj71Jq6N/apTWn8vXyPO/g/4YbwPoFtp2pWdxe6lK0k1xcGMNliQAMnnAUCn/ABC8F6R40sZZZbG/sNTspy8N/aRqkygAZXd3B969LcXP2yH54guxtwweeR0qALcfZdRAePJZ9pweOO9FiFWi2nbt1fc8Ls/h94u01NNl0HxprKW0pTKXtpHceX8vBXdx+gqa98P/ABdlvYJV8RW/2m1K7QlgiJOueTJjv7DivbNPW4/snS90ke7bHu+Xtt7Vo4l88ncvlbeBjnNJRCriUpNcqe/V9zw+w+HF1rOy/wDiTeXviEW6sIbBbZLeCJ2PLYQgsfQmu+sNH0TQdS02DR/DMVpGIpMeTbIp/g5J6k+5NdZKk/2OQeYhlzw23jrVa6Wb+27DbIu3y5dwK9fuUWsKNZSk3b+bq+xi6vomia+LyHWPDcN4hAGZrdGYfL2PUH3FeZv8EtAWyhfTbnxbpw+QtFb3gCkg8Ngg9M17jCsonudzrgkbfl6cUxFuPskX75A2Fydn0qrXM41lF6eXV9jxyT4aaxbagk2jeMPF8F1GAVkunjuExnoUOAfxqhF4B8WalDcSaj421/yo53BjtLaK33/NySV/wr3fZP55bzV8vbjbs5z9c1Qs1uPsd1mVN3nSY+Tp8xqeVGkcQnHZdO55VcfCt3Nuknijx46OSGBv06bT/s8VHa/CRImntoPEnjpIAoAX7enQjoTivZpEm8yD96oAb5vl68GlRZfPmO9QvGPl9qfKiPrOmy28+55H4b+G+heEI31G2stW1C+dkRZdQlWYxDfzs6bc969PkvJDPEG0u4JII3fLgD060mpJcDSyGkTf5i87P9sVfdJ/NQrKoQA7hs6n86drDnVjKKulu+r8jx2++Gt9Ya1qmq+BdS1Hw0b0N9pto7eKeKZuTkK5wvXtWp8JNI8Q6FpE114utpbzXL26zJKoQfu1BCcDAHFemqlwFfdOpJzt+TGP1prpc4hAnTdu+Y7OvHbmlYj26as0vxMzS1X7PqAW8OTO/wA24cVekC77XN3gg/3h83yms7Szbta6j/oh2id8jyutXZRbiS0BtCeeP3XT5TVIqqvff/A7HgP7TFrbzeMvAzSMjl9RWNi204X5ePpUv7SFlaSP8Pg0iSbtZ8kk7T8hccfT9Kh/aVkjfxf4QW3sbqX7JepcXBhtmYLH8vXA9ulM/aD1OymXwM9nZXDx2+pC9mKWjYEO8deP0qO5rZuKt5fke+3AiXULALebVAcBQy9NtR24Qy6l/wATEnL8YdePkFRtNZXF5pssdk+2RGdSbfHBX6UWhtDPqX/EvYfvO9v1+Qe1MlJqPXbsv5iIRJ/Z1h/xM3GJE/jXnmnBEHisH7cx/wBE6F1/vGmBrP8AsuwJsGI8xMD7P05+lKGtj4rUCyYf6J1MGP4j7UGuvvb7S6ImEaf2Tej+0HOTJzvXjrVqdENxZYvX4Lc715+WqmbX+yLwiyIH7zjyev6VamNuLmxxaEZLYHldPlpmMr3+/t2FVUN5d/6a3+rXjevH3qz9JVB4btcXzgZHO9f73Sry/Z/tl5i0IxEuf3XX71UNI+zjw1af6GcEj5RFn+KjqUvg+ce3ZmptT+0+bt8+V93cOeTVdIwbLU8XTn55Odw44FWT5P8AaQBtiT5XDeX05qshiFhqhEBxvkyoTr8opmUb/l27kOqRr52ik3bcTjALD5vlNaESoL2cm8Y/Kvy7hx1rP1QRebon+j9Z1x8n3flNaEYtzezr9l+YKuW8vr1o6lTfuL0fb+YoCNTotsBfMcMnzb19aszKh1e2/wBMYEQy8bl9UqsnkLotsRZnG5Pl8r3qzKIP7Yth9m58mXnyvdKQ38T/AO3u3YoaUibNYU3zDNw/zb144q6yI0em4vGGMfxD5vlqlpX2fZrLfYzxcP8AL5XXirgEIh00m1PO3pH935aFsXVvzv8A4H8pPCE/tO5/0pi2xPl3Dj71ZOrIn/CJXG66cr67h/fFa0JhOqXS/ZiCI0y/l9evFZGsmP8A4Q65ItTn+7s/2xzSlsKhf2kPWPY2p1X7dbf6Q2cNhcjnimRiP7Rf/wClNyV3fMPl+WlnMf8AaFn+4PIfnZ04psXl/atQ/wBGPBXnYPm+WqOdfD8vLuRlY/sVmFvH2+YuG3DnrxTVCf8ACTN+/bf9m+7kf3qkV1FlaEWbHLL8uwcdeajVgfFJXyD/AMe338D+9SZor+96PsTbUGnXX+kMV3yZbI+X5jxUkqr5un5mYnedvI+b921MDD7BdYgPDycYHzfMeafO2JdN/ddXPYfJ+7agz1u/n+Q6JVF9ckSsTsXIz0rM0d4x4aib7QVUO/z56/vGrUjP+nXP7o/cXnA+brWXobAeFom8jf8AM/yYH/PRqOpcfg+cfyZpOV/tODM5BMbYTP3veoQqeTqWJixJbcCfu/LVpm/06EGA8oTv4+X2qEn/AEfUT5OMFv8Agfy0zOL2+X5lDVhGbTSMXDbRcRYIb71XwE/tuXLtv+zp8ue25uapatIVs9KIt2/4+Ivl44q6jt/bUg8o/wDHunzcf3m4qTWV/Z/f27or/uV0m/xM2zMgLE9OKuzFPMtf3hzu+UZ+9xVRmb+ytQJgIP7z5OOeKvSyFfI/clixx2+XimjOe/zfbsjPsJIv7c1YCUl8Rbh6fKabMtrJpkYNzJ5fmL8249d1GmyE67q48hgQIucjn5TUwlZdPiItH++PkyP71CNJaTVv7vVdh8gt/t8JaVw4RsDceeRUHmWxt9Q/et9593zHjirrSSfbY/8AR2I2N82RxyPeqxmkFtf4tm4Z/wCJeeOvWhkRvZfLqu5HYvbnStMzIQMR45PJ21eBg+2Nh283ZyuTjFUrOaQaVpeLdjlYx1HHy9etXzJJ5x/0dsbfvZH5daFsKr8T+fVdyrI1q1lIBMxj3ctubg5qC9e3GuacXkYHy5cfMefuVdkkk+ysRasDn7uV9frVa6kl/tqxxbsR5cueV4+570MdPf8A8C6rsSxPb+fdHzG6jdyeOKjEtn/Z8O6VggCYO5varEMspnuM27DBGDuXnj601JZfsUR+zHOF+Xcvt70yf+B1XYcHtftRYSN5u3pubpWdYNaCzvcTNt8+TcdzcfNWr50vmlfsz4xnduX8utUdPllNtdf6K2fPk+XcvPzfWkVD4X8uqLDyWxa3/eN975OTz8ppEa2+0zfvG3cZG5uOKklll82D/R25Y5O4cfKfeljll8+UG3bbxg7hzx9aZn0+XddzJ1T7GdH4lfb5q4O5v+elaTvaGeEmR9+DtG5ueKq6pLIdKYm2YHzF43L/AHx71feWXzYgLdiDnJ3Djj60dTWT91er6rsiNRakTAO/zZ3fM1Ru1pstx5j7Q2F+ZueKsmWXY+bdsjOBuHP61GZpiISbVwS3I3LxwfegyTf9NGNpi6yYb4IdPDGd8ZD9atyf22Hth/xLs554f0NM0xIPJv8A/TGCmd8t5g4q3KIQ9sDesOeP3i88Gix1VJ++9F93kVYl1k3dz/yDcfL1D+lZWpjWT4eO8aaR5qcAP/z1Fb0Ih+13RF6wY7cjzBxx1rG1Rbf/AIRsg6g2BKnPmr/z2FS1ozShP95HRbx6Fy4Gt/2hZ5Om/wAfZ/T60lv/AG6Zb75tNzv/ALr/ANxcd6muBB/aVkRfsSA/Hmr/AHaS2EHnaj/p7n5xn96OPkFFiOb3dlt2/vFBF106fYfvdOH7xc/I/PP1p7DWP+EnT95YA/Zem1v731qWMWv9macDfMFEi7T5g55p+YB4tT/SSXNpwN4/vGixrzu8vdW0ugwJrI0263zWP/LTGEbpzU08esm4sv39luDNn5G5+X60Frb+yL7bduVzIGO/oasz+R9o08GZjydh3dflosYubv8ACuvTyKix6z9uu/39ljy0x+7b/a96p6RHq58PWpjntByDyh6bq10aEX97++bPlJu+bp96qGkC3/4Re1zMwjyMNk9d1FlcpVHyfCt49PJl3Zqf2/Pm2m3yxkbGz1+tVI01P7HqQ861yXkx8h44Fah8saquXbzPK4XJ5GaqoY1sdWIc48yTcc9DtFBlGb7Lp08ylqcWpFtIbzrUbZ13fKeTtNXoRqn2yYNJabcL0Rs96j1PyidGJkYEXC7Bn73ymtBDEL6bDnzNq7lz064phOo+RaLZ9PMyPL1X+x4FEtp5mU52N0zU0qan/a1qfNtAPJkz8h9U96WM240OEiZvJ3L85JzndVucp/bNoC5DeTIQM8HlKVhub5novtdPIydOh1MHVQk1qCZ2Iyh9Ksxx6qbay23FqGwMnyzyMVDppgZNaBmfHnvuOTxxVuAW5tNMPmuQgXYeeflprYurJqT0/DyCOLU/t8x+0223YnHlnOeax9Yi1X/hFrjNzb9P+eZ6bxXRQyRHUrgAt5hjTI56c1jawYF8I3Q3NsHU/N13ilJaBQm/aR0W8eiLk8Wq/bLbF1bAYbP7s+lJFDqpnvf9Lt8krt/ddPlq5cPEb+0JLbsNgYPPFIhtxNfZZ+SN/wB7j5aLGSqS5fhW3ZdyiIdXFnbAXluH3KCfK7VEItT/AOEiIF5Bt+z5I8r/AGqtn7GLK1BZzGHXafm5NRn7OfEpyX3i26fN/eoaNYzfve70f2UCwamLG4zew53vj910G40s8Gpmaw/02LHmHP7of3GqVWtRYXIBfbvfd97+8aLhrbztP5f752/e6eW1OxHPK707/ZXYakGo/bJx9ujxsXH7oVmaPBqX/CNx7L2IPuf/AJZDH+sNbELWpvrjBfdsXPDdKytGNmvhqMSNIE3Pz8//AD0al1NIylybdY/ZXZmi8Gp/bIAL6PZsbcDEOT7VALfUjFf7r+Pb82AIh/d71aka1+2253PnY2B8/Soh9j8i/wBhkyd277/92nYzjJ22/wDJV3KWo22o/Z9N330Zb7RFnEQ/Sri2+of2vJ/pybfIX/lkM/eaq2p/Y/sul5Mm0Txbfv8ANX1Nv/az/f3eQuPvdNzUFynLk27/AGV3RBFFfLYXpnvFcjzOkYx04qWe21Hdb41BfvfNmFeeO1Ru1r/Zd+QXKfvM/e9Ksym0LW+S+d3yff8ASnYzcne9u/2V2MvT7bUf7c1T/iYJjEWMQj0PWrJtNVNmo/tJPN3jnyFx1ptj9l/tzVMF9xEWR83oasgWAtFwZPL3gZy/XNJI0qVJcy06R+yuwNaah9qjI1L5QpyPIXPaqrWeom2v86mOS+P3C+ner7/ZRdJnzN+04+/7VWk+yC2vQ3mfebP3/SixnCctNO32V3Ktlaah/ZemY1LHyx5HkL029K0Daah53/IUITb93yFzmqdk1mNK0zPmYxHj7/XbWgv2Q3JI3+Zt5+/0oS0HVnLmenf7K7laW11I2zH+1AG9fIXHWq9zZ6h/a9jjVD9yXJ8heny1cc2P2WT/AFnl5Ofv+tVrl7MazYD95kpLj7/+zQ0OnKV9u/2V2JYrTUfPnB1Q4yMfuE9KatpqIsov+Jqc4XP7hPapYfsYubr/AFmSRu+/6Ui/YhYQ58zZ8uPv+1FieeV9u32V2FNnqPn5GqkJt+75CZzVKwtNR+z3ZGqnPnvj9wnrWp/opuOkm/b/ALfSqditn9nu22vt85933+eadgjUlyvTt9lD5bPUPMg/4mh4bn9wn9009LS/82TOpHHGP3KelSubZJLf7+d3y/e/umlT7OLib7+7A3fe6YosRzytt0/lXcy9Ts9R/sw/8TQ5Ei5/cpz84q+9pf8AnREamwABBHkpzVPURbJoxwshXzFwPn/56Vpv9nNxDkOXwdv3umKLFynLlWnV/ZXkQra3wWTOpEnnH7leKa9rfbYR/aZzuGT5K88GpwLULPtDgc7+G9KaVtfKtsK+zcNn3uOKLGanLt/5KirpDo0WoZtmAFw/y7fvVbmZA9r/AKMxyf7n3eDVXSFuDFqA8yPzDcPtO3gdPer0izb7cCSPIPzZXrwenNMdVr2j/wCD2IoWT7bdD7O3G35tnXjpWLqrxjwuxFo/+uX5dn/TYVtwrcfbro74tny4G05zj61j6mLoeF2/exbxKnOz/psPepexrQt7SPrHuX7mRf7SscWj9H52Dj5elLbSDztQP2NuHGPlHzfIKdcrc/2hY/vYsfPn5OT8v1otI7vztQ3zoSXGz5OnyCgi65fl5/zFRXxplhmyYnzE4wPl+agO58Wp/oxA+yfe44+Y1LHDc/2bZA3SqwdcnYOeajMVz/wliEzgp9kx9wf3qGapr3ttpdyUM39l3pFoRzJ8vHNWLh3FzYf6MSSW7j5flqARzjTL4m6DElyp2j5frU88cv2iy/0jnLZO0c/LRcxdr9OvfsCPJ9uvP9Hx+7TByPm+9WfpEkv/AAjFqfs2Tx8uR/e61oJHIb67H2k58tMfKvH3vas/S45v+Eatv9Kw3rtXH3qXUtW5em8e/ZmqWcamAISV8r7+Rxz0qsGYWWp/uejycZHPy1Y8uT+0gfPbaIvu4HPNVQr/AGLVMzn78mOBx8tBlG35d+5FqzN5mifuc5uF5yPl+U1oxyOb+YeRgBV+fI+brWbqqyZ0bE5x9pTPA5+U1fiST+0Zz5527FwuBkdaEVNL2a9H37lISSDRIWa1JbcvyZH96rsjv/aduPJyPKkOcjjlKqiOZdHhU3I37l+faMfeqxKj/wBq2379seTJxgc8p7Uwla72+137FHSmk3awBbnJnb+IfNxVqGWYWmn4tichQfmHy/LVbS4pc6uPtPzGdsHA+XjvU0UU5s9PK3ZHCbvlXn5fpSRdSzk9unfsWY5Zvt8y/Zjt2L824c9aytZeU+FbnNv26bh/fFakUcv9oTD7UxGxPl2r789KytYjdfCtzuumYY64UD749qJbBQt7SO28e5r3Ekv2y2xASMNk7hxxRA8purvMGACuPmHzfLROkn222xOwHzcYHPH0oiRzc3YE7Dlew+X5aZhpy9NvPuIHmFrFi1JO4fLvHHNVTJMPEfFtlfs33tw/vVZMcptYcXjA7hl9q88/Sq4SX/hISv2nj7PnG1c/e+lNmkLe9ts+5Kjz/YZ/9G53yYG8c/MaWaWYS2ObbkyH+McfI1J5cv2G4xdnO58Havy/Mfaknil87T/9KY/vDn5V5/dt7UugtLvbr37EqSTfbpx9n+XYuDuHPWsnSXnbwygS23He/G4f89WrSSOX+0LgfbGHyL8u1eOvtWTo0cv/AAjEZW+KfO/O1cf61vajqawS5Om8e/Zm28k/2uD/AEbja2TuHFRtJL9nvswYxuI+Yc/LRIHF9br9sblG+XC/N79KiKMIb8/bSc7uML8vy/SnoYpLTb8e5Bqks/2bTD9n5+0RZG8VeV5P7Uk/cnHkrzuH95qztUVza6Xi+PNxF82F5/Sr8auuqyBrkn9wvBCg/ebnpSNJpezW3Xv3RG0kx06+zb8/vONw54q1JJPmDFvxu+b5xxxVMhzpl/8A6USR5nzYXjj6VbnV824+0kHd6L83H0pmckr9OvfsUbB5hrmqZtyBiLB3D0NXlkuBAP8ARcMG+7vHrVOwjca5qf8ApRY7YvlwvHDe1W9r/Z/mvTncPnwvr06UDq25lttHv2Q95ZxcIBb5TacneOOlVzJP9mvM256tj5xyMVOyOLmPN0QNp+XC89Paop4pBbXZ+1MMhiOF+Xj6UERtpt+Pcr2kkx0zTP8AR+cR5+ccfLV8yz/aNv2f5Nv3t4rOtFcaTpebsjiPJwvPy9OlX8H7Vxd87PuYXPXr0oVrF1UuZ7de/cb5s5tnJtsNuPG8etVrqSb+2bDFvkbJed44+7UmMWsoN+D8x+f5eOagvP8AkM6eTebfkl4+Xn7tJ2HTS5nt179i/G8vnT/uOMjB3Dnio0eU2MP7n5sJxuHHSkjYCe4zeDqOMr8vFMVlOnw4vVXhPnyvPSndGfL5du/YuF5fNwIspjruHWqFhJOba8LQYYTvtG4c81bDp5+ftg6fcyv51Rs3QW15vvF/1z/Nlfl5ouhwj7r07dzQd5fMh/dcbjn5hxwaVGfz5QY/lGMHPXio5ZYxJBm5QDcerD5vlNJHPF9on/0lM8cbhxxRdEcrtt08+5V1J5jpLHyxv8xcjd28wVoMZDLFhBs53EnkVk6hJENGKm9TiRfm3Lz+8rReeDzoibtBwfl3r81K5pKL5dur7+RPmTbJ8gyM7eetRlptsH7td5YbxngDHao/Pg2zD7ZGc5/jX5eKYJ7cQ26i9jOCPmMi/NxRoZqD7fmY2k2Onm11M5lMYnfcdzcVeuLGw/0EMZQCfkw7c/LTtJeXytQPkDcLh8Lu+90q3K82+0xbqcnn5/u/KaDpq1Z+0er+/wAjOh0/T/t90v7/AHgLkbn6YrG1Ww03/hGHbdNt81Ru3N/z1Ga6mGSf7bdD7ONo24bf1OOlZN+058Mtm3UN5q/Lv6/vhUtaG1CtNVI+8949Rk+maWmp2GBNnD4G5+Rtp9pZ6YZdQAE5AbDDL8DaK0LmWf8AtOxH2Ychznf0OOnSkt5LoXGoH7Kv3xj951+RfanoQ6s3HWT2/mX8xkJp+lrptiTHNgyLgkvzzSSafph8UxoYpc/ZSdv7z+91rRjkuv7Nsv8ARUJ8xcjzOnP0ppkuf+ErXNsuPsnXzP8Aa+lJo0VWpeXvPaX2igNO0n+y74iGUgM+f9ZVmXT9J8+xxby7STjiT+7VsS3X9nXmbVM5kwPM6/pU88t19ps8WyZy2f3nTj6U7Ih1ql/ifX7XkZiabpIvrv8A0eXiNc8Sf7VUdNsdJbw1bsbeRhkc4k67q6JJLn7Zcn7MmdiY/edfve1Z+lS3Q8N2+y2QsRjHmY/i+lFlcqNapy/E94/a8mOax0r+0ADbvu8vj5ZPWqo0/S/sOpn7O+A8mch/7tbRkuftwxbLjy+T5nTn6VV825+xalm2QHdJj95/s/SixnCrU/mfT7XmZeo2Gm50bZA4zcLjh/7prQisdLGoz7YH8zYu7h/ek1KS5xpH+jrzcJu/edPlNXopLk38wa3QKEXB8zr19qaWo51J8i957P7XmYn2DSRo6bYJCm8ZJEmfvValstLXVbYeQ+4xSY+V/VKnE12dJjJtkLbhx5nH3vpVmWSf+1Lb9wuPKkyd/TlPaiwSqzu7yf2vteRhaTYaS8mrBreRlFw2eJOmOlWorDSRY2O+1fBC4+WTjip9GlufO1Um2QYuGx+868D2qzHJcG0sStsh4TOZMY+X6UJKxVWrU537z6fa8ipDp2ktfTBbV94RckrJ05rL1fTtKHhe6aO2cDHPD/3hXTpJcfapc26hdq4PmfX2rM1l5v8AhGLkvCobHTfn+IUmlYVGtU9pH3nvH7QsumaULy3T7M24hscP6UR6XpQnus2zdRnh/StKZpftlv8AuhjDfxe1JFLP59yPJXgjHz9ePpVWRj7apb4nt/N5maNO0c2kRNq+wkYGJOuarHTdKHiLYbZt32fPR/WtoSTm1iYW6bty5Xf05qvvnHiDAhXabfk7+fvUNFwrVPe957P7RTOnaT9jnP2VsBnz8sn940XGn6X5un4tnwZDj5ZOmxq1S8xs5SIl3ZfALcdTTZnn8yy/crnec/P0+RqVkSq07v3n1+15GamnaT9uuAbV9wRSflfpzWZotlpbeF42ktWILPxtf/nocV00TTfb5/3S7di4O/61maI8/wDwja7YVJ3Scb/+mjUrK5tGtPk+J7x+15Me9hpY1C2AtW3bG2na/Apq6fpnkX+y16bs/K3Py1pymf7dbnyk2bWz83INNLTGG9zEgxu24br8veqsYKrOy95/f5mLqdjpq2umEWhAM8QA2tkCtBdPsW1R82/PkryQ395qTVTP9m03Eab/ALRFuG7gVfUv/acg2jHkrznvuapsVOrPkXvPr180ZLWOnDTL8i2IUeZkYb0q1cWGn7rTdbE5b5DhuOKlcynTr75F3/vMDPtVmcy7rfCL9/5uenFUTKrO/wAT69fIxrCxsDrupqIDuCxZOG9Gq0+n6WLXm1Plbh8uG65p9g0h13VAyKFCxYOeTw1Wy1z9mBEUfm7vu7uMZo0HVqz517z2j18kVnsNPa4jVrYlsHBw2B0qA2Vh9nvcW5GCwbhueK1SZPPTCLs2nJzzmoJPNFvd5Rf4tuD1GO9BlGrP+Z/f5mXaWNgdK00/ZsqRHxhuu2ro0+wF3gWuH2Z3YPTNFp5h0vTPlXdiPcM9Plq7mT7Vgqvl7eDnnOaSLqVZ3fvPr18zNNhpptJCbL5NxypQ8nNV76wsF1nTQ1qDlJcYUnH3a2AZzbvlY/NycDPHWoLnf/a9jhV27JNxJ5H3elDCnWnzP3n16+RBFYWHn3P+iDIIydp54pqWGnnToD9kXYdmF2njpWjH5nn3GQuzjb69O9NjEosodoXfhcjt2zTI9rP+Z9OvkQnT7L7SP9ETft+/t4+lUbG1sza3260BQTyAgr157VtfP5v8Pl4/HNUdO84QXZYR7/Pk24zjr3pDhUlyvXt1Feys99tm1XJb5cr935T1ojs7M3U+LVN3y5YqMHirb790P3fvfN+R6UIH86XO3bxj16UGftJW36d/Mw9StbNNFObJSvmqAoQcfvK0ntLUzw5skLAHDbB8o9Kh1ITnSm2+UG8xcgg4/wBYKvN9o86PBj8vndwc5oNpVJcu/V9X5FZba0xORYgdd37sfN9KY1rZtFb/AOgLtLDC+WPl471cH2n95kw9fkwD+vNNIuCsWWiD5+bg46duaDNTff8AFmfpUcixaj/pEhPnvg4HHH0q28cjfY8XEgIPPA+b5fpRRVJFVJPnb/rYIYZPtdyftEm07cDA44+lZGrwTJ4acC6k3CROcD/nqPaiioezLoTftY+sTQuLeX+0bH/S5cYcEYXnj6U63t5vOvh9rl5cYOF4+Qe1FFCM+d8vy7L+YrJbzDTrMfbJs+YuThefm+lRNBL/AMJYg+1S4+yZ6L/e+lFFN9DaM3eXpLoiwbeVdMvAbuYnMhzhf8KsTW0v2i0/0qbIJycLzx9KKKDJ1Hf7+i7Cpby/bbk/apeY0xwvH3vas3SLeVvDNti6lBxnOB/e+lFFLqXGb5H6x6eTNMwy/bxi5lx5fIwvPP0qqYZPsGpA3MnLSc4Xj5fpRRTZEJvT5fmQ6nBJnRv9Jl4uEzwOflPtV9LeT+0Jm+1S4KLxheOvtRRQipzfIvR/mU4reVtFiBupclgd2Bn730q1NDJ/a9qftEuBDLxgc8p7UUUClN8z/wC3vyK2kQP5uqj7RLlp2weOOB7VatreR7Gy/wBJlBVVJIA54+lFFCFWm+Z/L8idY3+1ynz5MbVwMDjr7Vla3C//AAjV0pnkJI68cfMPaiiiWw6En7SPrE05o3+2W3758fN6c8fSkihb7RdnzpPmK46cfL9KKKZlzPl+X6iLA4s4l8+XIK/Nxk8/SoDC/wDwkIfz5MfZ8beMdfpRRQVGbvL5k4hb7JOvnyfMznPHHJ6cUlxG4m0/98/Ehz05/dt7UUUhKTu/n+QsUTf2lct50mCijHGB+lZejwsfCyoJpAQ8nzDGf9a1FFLqbRk+T5x/JmtJE3262bzX+VW44waYIysWoHzHO4see3y9qKKoxUnp/XUr6kha100F2yJ4ue5q4q/8TSRsn/UqMdvvNRRSLk/c+/8ANEMiEadfje2T5hz6cVZnXL253MMP+fFFFMzb1+/8inYpt13U23MdyxcHoOGq75JNv5fmSA5+8Dz1oopDrSfMvSP5IlZcyK2TwDx+VV5UxbXeGb5gx+nHaiigzi9StZxn+ytNXe3AjOe5+WruzF3v3NymMdutFFC2LqN8z+ZG8GbWSPzJPmJO7PI5qvdRk6vpx3thEl4z977vWiihjpyfN8n+RZjj/f3JLP8AMR36cdqasI+wwpvf5QnIbk9KKKaJ5nf7icxjzQ25umMZ4rP0+BRbXi7nw0787uRz2oopLccJPlfyLskQLwnc/wAp/vHng9aSKIC5mO5+dvG4+lFFBHM7f13M/VLZW0hl3yDEinIc5/1grQeBTNE26T5QRjccHiiin1NZSfKter/QcYFw/wA0nzf7Z4qJrVDHAu+XCHP3zk8d6KKDJTl3P//Z);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Normal rhythm strip in lead II. The PR interval is 0.15 sec and the QRS duration is 0.08 sec. Both the P and T waves are upright.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Morton F Arnsdorf, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_62_10213=[""].join("\n");
var outline_f9_62_10213=null;
var title_f9_62_10214="Standard biliary sphincterotomy technique: The cutting edge";
var content_f9_62_10214=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"1\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Standard biliary sphincterotomy technique: The cutting edge",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/62/10214/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/62/10214/contributors\">",
"     Priya Jamidar, MD, FACG, FASGE",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/62/10214/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/62/10214/contributors\">",
"     Douglas A Howell, MD, FASGE, FACG",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/62/10214/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/62/10214/contributors\">",
"     Anne C Travis, MD, MSc, FACG",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/62/10214/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Dec 3, 2012.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Approximately 150,000 patients undergo endoscopic biliary sphincterotomy every year in the United States. Biliary sphincterotomy refers to the cutting of the biliary sphincter and is typically carried out during endoscopic retrograde cholangiopancreatography (ERCP). The principal indications for sphincterotomy include removal of common bile duct stones, treatment of papillary stenosis, and facilitation of endotherapy (ie, stent placement, tissue sampling, and stricture dilation).",
"   </p>",
"   <p>",
"    Sphincterotomy is a technically complex procedure that is performed under visual and fluoroscopic guidance. Deep cannulation of the bile duct is followed by electrocautery to incise the sphincter of Oddi. This topic review will focus on the technique of endoscopic biliary sphincterotomy. Its clinical applications and complications are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/49/39705?source=see_link\">",
"     \"Overview of indications for and complications of ERCP and endoscopic biliary sphincterotomy\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     SPHINCTEROTOMES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sphincterotomes (also known as papillotomes) are available with a number of different configurations, which can be broadly categorized as pull, push, and needle-knife. Several modifications are available within each category that are designed for specific clinical settings or anatomic variations. This topic review will focus on the most commonly used sphincterotome (the Erlangen or pull-type version), which consists of a wire-loop partially enclosed in a Teflon catheter. The wire exits the catheter about 3 cm before its distal end and reenters the catheter about 3 mm from its tip. The portion of the catheter distal to the reentry point is referred to as the \"nose\". When the wire is tightened, the tip of the catheter is bowed so that the exposed wire is brought away from the catheter. There are also sphincterotomes available that can rotate (Autotome Rx, Boston Scientific, Natick, MA) and may facilitate better sphincterotome and cutting wire orientation.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Nose length",
"    </span>",
"    &nbsp;&mdash;&nbsp;Pull-type sphincterotomes are available with long and short noses. Compared with the long-nosed devices, the short-nosed devices are more responsive to bowing, provide more control during sphincterotomy, and often do not require deep cannulation before the cutting wire exits the endoscope. However, they are more likely to become inadvertently dislodged from the bile duct. With the widespread (nearly universal) use of multilumen sphincterotomes and over the wire sphincterotomies, the long-nose devices are now rarely used.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h2\">",
"     Diathermy wire",
"    </span>",
"    &nbsp;&mdash;&nbsp;Another variable distinguishing sphincterotomes is the length of the exposed wire, which ranges from 15 to 40 mm. Devices with longer wires follow the natural curve of the endoscope and elevator, and are more likely to enter the papilla in the correct orientation. However, the longer length of wire may not always be an advantage since the ideal transfer of energy occurs when a short segment of cutting wire is applied to sphincter tissue. The most commonly used cutting wires are 25 and 30 mm long. To limit contact of the cutting wire with the endoscope channel, one sphincterotome has insulation covering the proximal one-half (CleverCut, Olympus).",
"   </p>",
"   <p>",
"    The diathermy wire can be either braided or monofilament. Most endoscopists prefer the monofilament wire, since it provides a cleaner incision.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Number of lumens",
"    </span>",
"    &nbsp;&mdash;&nbsp;The development of multi-lumen sphincterotomes has been a major advance; double and triple lumen sphincterotomes are available. In the case of the former, contrast can be injected via the second lumen, which can also be used for guidewire placement. With the triple lumen variety, contrast can be injected without removing the guidewire. A cannulation catheter can be exchanged for a sphincterotome over a guidewire with duct access maintained throughout.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     GUIDEWIRES",
"    </span>",
"    &nbsp;&mdash;&nbsp;Guidewires used for sphincterotomy must be electrically nonconductive. Teflon-sheathed, rather than Teflon-coated, guidewires are preferred since they may be less likely to short-circuit as a result of surface imperfections [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10214/abstract/1\">",
"     1",
"    </a>",
"    ]. However, a theoretical concern about most metal-core guidewires is that they have the potential to produce unacceptably high current levels when damaged [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10214/abstract/2\">",
"     2",
"    </a>",
"    ]. Despite this concern, there has been no convincing evidence that non-wire guided sphincterotomy is safer than wire-guided sphincterotomy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10214/abstract/3\">",
"     3",
"    </a>",
"    ]. Wires commonly used for sphincterotomy include the regular, inexpensive Teflon-coated guidewire, the basic Teflon-sheathed wire (glide wire), and other more expensive Teflon-sheathed wires (eg, Jaguar, Dream, Visi-Glide and Metro) that are easier to use for stent placement compared with the glide wire because of their stiffness.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h1\">",
"     ELECTROSURGICAL GENERATORS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electrical current is applied to the diathermy wire via a standard electrosurgical cautery generator. Sphincterotomes are usually monopolar, thereby requiring grounding pads to complete the electrical circuit. High frequency electrical current can be applied either as pure-cut, pure-coagulation, or a blend of the two. Pure-coagulation current during sphincterotomy may increase the risk of pancreatitis, while pure-cut current appears to be associated with a higher rate of bleeding. As a result, most endoscopists blend cutting with coagulation current. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/63/28666?source=see_link\">",
"     \"Post-ERCP pancreatitis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    High frequency current is required for sphincterotomy. It is typically delivered by conventional generators (electrosurgical units; ESUs) that use constant wattage (eg, Valleylab, Olympus). A potential problem with these devices may occur from variations in voltage, which cause changes in thermal effects. As the wire coagulates the tissue, the tissue resistance rises. It is important to appreciate that voltage is the primary determinant of thermal damage. From Ohm's law:",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; P = V x C (power = voltage x current)",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; C =",
"    <span class=\"nowrap\">",
"     V/r",
"    </span>",
"    (current =",
"    <span class=\"nowrap\">",
"     voltage/resistance)",
"    </span>",
"   </p>",
"   <p>",
"    &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; &nbsp; Thus P = V x",
"    <span class=\"nowrap\">",
"     V/r",
"    </span>",
"    or r x P = V (2)",
"   </p>",
"   <p>",
"    These equations illustrate that with conventional (constant power) ESUs, as resistance rises, so does voltage. These units deliver low voltage at low resistance (such as during the start of the cut or open-air activation), and high voltage at high resistance. This explains how a \"zipper cut\" may occur. Resistance continues to rise at a local point in contact with the wire. The ESU delivers higher amounts of voltage while tension is applied to the diathermy wire by bowing the sphincterotome. When the wire breaks through, there is a very short period when the wire is cutting through low resistance tissue at high voltage, potentially leading to a runaway cut.",
"   </p>",
"   <p>",
"    These principles also illustrate how excessive thermal injury may occur. As mentioned above, current is equal to the voltage divided by the resistance, so resistance is inversely proportional to current while voltage is directly proportional. If voltage is constant (see",
"    <a class=\"local\" href=\"#H9\">",
"     'ERBE generators'",
"    </a>",
"    below), then as resistance rises, current falls off. The current level must be high at the start of the cut to establish the electrical arcs needed to cut tissue. As the cut proceeds, the current should decrease. However, with conventional units, the voltage variation that accompanies these factors can cause excessive coagulation (thermal injury). A greater degree of thermal injury occurs at higher voltages with conventional units.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Author's setting preferences for conventional generators",
"    </span>",
"    &nbsp;&mdash;&nbsp;A randomized prospective study found that a pure-cut current was associated with a lower frequency of pancreatitis compared with a blended current [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10214/abstract/4\">",
"     4",
"    </a>",
"    ]. No difference in the relative risk of bleeding was reported, possibly because of an insufficient number of patients studied.",
"   </p>",
"   <p>",
"    We perform the first third of the sphincterotomy with the generator in the \"cut\" setting, the middle third with blended current, and the final third using coagulation current. The rationale for the above is as follows: The risk of causing pancreatitis may be highest during the initial portion of the sphincterotomy, whereas the risk of causing bleeding may be highest near the apex of the sphincterotomy (because of the proximity of the pancreatic orifice and blood vessels, respectively). The cut setting is used initially to rapidly (and presumably with minimal thermal injury) cut away from the pancreatic orifice. Blended current is used for the middle portion of the cut since, at this point, the risks of pancreatitis and bleeding may be lowest. The sphincterotomy is completed with coagulation current because at this point, the risk of bleeding is highest. The above recommendations are based upon our experience. Many experts perform the entire sphincterotomy using the blended current setting only. In addition, many endoscopy units (including the author's) now perform sphincterotomy solely using the ERBE generator instead of standard ESUs. (See",
"    <a class=\"local\" href=\"#H9\">",
"     'ERBE generators'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h2\">",
"     ERBE generators",
"    </span>",
"    &nbsp;&mdash;&nbsp;The ERBE generator (ERBE USA Inc, Atlanta, GA) accomplishes its tasks by using constant voltage rather than constant wattage. Unlike conventional electrosurgical generators, it does not permit voltage to build and wane in response to changes in tissue impedance. The wattage is adjusted up to 1100 times per second. Since voltage is the principal determinant of thermal injury during sphincterotomy, the ERBE delivers more predictable and reproducible cutting effects and less overall thermal injury.",
"   </p>",
"   <p>",
"    The \"endocut\" mode delivers energy with fractionated, intermittent pulses of current, resulting in cutting with hemostasis. The generator automatically turns on and off so that the cut takes place in short stages. It has been hypothesized that the continuous, controlled interchange between precise cutting and coagulation may decrease the incidence of bleeding, since overly rapid cutting does not take place. Some experts believe that the incidence of pancreatitis and perforation may be decreased since excessive coagulation is avoided [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10214/abstract/5\">",
"     5",
"    </a>",
"    ]. Although a similar process can be achieved by intermittently pressing the foot pedal, this method provides relatively little control over the length and effectiveness of cutting [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10214/abstract/6\">",
"     6",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Some studies suggest a possible advantage of the ERBE generator [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10214/abstract/7,8\">",
"     7,8",
"    </a>",
"    ] over conventional generators. A randomized study involving 100 patients found the risk of bleeding was less with ERBE than with a conventional unit [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10214/abstract/7\">",
"     7",
"    </a>",
"    ]. There was no difference in incision length or pancreatitis. However, abrupt opening of the papillary roof was more frequently observed with the conventional generator than with ERBE. In a large study of 2711 consecutive sphincterotomies (1218 using the Valleylab generator and 1091 the ERBE generator), there was an increase in endoscopically observed bleeding with the Valleylab generator. No significant differences were noted in terms of clinically evident bleeding or pancreatitis between the two groups [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10214/abstract/9\">",
"     9",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In a meta-analysis of four prospective randomized trials comparing pure current with mixed current (endocut or blended), there was no difference in the rate of pancreatitis, but there was significantly more bleeding in the pure current than in the mixed current group [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10214/abstract/10\">",
"     10",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h1\">",
"     ENDOSCOPIC TECHNIQUE",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H340759449\">",
"    <span class=\"h2\">",
"     Standard anatomy",
"    </span>",
"    &nbsp;&mdash;&nbsp;Deep cannulation is a prerequisite prior to sphincterotomy, though in some cases a precut papillotomy may be required to gain access to the biliary tree. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/10/25767?source=see_link\">",
"     \"Precut (access) papillotomy\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/5/7254?source=see_link\">",
"     \"Precut sphincterotomy: Another perspective on indications and techniques\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Care should be taken not to overfill the biliary tree because of the risk of sepsis if bile is infected. Glucagon rather than air insufflation should be used to diminish duodenal motility.",
"   </p>",
"   <p>",
"    Sphincterotomy is commonly performed with the endoscope in the short-position, although the long-position is preferred by some. Bowing of the sphincterotome is usually required to force the wire upward toward the roof of the papilla. This maneuver can be facilitated by using the elevator and the up-down deflecting knobs. However, the short scope position together with the tendency of sphincterotomes to twist in a clockwise direction while bowing may result in unsafe conditions. Ampullary distortion may result in increased area exposure and excessive coagulation. The position of the papilla combined with the clockwise rotation of the wire tends to send the cut in the pancreatic direction, \"the 2 o'clock position.\" This can be corrected by adjusting the",
"    <span class=\"nowrap\">",
"     left/right",
"    </span>",
"    <span class=\"nowrap\">",
"     (L/R)",
"    </span>",
"    knobs and twisting or torquing the scope to the left, but it is most effectively corrected by assuming a semi-long scope position. In this position, minimal bowing is necessary and the incision can be observed from above.",
"   </p>",
"   <p>",
"    A sphincterotomy should be created between the 11 and 1 o'clock position. Following deep cannulation, the endoscopist can withdraw the sphincterotome, tailoring it to the incision length. Generally, about one-half to two-thirds of the wire should be visible in the duodenum. It is important that the sphincterotomy be performed without too much wire in the papilla to prevent an uncontrolled \"zipper cut\" and resulting retroperitoneal perforation. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Electrosurgical generators'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    The sphincterotomy length should be tailored to the indication and to duct size and local anatomy. The incision should be directed along the longitudinal axis of the intramural segment of the common bile duct and should never be continued beyond the junction of the intramural segment of the bile duct and the duodenal wall. This landmark is identified by locating where the superior margin of the bulging impression of the intramural bile duct meets the duodenal wall. Relying on the horizontal fold to denote this landmark may be inaccurate, and these folds can often be transected without consequence. A 75 percent bowed sphincterotome or an inflated stone balloon can be used to assess sphincterotomy size. Both of these devices should be able to move easily in and out of the orifice if an adequate sphincterotomy has been created.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Billroth II",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sphincterotomy in patients who have undergone a partial gastrectomy with Billroth II anastomosis poses a special challenge. However, in experienced hands, it is usually successful [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10214/abstract/11\">",
"     11",
"    </a>",
"    ]. Since the papilla is upside down, the bile duct is cannulated by orienting the catheter downwards in the six o'clock position. There are two major techniques for performing sphincterotomy in this situation. The first involves stenting the bile duct and then using a needle-knife to cut over the stent. The incision is continued along the stent towards the junction of the intramural segment and the duodenal wall (in the six o'clock position). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?5/18/5415?source=see_link\">",
"     \"ERCP after Billroth II reconstruction\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    A reverse sphincterotome can also be used. These sigmoid loop sphincterotomes are designed so that the diathermy wire is oriented towards the six rather than the 12 o'clock position. However, in practice, reverse sphincterotomes often do not orient correctly. Thus, we prefer the freehand technique described above. In addition, some endoscopists report success using the rotatable sphincterotome. (See",
"    <a class=\"local\" href=\"#H2\">",
"     'Sphincterotomes'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    In difficult cannulations, a needle-knife fistulotomy can be created with subsequent antegrade passage of a guidewire across the ampulla. The fistulotomy can then be extended using a wire guided sphincterotome [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10214/abstract/12\">",
"     12",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Periampullary diverticulum",
"    </span>",
"    &nbsp;&mdash;&nbsp;Sphincterotomy may be more difficult in presence of a periampullary diverticulum [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10214/abstract/13\">",
"     13",
"    </a>",
"    ]. The incision can usually be continued to the edge of the diverticulum. However, the size of the sphincterotomy may need to be limited since it is sometimes difficult to visualize the incision. When the papilla and bile duct are located within the partition (ie, a pantaloon diverticulum), it is usually possible to visualize the whole papilla during sphincterotomy, permitting a larger incision.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H340759396\">",
"    <span class=\"h1\">",
"     SUMMARY",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Biliary sphincterotomy refers to the cutting of the biliary sphincter and is typically carried out during endoscopic retrograde cholangiopancreatography. The principal indications for sphincterotomy include removal of common bile duct stones, treatment of papillary stenosis, and facilitation of endotherapy (ie, stent placement, tissue sampling, and stricture dilation). (See",
"      <a class=\"local\" href=\"#H1\">",
"       'Introduction'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Multiple sphincterotomes are available that vary in configuration, but the most common consists of a wire-loop partially enclosed in a Teflon catheter. (See",
"      <a class=\"local\" href=\"#H2\">",
"       'Sphincterotomes'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Sphincterotomy is performed by cannulating the papilla with the sphincterotome (often over a guidewire) and then applying electrical current to the sphincterotome wire. High frequency electrical current can be applied either as pure-cut, pure-coagulation, or a blend of the two. Pure-coagulation current during sphincterotomy may increase the risk of pancreatitis, whereas pure-cut current appears to be associated with a higher rate of bleeding. As a result, most endoscopists blend cutting with coagulation current. (See",
"      <a class=\"local\" href=\"#H7\">",
"       'Electrosurgical generators'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10214/abstract/1\">",
"      Johlin FC, Tucker RD, Ferguson S. The effect of guidewires during electrosurgical sphincterotomy. Gastrointest Endosc 1992; 38:536.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10214/abstract/2\">",
"      O'Brien JW, Chen SL, Connolly R, Libby ED. Current induction in a fiberglass guidewire compared to conventional wires during simulated papillotomy. Gastrointest Endosc 1997; 45:493.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10214/abstract/3\">",
"      Sherman S, Uzer MF, Lehman GA. Wire-guided sphincterotomy. Am J Gastroenterol 1994; 89:2125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10214/abstract/4\">",
"      Elta GH, Barnett JL, Wille RT, et al. Pure cut electrocautery current for sphincterotomy causes less post-procedure pancreatitis than blended current. Gastrointest Endosc 1998; 47:149.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10214/abstract/5\">",
"      Haag R, Cuschieri A. Recent advances in high-frequency electrosurgery: development of automated systems. J R Coll Surg Edinb 1993; 38:354.",
"     </a>",
"    </li>",
"    <li>",
"     Grund KE, Farin G. New principles and application of high frequency surgery, including argon plasma coagulation. In: Annual of Gastrointestinal Endoscopy, 10th ed, Rapid Science Publishers, 1997.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10214/abstract/7\">",
"      Kohler A, Maier M, Benz C, et al. A new HF current generator with automatically controlled system (Endocut mode) for endoscopic sphincterotomy--preliminary experience. Endoscopy 1998; 30:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10214/abstract/8\">",
"      Norton ID, Petersen BT, Bosco J, et al. A randomized trial of endoscopic biliary sphincterotomy using pure-cut versus combined cut and coagulation waveforms. Clin Gastroenterol Hepatol 2005; 3:1029.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10214/abstract/9\">",
"      Perini RF, Sadurski R, Cotton PB, et al. Post-sphincterotomy bleeding after the introduction of microprocessor-controlled electrosurgery: does the new technology make the difference? Gastrointest Endosc 2005; 61:53.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10214/abstract/10\">",
"      Verma D, Kapadia A, Adler DG. Pure versus mixed electrosurgical current for endoscopic biliary sphincterotomy: a meta-analysis of adverse outcomes. Gastrointest Endosc 2007; 66:283.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10214/abstract/11\">",
"      Forbes A, Cotton PB. ERCP and sphincterotomy after Billroth II gastrectomy. Gut 1984; 25:971.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10214/abstract/12\">",
"      Al-Kawas FH, Geller AJ. A new approach to sphincterotomy in patients with Billroth II gastrectomy. Gastrointest Endosc 1996; 43:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10214/abstract/13\">",
"      Vaira D, Dowsett JF, Hatfield AR, et al. Is duodenal diverticulum a risk factor for sphincterotomy? Gut 1989; 30:939.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 640 Version 3.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0604-61.55.141.10-3C5F28D7A6-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_62_10214=[""].join("\n");
var outline_f9_62_10214=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H340759396\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      SPHINCTEROTOMES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Nose length",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      Diathermy wire",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Number of lumens",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      GUIDEWIRES",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      ELECTROSURGICAL GENERATORS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Author's setting preferences for conventional generators",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      ERBE generators",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      ENDOSCOPIC TECHNIQUE",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H340759449\">",
"      Standard anatomy",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Billroth II",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Periampullary diverticulum",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H340759396\">",
"      SUMMARY",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/18/5415?source=related_link\">",
"      ERCP after Billroth II reconstruction",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/49/39705?source=related_link\">",
"      Overview of indications for and complications of ERCP and endoscopic biliary sphincterotomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/63/28666?source=related_link\">",
"      Post-ERCP pancreatitis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/10/25767?source=related_link\">",
"      Precut (access) papillotomy",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/5/7254?source=related_link\">",
"      Precut sphincterotomy: Another perspective on indications and techniques",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_62_10215="Infiltrating UC IHC";
var content_f9_62_10215=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F69785&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F69785&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 535px\">",
"   <div class=\"ttl\">",
"    Infiltrating urothelial carcinoma: immunohistochemical features",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 515px; height: 201px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Cords and individual urothelial carcinoma cells infiltrating muscularis propria showing diffuse, strong cytoplasmic reactivity for CK7 (A, 20x), and CK20 (B, 20x).",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Cristina Magi-Galluzzi, MD, PhD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_62_10215=[""].join("\n");
var outline_f9_62_10215=null;
var title_f9_62_10216="Pulmonary LAM PA";
var content_f9_62_10216=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PULM%2F75498%7EPULM%2F56652&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PULM%2F75498%7EPULM%2F56652&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=3\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Pulmonary lymphangioleiomyomatosis",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 334px; height: 362px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior roentgenogram in a 37-year-old woman with pulmonary lymphangioleiomyomatosis shows normal lung volume and difficult to see cystic changes in all lung zones.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Robert S Crausman, MD and Talmadge E King Jr, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
" <div class=\"graphic2\" style=\"width: 1040px;\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Lymphangioleiomyomatosis in a young woman",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 357px; height: 351px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Chest radiograph shows hyperexpanded lungs permeated by fine reticulonodular opacities. The right pleural effusion is due to a chylothorax.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Paul Stark, MD.",
"    </div>",
"   </div>",
"  </div>",
"  <div class=\"figure\" style=\"width: 450px\">",
"   <div class=\"ttl\">",
"    Normal chest radiograph",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 371px; height: 324px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Posteroanterior view of a normal chest radiograph.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Carol M Black, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_62_10216=[""].join("\n");
var outline_f9_62_10216=null;
var title_f9_62_10217="Wernicke's encephalopathy";
var content_f9_62_10217=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"3\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Wernicke's encephalopathy",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/62/10217/contributors\">",
"     Authors",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/62/10217/contributors\">",
"     Michael E Charness, MD",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/62/10217/contributors\">",
"     Yuen T So, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/62/10217/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/62/10217/contributors\">",
"     Michael J Aminoff, MD, DSc",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/62/10217/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/62/10217/contributors\">",
"     Janet L Wilterdink, MD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/62/10217/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Nov 4, 2009.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H1\">",
"    <span class=\"h1\">",
"     INTRODUCTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Wernicke-Korsakoff syndrome is the best known neurologic complication of thiamine (vitamin B1) deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1\">",
"     1",
"    </a>",
"    ]. The term refers to two different syndromes, each representing a different stage of the disease. Wernicke's encephalopathy (WE) is an acute syndrome requiring emergent treatment to prevent death and neurologic morbidity. Korsakoff's syndrome (KS) refers to a chronic neurologic condition that usually occurs as a consequence of WE.",
"   </p>",
"   <p>",
"    In 1881, Carl Wernicke described an acute encephalopathy characterized by mental confusion, ophthalmoplegia, and gait ataxia and associated with autopsy findings of punctate hemorrhages around the third and fourth ventricles and the aqueduct. A few years later, Russian psychiatrist Sergei Korsakoff described a chronic amnestic syndrome in which memory was impaired far out of proportion to other cognitive domains. While both observations were described in the context of chronic alcoholism, neither Wernicke nor Korsakoff initially recognized the relationship between the disorders, which was not appreciated until later by other investigators.",
"   </p>",
"   <p>",
"    This topic will review Wernicke's encephalopathy. Korsakoff's syndrome and other chronic neurologic complications of alcohol abuse, including alcohol withdrawal are discussed separately. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/24/40328?source=see_link\">",
"     \"Overview of the chronic neurologic complications of alcohol\"",
"    </a>",
"    and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/61/20441?source=see_link\">",
"     \"Management of moderate and severe alcohol withdrawal syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H2\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Typical brain lesions of Wernicke's encephalopathy (WE) are observed at autopsy in 0.8 to 2.8 percent of the general population in the Western world, and the vast majority of affected patients are alcoholic [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/2,3\">",
"     2,3",
"    </a>",
"    ]. The prevalence of WE lesions seen on autopsy was 12.5 percent of alcohol abusers in one report [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/4\">",
"     4",
"    </a>",
"    ]. Among those with alcohol-related deaths, it has been reported to be even higher, 29 to 59 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/5,6\">",
"     5,6",
"    </a>",
"    ]. Autopsy studies have consistently revealed a higher incidence of Wernicke lesions in the general population than is predicted by clinical studies [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1,7\">",
"     1,7",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    While cases of WE in men outnumber those in women, women appear to be more susceptible to developing WE than men. In several series, the female to male ratio for WE was higher than the ratio for alcohol dependence [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1,7\">",
"     1,7",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H3\">",
"    <span class=\"h2\">",
"     Associated conditions",
"    </span>",
"    &nbsp;&mdash;&nbsp;While most often associated with chronic alcoholism, WE occurs also in the setting of poor nutrition caused by malabsorption, poor dietary intake, increased metabolic requirement (eg, during systemic illnesses), or increased loss of the water-soluble vitamin thiamine (eg, in renal dialysis). In one autopsy series, non-alcohol abusers accounted for 12 of 52 cases (23 percent) of WE [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/8\">",
"     8",
"    </a>",
"    ]. Conditions associated with WE include:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Chronic alcoholism",
"     </li>",
"     <li>",
"      Anorexia nervosa or dieting [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/9\">",
"       9",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Hyperemesis of pregnancy [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/10,11\">",
"       10,11",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Prolonged intravenous feeding without proper supplementation [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/12,13\">",
"       12,13",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Prolonged fasting or starvation, or unbalanced nutrition, especially with refeeding [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/14\">",
"       14",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Gastrointestinal surgery (including bariatric surgery) [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/12,15-20\">",
"       12,15-20",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Systemic malignancy [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/21-23\">",
"       21-23",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Transplantation [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/24\">",
"       24",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Hemodialysis or peritoneal dialysis [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/25-27\">",
"       25-27",
"      </a>",
"      ]",
"     </li>",
"     <li>",
"      Acquired immunodeficiency syndrome [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/28-30\">",
"       28-30",
"      </a>",
"      ]",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    One report also describes WE in the setting of a genetic disorder of thiamine metabolism [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H4\">",
"    <span class=\"h1\">",
"     PATHOPHYSIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;Thiamine is a cofactor for several key enzymes important in energy metabolism, including transketolase, alpha-ketoglutarate dehydrogenase, and pyruvate dehydrogenase [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1\">",
"     1",
"    </a>",
"    ]. Thiamine requirements depend on metabolic rate, with the greatest need during periods of high metabolic demand and high glucose intake. This is manifest by the precipitation of Wernicke's encephalopathy (WE) in susceptible patients by administration of intravenous glucose before thiamine supplementation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/32\">",
"     32",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Evidence for the role of thiamine in WE is supported by observations that the thiamine antagonist pyrithiamine causes experimental thiamine deficiency in rats, resulting in a sequence of ataxia, loss of the righting reflex, and convulsions [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/33,34\">",
"     33,34",
"    </a>",
"    ]. In some cases, low levels of magnesium, an essential cofactor of thiamine into its active diphosphate and triphosphate forms, have been implicated with thiamine deficiency in WE [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/35\">",
"     35",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is unclear how thiamine deficiency causes brain lesions. Because of its role in cerebral energy utilization, it has been proposed that its deficiency initiates neuronal injury by inhibiting metabolism in brain regions with high metabolic requirements and high thiamine turnover. Events such as blood-brain barrier breakdown, N-methyl-D-aspartic acid (NMDA) receptor-mediated excitotoxicity, and increased reactive oxygen species have been implicated in thiamine deficiency-induced neurotoxicity [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/36\">",
"     36",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Thiamine deficiency in alcohol abusers results from a combination of inadequate dietary intake, reduced gastrointestinal absorption, decreased hepatic storage, and impaired utilization [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/37\">",
"     37",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Only a subset of thiamine-deficient alcohol abusers develop WE. Greater susceptibility among identical rather than fraternal twins suggests a genetic predisposition [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/36\">",
"     36",
"    </a>",
"    ]. Investigators have found that in alcohol abusers with WE, the thiamine-dependent enzyme transketolase has an altered affinity for thiamine [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/38-46\">",
"     38-46",
"    </a>",
"    ]. Variants in the high affinity thiamine transporter gene have also been implicated [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/47,48\">",
"     47,48",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H5\">",
"    <span class=\"h2\">",
"     Pathology",
"    </span>",
"    &nbsp;&mdash;&nbsp;Acute WE lesions are characterized by vascular congestion, microglial proliferation, and petechial hemorrhages. In chronic cases, there is demyelination, gliosis, and loss of neuropil with relative preservation of neurons. Neuronal loss is most prominent in the relatively unmyelinated medial thalamus [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1,49\">",
"     1,49",
"    </a>",
"    ]. Atrophy of the mamillary bodies is a highly specific finding in chronic WE and Korsakoff syndrome and is present in up to 80 percent of cases [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1,50\">",
"     1,50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The lesions of WE occur in a characteristic, symmetrical distribution in structures surrounding the third ventricle, aqueduct, and fourth ventricle [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1,50\">",
"     1,50",
"    </a>",
"    ]. The mamillary bodies are involved in virtually all cases, and the dorsomedial thalamus, locus ceruleus, periaqueductal gray, ocular motor nuclei, and vestibular nuclei are commonly affected. Lesions occur less frequently in the colliculi, fornices, septal region, hippocampus, and cerebral cortex, which may show patchy, diffuse neuronal loss and astrocytic proliferation.",
"   </p>",
"   <p>",
"    In about one-half of cases, sagittal sections through the cerebellum reveal selective loss of Purkinje cells at the tips of the folia of the anterior superior cerebellar vermis. The latter changes are identical to those found in alcoholic cerebellar degeneration, where they can occur in the absence of other Wernicke lesions. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/24/40328?source=see_link&amp;anchor=H7#H7\">",
"     \"Overview of the chronic neurologic complications of alcohol\", section on 'Alcoholic cerebellar degeneration'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H6\">",
"    <span class=\"h1\">",
"     CLINICAL MANIFESTATIONS",
"    </span>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H7\">",
"    <span class=\"h2\">",
"     Classic signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;The classic triad of Wernicke's encephalopathy (WE) includes:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Encephalopathy",
"     </li>",
"     <li>",
"      Oculomotor dysfunction",
"     </li>",
"     <li>",
"      Gait ataxia",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Clinical recognition of WE is straightforward when an alcoholic presents with this classic triad. However, this may be the exception, not the rule. Detailed clinical and neuropathological data from 82 autopsies and 245 patients examined over 10 years revealed that all features of the triad were recognized in only one-third of patients; in most, elements of the clinical triad appeared alone or in combination [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1\">",
"     1",
"    </a>",
"    ]. Confusion was the most common presenting symptom, followed by staggering gait and ocular problems. A similar constellation of symptoms has been reported in smaller series [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/4,51\">",
"     4,51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Absence of one or more of the classic symptoms likely leads to under diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/4,52\">",
"     4,52",
"    </a>",
"    ]. In one series, WE was diagnosed premortem in only 26 of 131 patients whose brains revealed chronic WE lesions. All signs of the classic triad were recorded in 17 percent; none were recorded in 19 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/52\">",
"     52",
"    </a>",
"    ]. Clinical records recorded a high incidence of mental status abnormalities (82 percent), but much lower incidences of ataxia (23 percent), ocular motor abnormalities (29 percent), and polyneuropathy (11 percent).",
"   </p>",
"   <p>",
"    The symptoms may present more or less simultaneously. Often, however, ataxia precedes other symptoms by a few days or weeks [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Encephalopathy &mdash; The encephalopathy is characterized by profound disorientation, indifference, and inattentiveness [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1\">",
"       1",
"      </a>",
"      ]. If these are less severe and permit higher cognitive testing, impaired memory and learning are also evident. Some patients exhibit an agitated delirium related to concomitant ethanol withdrawal. Fewer than 5 percent present with a depressed level of consciousness, although the course in untreated patients will progress through stupor and coma to death [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1,53\">",
"       1,53",
"      </a>",
"      ]. In one autopsy series, patients with unrecognized WE frequently had lethargy or coma.",
"     </li>",
"     <li>",
"      Oculomotor dysfunction &mdash; Nystagmus, lateral rectus palsy, and conjugate gaze palsies reflect lesions of the oculomotor, abducens, and vestibular nuclei. Ocular abnormalities usually occur in combination rather than alone.",
"      <br/>",
"      <br/>",
"      Nystagmus is the most common finding and is typically evoked by horizontal gaze to both sides [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1\">",
"       1",
"      </a>",
"      ]. Vertical nystagmus can also occur, usually evoked by upward, rather than downward, gaze. Rotatory and vertical nystagmus alone are uncommon. Lateral rectus palsy is virtually always bilateral. Vertical gaze palsies are less common than conjugate gaze palsies, and isolated vertical gaze palsy, internuclear ophthalmoplegia, and complete ophthalmoplegia are rare. Pupillary abnormalities, usually sluggish or unequal pupils, may be present. A light-near dissociation is sometimes seen. In advanced cases, there may be complete loss of eye movements with miotic, nonreactive pupils. Ptosis is uncommon.",
"     </li>",
"     <li>",
"      Gait ataxia &mdash; Ataxia primarily involves stance and gait and is likely due to a combination of polyneuropathy, cerebellar involvement, and vestibular dysfunction [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1,54\">",
"       1,54",
"      </a>",
"      ]. When severe, walking is impossible. Less affected patients walk with a wide-based gait and slow, short-spaced steps. Gait abnormalities are appreciated only on tandem gait in some patients.",
"      <br/>",
"      <br/>",
"      Cerebellar pathology is generally restricted to the anterior and superior vermis; thus, ataxia of the legs or arms and dysarthria or scanning speech are uncommon [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1\">",
"       1",
"      </a>",
"      ]. Vestibular dysfunction may be the major cause of acute gait ataxia in WE, also explaining the dissociation between gait and limb abnormalities [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1,54,55\">",
"       1,54,55",
"      </a>",
"      ]. These findings contrast with those reported in patients with alcoholic cerebellar degeneration, in whom lower extremity ataxia is common [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/56\">",
"       56",
"      </a>",
"      ]. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/24/40328?source=see_link&amp;anchor=H7#H7\">",
"       \"Overview of the chronic neurologic complications of alcohol\", section on 'Alcoholic cerebellar degeneration'",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H8\">",
"    <span class=\"h2\">",
"     Other signs",
"    </span>",
"    &nbsp;&mdash;&nbsp;In addition to the classic triad, stupor or coma, hypotension, and hypothermia were prominent findings in unsuspected cases [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/52\">",
"     52",
"    </a>",
"    ]. Patients with WE may also present with the following findings:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Evidence of protein-calorie malnutrition is observed frequently in patients with WE [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1\">",
"       1",
"      </a>",
"      ]. However, not all patients are malnourished; in Australia, some beer drinkers with WE were even reported to be overweight [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/57\">",
"       57",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      Vestibular dysfunction without hearing loss is a common finding [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1,54,55,58\">",
"       1,54,55,58",
"      </a>",
"      ]. In one study of 17 patients with acute WE, cold caloric responses were absent on at least one side in all, and abnormalities were bilateral in 11 [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/54\">",
"       54",
"      </a>",
"      ]. The presence of spontaneous nystagmus with absent caloric responses appears to be a relatively specific finding in WE [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/55\">",
"       55",
"      </a>",
"      ]. Vertigo is unusual. Some vestibular dysfunction is permanent after WE.",
"     </li>",
"     <li>",
"      Peripheral neuropathy is common and typically involves just the lower extremities [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1\">",
"       1",
"      </a>",
"      ]. Patients complain of the gradual onset of weakness, paresthesias, and pain affecting the distal lower extremities. In many patients there are no symptoms of neuropathy, but examination reveals diminished or absent ankle jerks and patchy distal sensory loss.",
"     </li>",
"     <li>",
"      Hypothermia has been described in 1 to 4 percent of patients with WE who went to autopsy, and it has been noted in numerous case reports [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1,52,59\">",
"       1,52,59",
"      </a>",
"      ]. Hypothermia may cause unreactive pupils [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/60\">",
"       60",
"      </a>",
"      ], a finding rarely encountered in normothermic patients with WE [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1\">",
"       1",
"      </a>",
"      ]. Lesions in the posterior and posterolateral hypothalamus were noted in two patients with WE and hypothermia in one report [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/61\">",
"       61",
"      </a>",
"      ]. This location is consistent with the known thermoregulatory functions of the hypothalamus. Other signs of autonomic involvement may include hypotension and syncope. In one autopsy series, hypotension and hypothermia were prevalent in unsuspected cases of WE [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/52\">",
"       52",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      While overt beriberi heart disease is rare in WE, other cardiovascular signs and symptoms are common and include tachycardia, exertional dyspnea, elevated cardiac output, and EKG abnormalities [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1\">",
"       1",
"      </a>",
"      ]. These reverse with thiamine administration.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H9\">",
"    <span class=\"h1\">",
"     DIAGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Wernicke's encephalopathy (WE) is primarily a clinical diagnosis. Laboratory studies and neuroimaging studies can be helpful, but the biggest barrier to diagnosis is a low index of suspicion when all clinical symptoms are not present and in the nonalcoholic patient. Institution of treatment takes priority over diagnosis, and response to treatment may be diagnostic. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Treatment'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H10\">",
"    <span class=\"h2\">",
"     Differential diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;WE should be considered in the differential diagnosis of all patients presenting with acute delirium or acute ataxia. It follows that other causes of delirium are considered in the diagnosis of a patient presenting with WE (",
"    <a class=\"graphic graphic_table graphicRef59893 \" href=\"UTD.htm?3/43/3773\">",
"     table 1",
"    </a>",
"    ). (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/10/39081?source=see_link\">",
"     \"Diagnosis of delirium and confusional states\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    In one case series of 36 hospitalized geriatric patients, thiamine deficiency was common and associated with delirium [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/62\">",
"     62",
"    </a>",
"    ]. In another small series, thiamine deficiency appeared to contribute to postoperative confusion in older patients after hip surgery [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/63\">",
"     63",
"    </a>",
"    ]. These results appear to be contradicted by a larger series of 118 older inpatients in which there was no association between thiamine deficiency and delirium; however, the inclusion of patients with dementia and a broader definition of delirium in this study may have influenced these results [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/64\">",
"     64",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Also, structural disease in the medial thalami or inferior medial temporal lobes such as occurs with top of the basilar stroke, hippocampal damage after cardiac arrest, herpes simplex encephalitis, and third ventricular tumors are likely considered because of the neuroanatomic overlap with WE [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/65,66\">",
"     65,66",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H11\">",
"    <span class=\"h2\">",
"     Clinical criteria",
"    </span>",
"    &nbsp;&mdash;&nbsp;Clinical recognition of WE is likely when an alcoholic presents with the classic symptom triad. However, autopsy-based series suggest that many patients lack one or more elements of this triad, and in some, lethargy or coma is the predominant clinical feature [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1,4,52\">",
"     1,4,52",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H7\">",
"     'Classic signs'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    While autopsy studies likely underestimate the presence of classic signs that were not properly elicited, recognized, or recorded, it is clear that the diagnosis of WE can be missed when reliance is placed on the presence of all three of the typical symptoms.",
"   </p>",
"   <p>",
"    One group proposed criteria for the diagnosis of WE and KS in chronic alcohol abusers based upon clinical-neuropathological correlation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/67\">",
"     67",
"    </a>",
"    ]. WE is diagnosed in patients with two of the following four Caine criteria:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Dietary deficiency",
"     </li>",
"     <li>",
"      Oculomotor abnormalities",
"     </li>",
"     <li>",
"      Cerebellar dysfunction",
"     </li>",
"     <li>",
"      Either altered mental status or mild memory impairment",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Applying these criteria to a cohort of 106 autopsied alcohol abusers increased the diagnostic sensitivity for WE from 22 percent using the classic triad, to 85 percent.",
"   </p>",
"   <p>",
"    The Caine criteria are clearly more sensitive than the classic triad, but given the high morbidity and mortality associated with the disorder, they are not sensitive enough. Specificity is low, and these criteria were not intended to apply to nonalcoholics in whom the diagnosis is further impeded by a lower index of suspicion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H12\">",
"    <span class=\"h2\">",
"     Laboratory testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no laboratory studies that are diagnostic of WE. Thiamine deficiency can be most reliably detected by measurement of erythrocyte thiamine transketolase (ETKA) before and after the addition of thiamine pyrophosphate (TPP). A low ETKA, along with a more than 25 percent stimulation, establishes the diagnosis of thiamine deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/68\">",
"     68",
"    </a>",
"    ]. This test is often not readily available, especially in the emergency setting. A serum thiamine or thiamine pyrophosphate level in serum or whole blood can also be measured by chromatography [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/69\">",
"     69",
"    </a>",
"    ]. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?27/62/28650?source=see_link&amp;anchor=H3#H3\">",
"     \"Overview of water-soluble vitamins\", section on 'Vitamin B1 (thiamine)'",
"    </a>",
"    .) The sensitivity and specificity of these blood tests in symptomatic patients are unclear.",
"   </p>",
"   <p>",
"    Results from these measurements are not considered necessary for patient management. When the diagnosis of Wernicke's encephalopathy is entertained, immediate thiamine replacement takes precedence over laboratory diagnosis. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Treatment'",
"    </a>",
"    below.)",
"   </p>",
"   <p>",
"    Patients with WE will likely also be tested for other toxic and metabolic conditions that can lead to delirium. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?38/10/39081?source=see_link\">",
"     \"Diagnosis of delirium and confusional states\"",
"    </a>",
"    .) In the setting of fever, or other suspicion for central nervous system infection, a lumbar puncture is required. In WE, the cerebrospinal fluid may be normal or may show a mild protein elevation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1\">",
"     1",
"    </a>",
"    ]. Pleocytosis or protein &gt;100",
"    <span class=\"nowrap\">",
"     mg/dL",
"    </span>",
"    suggest alternative diagnoses. An EEG may be ordered if nonconvulsive seizures are suspected. In WE, only about half of patients will demonstrate EEG abnormalities, usually diffuse mild to moderate slow wave activity [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1\">",
"     1",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H13\">",
"    <span class=\"h2\">",
"     Imaging studies",
"    </span>",
"    &nbsp;&mdash;&nbsp;Imaging studies are not necessary in all patients with suspected WE and should not delay treatment. (See",
"    <a class=\"local\" href=\"#H14\">",
"     'Treatment'",
"    </a>",
"    below.) However, diagnostic imaging can be helpful by providing evidence of WE in many patients and may rule out alternative diagnoses.",
"   </p>",
"   <p>",
"    Abnormalities on computerized tomography (CT) scans or magnetic resonance imaging (MRI) have been reported in small numbers of patients with acute WE [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/70\">",
"     70",
"    </a>",
"    ]. CT may show symmetric, low density abnormalities in the diencephalon, midbrain, and periventricular regions that enhance after the injection of contrast [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/71-74\">",
"     71-74",
"    </a>",
"    ]. Gross hemorrhages are uncommon in acute WE, but they have also been detected by CT [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/75\">",
"     75",
"    </a>",
"    ]. These findings are uncommon in other disorders, and when present, should strongly suggest the diagnosis. However, CT is an insensitive test for WE; a normal CT scan does not rule out the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/51\">",
"     51",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    MRI is more sensitive than CT in detecting acute diencephalic and periventricular lesions [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/51,76,77\">",
"     51,76,77",
"    </a>",
"    ]. Typical findings include areas of increased T2 and decreased T1 signal surrounding the aqueduct and third ventricle and within the medial thalamus and mamillary bodies [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/77-80\">",
"     77-80",
"    </a>",
"    ]. Diffusion-weighted imaging (DWI) is abnormal in these areas as well [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/81,82\">",
"     81,82",
"    </a>",
"    ]. The distribution of these findings is consistent with the pathologic lesions. (",
"    <a class=\"graphic graphic_diagnosticimage graphicRef82317 \" href=\"UTD.htm?13/38/13925\">",
"     image 1",
"    </a>",
"    and",
"    <a class=\"graphic graphic_diagnosticimage graphicRef62065 \" href=\"UTD.htm?43/22/44385\">",
"     image 2",
"    </a>",
"    ).",
"   </p>",
"   <p>",
"    In one report comparing 15 patients with acute WE to 15 asymptomatic alcohol abusers and 15 controls, the sensitivity and specificity of MRI were 53 and 93 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/51\">",
"     51",
"    </a>",
"    ]. Other series have reported a higher prevalence of MRI abnormalities in patients with acute WE [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/77,83\">",
"     77,83",
"    </a>",
"    ]. Abnormal T2 signal disappears within as little as 48 hours after treatment with thiamine&nbsp;[",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/83\">",
"     83",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Mamillary body atrophy is a relatively specific abnormality in patients with chronic lesions of WE [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/84\">",
"     84",
"    </a>",
"    ]. A large decrease in the volume of the mamillary bodies can be identified by MRI in approximately 80 percent of alcohol abusers with a history of classic WE, and it is not found in controls, patients with Alzheimer disease (AD), or alcohol abusers without a history of WE [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/84-86\">",
"     84-86",
"    </a>",
"    ]. Mamillary body atrophy can be detected within one week of the onset of WE [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/83\">",
"     83",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H14\">",
"    <span class=\"h1\">",
"     TREATMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of WE is difficult to confirm and, untreated, most patients progress to coma and death. Fortunately, intravenous administration of thiamine is safe, simple, inexpensive, and effective [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/87\">",
"     87",
"    </a>",
"    ]. Adverse reactions, including anaphylaxis and bronchospasm are reported but are extremely rare; in the United Kingdom, there were four reported cases for every five million intramuscular doses used and one report for every one million intravenous doses used [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/88-91\">",
"     88-91",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Diagnostic testing should not delay treatment; treatment should immediately follow consideration of the diagnosis.",
"   </p>",
"   <p>",
"    Patients with suspected Wernicke's encephalopathy (WE) require immediate parenteral administration of thiamine. A recommended regimen is 500 mg of thiamine intravenously, infused over 30 minutes, three times daily for two consecutive days and 500 mg intravenously or intramuscularly once daily for an additional five days, in combination with other B vitamins [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/89\">",
"     89",
"    </a>",
"    ]. Administration of glucose without thiamine can precipitate or worsen WE; thus, thiamine should be administered before glucose. Because gastrointestinal absorption of thiamine is erratic in alcoholic and malnourished patients, oral administration of thiamine is an unreliable initial treatment for WE [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/37\">",
"     37",
"    </a>",
"    ]. High-dose parenteral thiamine therapy is justified based on the failure of lower doses to produce clinical improvement in some patients with WE; however, there are no randomized studies to support a particular dosing regimen [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/88,89,91-93\">",
"     88,89,91-93",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although dietary requirements for thiamine are only 1 to 2 mg daily, absorption and utilization of thiamine are incomplete, and some patients have genetically determined requirements for much larger doses [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/39,94\">",
"     39,94",
"    </a>",
"    ]. Daily oral administration of 100 mg of thiamine should be continued after the completion of parenteral treatment and after discharge from the hospital until patients are no longer considered at risk. Magnesium and other vitamins are replaced as well, along with other nutritional deficits if present.",
"   </p>",
"   <p>",
"    By establishing a sufficiently low threshold for treatment, all patients with WE will receive thiamine, including those whose diagnosis is unsuspected. For practical purposes, all patients with undiagnosed altered mental status, oculomotor disorders, or ataxia should receive parenteral thiamine.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H15\">",
"    <span class=\"h1\">",
"     CLINICAL COURSE AND PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prompt administration of thiamine leads to improvement in ocular signs within hours to days [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1\">",
"     1",
"    </a>",
"    ]. If ocular palsies fail to respond, other diagnoses should be considered. In one report, recovery of vestibular function began during the second week after thiamine treatment; improvement in gait ataxia coincided with recovery of vestibular function [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/54\">",
"     54",
"    </a>",
"    ]. Confusion subsides over days and weeks. Signal abnormality on MRI resolves with clinical improvement [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/83,95\">",
"     83,95",
"    </a>",
"    ]. This early therapeutic response likely represents the recovery from a biochemical rather than a structural lesion.",
"   </p>",
"   <p>",
"    In the largest cohort of patients reported on, residual deficits were the rule [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/1\">",
"     1",
"    </a>",
"    ]. While gaze palsies recovered completely in most cases, 60 percent had permanent horizontal nystagmus. Only about 40 percent recovered from ataxia; remaining deficits ranged from inability to walk at all to a wide-based slow shuffling gait. As the acute encephalopathy and confusion receded, deficits in learning and memory become more obvious; the latter recovered completely or substantively in only about 20 percent; the remainder had a permanent amnestic syndrome. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?39/24/40328?source=see_link&amp;anchor=H3#H3\">",
"     \"Overview of the chronic neurologic complications of alcohol\", section on 'Korsakoff's syndrome'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Case reports and small case series suggest that prognosis may be less dismal [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/57,82,96\">",
"     57,82,96",
"    </a>",
"    ]. One exceptional case reports near complete recovery in a severely affected patient whose treatment was delayed for four months [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/97\">",
"     97",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H16\">",
"    <span class=\"h1\">",
"     PREVENTION",
"    </span>",
"    &nbsp;&mdash;&nbsp;Wernicke's encephalopathy (WE) may be iatrogenically precipitated by glucose loading in patients with unsuspected thiamine deficiency [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/32\">",
"     32",
"    </a>",
"    ]. To avoid this complication, it has become standard practice in emergency departments to administer thiamine prior to or along with glucose infusion, particularly in those who are at risk for thiamine deficiency (see",
"    <a class=\"local\" href=\"#H3\">",
"     'Associated conditions'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    Patients at risk for WE should also receive thiamine supplementation (see",
"    <a class=\"local\" href=\"#H3\">",
"     'Associated conditions'",
"    </a>",
"    above). As an example, patients admitted for alcohol withdrawal typically receive thiamine 100 mg daily. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?19/61/20441?source=see_link\">",
"     \"Management of moderate and severe alcohol withdrawal syndromes\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    The prevention of WE and Korsakoff's amnestic syndrome (KS) might be possible through the widespread oral administration of thiamine to outpatients at risk. Enrichment of flour with thiamine decreased the autopsy prevalence of WE in Australia [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/98\">",
"     98",
"    </a>",
"    ]. There is also interest in whether preventing thiamine deficiency would also reduce the high prevalence of cognitive deficits in alcohol abusers without known episodes of WE [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10217/abstract/99\">",
"     99",
"    </a>",
"    ]. The low cost and safety of oral thiamine argues for widespread supplementation in alcohol abusers and others at risk for developing thiamine deficiency. Fortification of alcoholic beverages has also been proposed.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"PATIENT_INFORMATION\">",
"    <span class=\"h1\">",
"     INFORMATION FOR PATIENTS",
"    </span>",
"    &nbsp;&mdash;&nbsp;UpToDate offers two types of patient education materials, &ldquo;The Basics&rdquo; and &ldquo;Beyond the Basics.&rdquo; The Basics patient education pieces are written in plain language, at the 5",
"    <sup>",
"     th",
"    </sup>",
"    to 6",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level, and they answer the four or five key questions a patient might have about a given condition. These articles are best for patients who want a general overview and who prefer short, easy-to-read materials. Beyond the Basics patient education pieces are longer, more sophisticated, and more detailed. These articles are written at the 10",
"    <sup>",
"     th",
"    </sup>",
"    to 12",
"    <sup>",
"     th",
"    </sup>",
"    grade reading level and are best for patients who want in-depth information and are comfortable with some medical jargon.",
"   </p>",
"   <p>",
"    Here are the patient education articles that are relevant to this topic. We encourage you to print or e-mail these topics to your patients. (You can also locate patient education articles on a variety of subjects by searching on &ldquo;patient info&rdquo; and the keyword(s) of interest.)",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Beyond the Basics topic (see",
"      <a class=\"medical medical_patient\" href=\"UTD.htm?10/57/11155?source=see_link\">",
"       \"Patient information: Delirium (Beyond the Basics)\"",
"      </a>",
"      )",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H17\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Wernicke's encephalopathy (WE) and Korsakoff's amnestic syndrome (KS) are, respectively, acute and chronic brain disorders that result from thiamine deficiency.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      WE is most often associated with alcoholism but can also occur in other situations including malnutrition from any cause (particularly at the time of refeeding) and in dialysis patients. (See",
"      <a class=\"local\" href=\"#H3\">",
"       'Associated conditions'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      WE produces petechial hemorrhagic necrosis in midline brain structures and corresponding deficits in mentation, oculomotor function, and gait ataxia. All three of these classic symptoms are present in only one-third of patients. Any one of these, but most often encephalopathy, may be seen in isolation. WE should be considered when one or more occur. (See",
"      <a class=\"local\" href=\"#H6\">",
"       'Clinical manifestations'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      While laboratory measurements and neuroimaging are often abnormal in WE, there is no single test with sufficiently high diagnostic accuracy. The first imperative is to administer thiamine rather than confirm the diagnosis, whenever WE is considered. (See",
"      <a class=\"local\" href=\"#H9\">",
"       'Diagnosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Untreated, WE leads to coma and death. Prognosis is improved by prompt administration of thiamine. Immediate, parenteral administration of thiamine is required whenever the diagnosis of WE is entertained. A suggested treatment regimen is 500 mg intravenous (IV), infused over 30 minutes, repeated three times daily for two consecutive days and 500 mg IV or IM once daily for an additional five days. Oral thiamine and multivitamin supplementation are recommended thereafter as long as the patient remains at risk. (See",
"      <a class=\"local\" href=\"#H15\">",
"       'Clinical course and prognosis'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Wernicke's encephalopathy may be precipitated by administration of intravenous glucose solutions to individuals with thiamine deficiency. In susceptible individuals glucose administration should be preceded or accompanied by thiamine 100 mg IV (",
"      <a class=\"grade\" href=\"._grade_1?title=Grade 1A\">",
"       Grade 1A",
"      </a>",
"      ). (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Thiamine supplementation, along with other multivitamin supplementation, is recommended for patients at risk for thiamine deficiency. (See",
"      <a class=\"local\" href=\"#H16\">",
"       'Prevention'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     Victor, M, Adams, RA, Collins, GH. The Wernicke-Korsakoff syndrome and related disorders due to alcoholism and malnutrition. FA Davis, Philadelphia 1989.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/2\">",
"      Charness ME, Simon RP, Greenberg DA. Ethanol and the nervous system. N Engl J Med 1989; 321:442.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/3\">",
"      Torvik A. Wernicke's encephalopathy--prevalence and clinical spectrum. Alcohol Alcohol Suppl 1991; 1:381.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/4\">",
"      Torvik A, Lindboe CF, Rogde S. Brain lesions in alcoholics. A neuropathological study with clinical correlations. J Neurol Sci 1982; 56:233.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/5\">",
"      Naidoo DP, Bramdev A, Cooper K. Autopsy prevalence of Wernicke's encephalopathy in alcohol-related disease. S Afr Med J 1996; 86:1110.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/6\">",
"      Skullerud K, Andersen SN, Lundevall J. Cerebral lesions and causes of death in male alcoholics. A forensic autopsy study. Int J Legal Med 1991; 104:209.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/7\">",
"      Harper C. The incidence of Wernicke's encephalopathy in Australia--a neuropathological study of 131 cases. J Neurol Neurosurg Psychiatry 1983; 46:593.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/8\">",
"      Lindboe CF, L&oslash;berg EM. Wernicke's encephalopathy in non-alcoholics. An autopsy study. J Neurol Sci 1989; 90:125.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/9\">",
"      Sharma S, Sumich PM, Francis IC, et al. Wernicke's encephalopathy presenting with upbeating nystagmus. J Clin Neurosci 2002; 9:476.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/10\">",
"      G&aacute;rdi&aacute;n G, V&ouml;r&ouml;s E, J&aacute;rd&aacute;nh&aacute;zy T, et al. Wernicke's encephalopathy induced by hyperemesis gravidarum. Acta Neurol Scand 1999; 99:196.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/11\">",
"      Spruill SC, Kuller JA. Hyperemesis gravidarum complicated by Wernicke's encephalopathy. Obstet Gynecol 2002; 99:875.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/12\">",
"      Parkin AJ, Blunden J, Rees JE, Hunkin NM. Wernicke-Korsakoff syndrome of nonalcoholic origin. Brain Cogn 1991; 15:69.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/13\">",
"      Vortmeyer AO, Hagel C, Laas R. Haemorrhagic thiamine deficient encephalopathy following prolonged parenteral nutrition. J Neurol Neurosurg Psychiatry 1992; 55:826.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/14\">",
"      Suzuki Y, Matsuda T, Washio N, Ohtsuka K. Transition from upbeat to downbeat nystagmus observed in a patient with Wernicke's encephalopathy. Jpn J Ophthalmol 2005; 49:220.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/15\">",
"      Chaves LC, Faintuch J, Kahwage S, Alencar Fde A. A cluster of polyneuropathy and Wernicke-Korsakoff syndrome in a bariatric unit. Obes Surg 2002; 12:328.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/16\">",
"      Peltier G, Hermreck AS, Moffat RE, et al. Complications following gastric bypass procedures for morbid obesity. Surgery 1979; 86:648.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/17\">",
"      Paulson GW, Martin EW, Mojzisik C, Carey LC. Neurologic complications of gastric partitioning. Arch Neurol 1985; 42:675.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/18\">",
"      Foster D, Falah M, Kadom N, Mandler R. Wernicke encephalopathy after bariatric surgery: losing more than just weight. Neurology 2005; 65:1987; discussion 1847.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/19\">",
"      Singh S, Kumar A. Wernicke encephalopathy after obesity surgery: a systematic review. Neurology 2007; 68:807.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/20\">",
"      Aasheim ET. Wernicke encephalopathy after bariatric surgery: a systematic review. Ann Surg 2008; 248:714.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/21\">",
"      Pittella JE, de Castro LP. Wernicke's encephalopathy manifested as Korsakoff's syndrome in a patient with promyelocytic leukemia. South Med J 1990; 83:570.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/22\">",
"      Engel PA, Grunnet M, Jacobs B. Wernicke-Korsakoff syndrome complicating T-cell lymphoma: unusual or unrecognized? South Med J 1991; 84:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/23\">",
"      Macleod AD. Wernicke's encephalopathy and terminal cancer: case report. Palliat Med 2000; 14:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/24\">",
"      Bleggi-Torres LF, de Medeiros BC, Werner B, et al. Neuropathological findings after bone marrow transplantation: an autopsy study of 180 cases. Bone Marrow Transplant 2000; 25:301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/25\">",
"      Hung SC, Hung SH, Tarng DC, et al. Thiamine deficiency and unexplained encephalopathy in hemodialysis and peritoneal dialysis patients. Am J Kidney Dis 2001; 38:941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/26\">",
"      Jagadha V, Deck JH, Halliday WC, Smyth HS. Wernicke's encephalopathy in patients on peritoneal dialysis or hemodialysis. Ann Neurol 1987; 21:78.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/27\">",
"      Descombes E, Dessibourg CA, Fellay G. Acute encephalopathy due to thiamine deficiency (Wernicke's encephalopathy) in a chronic hemodialyzed patient: a case report. Clin Nephrol 1991; 35:171.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/28\">",
"      Davtyan DG, Vinters HV. Wernicke's encephalopathy in AIDS patient treated with zidovudine. Lancet 1987; 1:919.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/29\">",
"      Schwenk J, Gosztonyi G, Thierauf P, et al. Wernicke's encephalopathy in two patients with acquired immunodeficiency syndrome. J Neurol 1990; 237:445.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/30\">",
"      Soffer D, Zirkin H, Alkan M, Berginer VM. Wernicke's encephalopathy in acquired immune deficiency syndrome (AIDS): a case report. Clin Neuropathol 1989; 8:192.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/31\">",
"      Kono S, Miyajima H, Yoshida K, et al. Mutations in a thiamine-transporter gene and Wernicke's-like encephalopathy. N Engl J Med 2009; 360:1792.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/32\">",
"      Koguchi K, Nakatsuji Y, Abe K, Sakoda S. Wernicke's encephalopathy after glucose infusion. Neurology 2004; 62:512.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/33\">",
"      Todd KG, Butterworth RF. Evaluation of the role of NMDA-mediated excitotoxicity in the selective neuronal loss in experimental Wernicke encephalopathy. Exp Neurol 1998; 149:130.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/34\">",
"      Langlais PJ, Mair RG. Protective effects of the glutamate antagonist MK-801 on pyrithiamine-induced lesions and amino acid changes in rat brain. J Neurosci 1990; 10:1664.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/35\">",
"      McLean J, Manchip S. Wernicke's encephalopathy induced by magnesium depletion. Lancet 1999; 353:1768.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/36\">",
"      Martin PR, Singleton CK, Hiller-Sturmh&ouml;fel S. The role of thiamine deficiency in alcoholic brain disease. Alcohol Res Health 2003; 27:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/37\">",
"      Thomson AD, Ryle PR, Shaw GK. Ethanol, thiamine and brain damage. Alcohol Alcohol 1983; 18:27.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/38\">",
"      Blass JP, Gibson GE. Abnormality of a thiamine-requiring enzyme in patients with Wernicke-Korsakoff syndrome. N Engl J Med 1977; 297:1367.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/39\">",
"      Mukherjee AB, Svoronos S, Ghazanfari A, et al. Transketolase abnormality in cultured fibroblasts from familial chronic alcoholic men and their male offspring. J Clin Invest 1987; 79:1039.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/40\">",
"      Jeyasingham MD, Pratt OE, Burns A, et al. The activation of red blood cell transketolase in groups of patients especially at risk from thiamin deficiency. Psychol Med 1987; 17:311.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/41\">",
"      Greenwood J, Jeyasingham M, Pratt OE, et al. Heterogeneity of human erythrocyte transketolase: a preliminary report. Alcohol Alcohol 1984; 19:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/42\">",
"      McCool BA, Plonk SG, Martin PR, Singleton CK. Cloning of human transketolase cDNAs and comparison of the nucleotide sequence of the coding region in Wernicke-Korsakoff and non-Wernicke-Korsakoff individuals. J Biol Chem 1993; 268:1397.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/43\">",
"      Heap LC, Pratt OE, Ward RJ, et al. Individual susceptibility to Wernicke-Korsakoff syndrome and alcoholism-induced cognitive deficit: impaired thiamine utilization found in alcoholics and alcohol abusers. Psychiatr Genet 2002; 12:217.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/44\">",
"      Martin PR, McCool BA, Singleton CK. Molecular genetics of transketolase in the pathogenesis of the Wernicke-Korsakoff syndrome. Metab Brain Dis 1995; 10:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/45\">",
"      Nixon PF. Is there a genetic component to the pathogenesis of the Wernicke-Korsakoff syndrome? Alcohol Alcohol 1984; 19:219.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/46\">",
"      Wang JJ, Martin PR, Singleton CK. A transketolase assembly defect in a Wernicke-Korsakoff syndrome patient. Alcohol Clin Exp Res 1997; 21:576.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/47\">",
"      Guerrini I, Thomson AD, Cook CC, et al. Direct genomic PCR sequencing of the high affinity thiamine transporter (SLC19A2) gene identifies three genetic variants in Wernicke Korsakoff syndrome (WKS). Am J Med Genet B Neuropsychiatr Genet 2005; 137B:17.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/48\">",
"      Todd K, Butterworth RF. Mechanisms of selective neuronal cell death due to thiamine deficiency. Ann N Y Acad Sci 1999; 893:404.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/49\">",
"      Torvik A. Two types of brain lesions in Wernicke's encephalopathy. Neuropathol Appl Neurobiol 1985; 11:179.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/50\">",
"      Malamud, N, Skillicorn, SA. Relationship between the Wernicke and the Korsakoff syndrome: a clinicopathologic study of seventy cases. Arch Neurol Psychiat 1956; 76:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/51\">",
"      Antunez E, Estruch R, Cardenal C, et al. Usefulness of CT and MR imaging in the diagnosis of acute Wernicke's encephalopathy. AJR Am J Roentgenol 1998; 171:1131.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/52\">",
"      Harper CG, Giles M, Finlay-Jones R. Clinical signs in the Wernicke-Korsakoff complex: a retrospective analysis of 131 cases diagnosed at necropsy. J Neurol Neurosurg Psychiatry 1986; 49:341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/53\">",
"      Wallis WE, Willoughby E, Baker P. Coma in the Wernicke-Korsakoff syndrome. Lancet 1978; 2:400.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/54\">",
"      Ghez C. Vestibular paresis: a clinical feature of Wernicke's disease. J Neurol Neurosurg Psychiatry 1969; 32:134.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/55\">",
"      Goor C, Endtz LJ, Muller Kobold MJ. Electro-nystagmography for the diagnosis of vestibular dysfunction in the Wernicke-Korsakow syndrome. Clin Neurol Neurosurg 1975; 78:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/56\">",
"      Victor, M, Adams, RD, Mancall, EL. A restricted form of cerebellar cortical degeneration occurring in alcoholic patients. Arch Neurol 1959; 1:579.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/57\">",
"      Wood B, Currie J, Breen K. Wernicke's encephalopathy in a metropolitan hospital. A prospective study of incidence, characteristics and outcome. Med J Aust 1986; 144:12.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/58\">",
"      Choi KD, Oh SY, Kim HJ, Kim JS. The vestibulo-ocular reflexes during head impulse in Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry 2007; 78:1161.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/59\">",
"      Harper C. Wernicke's encephalopathy: a more common disease than realised. A neuropathological study of 51 cases. J Neurol Neurosurg Psychiatry 1979; 42:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/60\">",
"      Fischbeck KH, Simon RP. Neurological manifestations of accidental hypothermia. Ann Neurol 1981; 10:384.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/61\">",
"      Philip G, Smith JF. Hypothermia and Wernicke's encephalopathy. Lancet 1973; 2:122.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/62\">",
"      O'Keeffe ST, Tormey WP, Glasgow R, Lavan JN. Thiamine deficiency in hospitalized elderly patients. Gerontology 1994; 40:18.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/63\">",
"      Older MW, Dickerson JW. Thiamine and the elderly orthopaedic patient. Age Ageing 1982; 11:101.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/64\">",
"      Pepersack T, Garbusinski J, Robberecht J, et al. Clinical relevance of thiamine status amongst hospitalized elderly patients. Gerontology 1999; 45:96.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/65\">",
"      Yoneoka Y, Takeda N, Inoue A, et al. Acute Korsakoff syndrome following mammillothalamic tract infarction. AJNR Am J Neuroradiol 2004; 25:964.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/66\">",
"      Renou P, Ducreux D, Batouche F, Denier C. Pure and acute Korsakoff syndrome due to a bilateral anterior fornix infarction: a diffusion tensor tractography study. Arch Neurol 2008; 65:1252.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/67\">",
"      Caine D, Halliday GM, Kril JJ, Harper CG. Operational criteria for the classification of chronic alcoholics: identification of Wernicke's encephalopathy. J Neurol Neurosurg Psychiatry 1997; 62:51.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/68\">",
"      Leigh, D. Erythrocyte transketolase activity in the Wernicke-Korsakoff syndrome. Br J Psychol 1981; 138:153.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/69\">",
"      O'Keeffe ST. Thiamine deficiency in elderly people. Age Ageing 2000; 29:99.",
"     </a>",
"    </li>",
"    <li>",
"     Warach, SJ, Charness, ME. Imaging the brain lesions of alcoholics. In: Neuroimaging: A Companion to Adams and Victor's Principles of Neurology, Greenberg, JO (Ed), McGraw-Hill, New York 1994. p.503.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/71\">",
"      McDowell JR, LeBlanc HJ. Computed tomographic findings in Wernicke-Korsakoff syndrome. Arch Neurol 1984; 41:453.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/72\">",
"      Mensing JW, Hoogland PH, Slooff JL. Computed tomography in the diagnosis of Wernicke's encephalopathy: a radiological-neuropathological correlation. Ann Neurol 1984; 16:363.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/73\">",
"      Hofmann E, Friedburg H, Rasenack J, et al. [Wernicke's encephalopathy on CT and MR]. Rofo 1988; 148:97.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/74\">",
"      Kitaguchi T, Kobayashi T, Tobimatsu S, et al. Computed tomography and magnetic resonance imaging in a young patient with Wernicke's encephalopathy. J Neurol 1987; 234:449.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/75\">",
"      Roche SW, Lane RJ, Wade JP. Thalamic hemorrhages in Wernicke-Korsakoff syndrome demonstrated by computed tomography. Ann Neurol 1988; 23:312.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/76\">",
"      Ostertun B, Dewes W, Hanisch E, Harder T. [MR tomography and computer tomography of alcohol-induced brain tissue changes]. Rofo 1990; 152:87.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/77\">",
"      Gallucci M, Bozzao A, Splendiani A, et al. Wernicke encephalopathy: MR findings in five patients. AJNR Am J Neuroradiol 1990; 11:887.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/78\">",
"      Yokote K, Miyagi K, Kuzuhara S, et al. Wernicke encephalopathy: follow-up study by CT and MR. J Comput Assist Tomogr 1991; 15:835.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/79\">",
"      Yamashita M, Yamamoto T. Wernicke encephalopathy with symmetric pericentral involvement: MR findings. J Comput Assist Tomogr 1995; 19:306.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/80\">",
"      Zuccoli G, Pipitone N. Neuroimaging findings in acute Wernicke's encephalopathy: review of the literature. AJR Am J Roentgenol 2009; 192:501.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/81\">",
"      Doherty MJ, Watson NF, Uchino K, et al. Diffusion abnormalities in patients with Wernicke encephalopathy. Neurology 2002; 58:655.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/82\">",
"      Watson WD, Swallow CE, Landau ME. MR imaging and post LP headache. Neurology 2003; 61:1450.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/83\">",
"      Park SH, Kim M, Na DL, Jeon BS. Magnetic resonance reflects the pathological evolution of Wernicke encephalopathy. J Neuroimaging 2001; 11:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/84\">",
"      Charness ME. Intracranial voyeurism: revealing the mammillary bodies in alcoholism. Alcohol Clin Exp Res 1999; 23:1941.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/85\">",
"      Charness, ME, DeLaPaz, RL. Periodic alternating nystagmus in an alcoholic with small mamillary bodies. Neurology 1988; 38 (Suppl):421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/86\">",
"      Charness ME, DeLaPaz RL. Mamillary body atrophy in Wernicke's encephalopathy: antemortem identification using magnetic resonance imaging. Ann Neurol 1987; 22:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/87\">",
"      Wrenn KD, Murphy F, Slovis CM. A toxicity study of parenteral thiamine hydrochloride. Ann Emerg Med 1989; 18:867.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/88\">",
"      Agabio R. Thiamine administration in alcohol-dependent patients. Alcohol Alcohol 2005; 40:155.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/89\">",
"      Cook CC, Hallwood PM, Thomson AD. B Vitamin deficiency and neuropsychiatric syndromes in alcohol misuse. Alcohol Alcohol 1998; 33:317.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/90\">",
"      McIntosh C, Chick J. Alcohol and the nervous system. J Neurol Neurosurg Psychiatry 2004; 75 Suppl 3:iii16.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/91\">",
"      Thomson AD, Cook CC, Touquet R, et al. The Royal College of Physicians report on alcohol: guidelines for managing Wernicke's encephalopathy in the accident and Emergency Department. Alcohol Alcohol 2002; 37:513.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/92\">",
"      Day E, Bentham P, Callaghan R, et al. Thiamine for Wernicke-Korsakoff Syndrome in people at risk from alcohol abuse. Cochrane Database Syst Rev 2004; :CD004033.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/93\">",
"      Ambrose ML, Bowden SC, Whelan G. Thiamin treatment and working memory function of alcohol-dependent people: preliminary findings. Alcohol Clin Exp Res 2001; 25:112.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/94\">",
"      Hoyumpa AM Jr. Alcohol and thiamine metabolism. Alcohol Clin Exp Res 1983; 7:11.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/95\">",
"      Chu K, Kang DW, Kim HJ, et al. Diffusion-weighted imaging abnormalities in wernicke encephalopathy: reversible cytotoxic edema? Arch Neurol 2002; 59:123.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/96\">",
"      Zhong C, Jin L, Fei G. MR Imaging of nonalcoholic Wernicke encephalopathy: a follow-up study. AJNR Am J Neuroradiol 2005; 26:2301.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/97\">",
"      Carota A, Schnider A. Dramatic recovery from prolonged Wernicke-Korsakoff disease. Eur Neurol 2005; 53:45.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/98\">",
"      Harper CG, Sheedy DL, Lara AI, et al. Prevalence of Wernicke-Korsakoff syndrome in Australia: has thiamine fortification made a difference? Med J Aust 1998; 168:542.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10217/abstract/99\">",
"      Martin PR, Adinoff B, Weingartner H, et al. Alcoholic organic brain disease: nosology and pathophysiologic mechanisms. Prog Neuropsychopharmacol Biol Psychiatry 1986; 10:147.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 4818 Version 7.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [0504-61.234.146.186-422ACB6E1F-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_62_10217=[""].join("\n");
var outline_f9_62_10217=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H17\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H1\">",
"      INTRODUCTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H2\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H3\">",
"      Associated conditions",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H4\">",
"      PATHOPHYSIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H5\">",
"      Pathology",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H6\">",
"      CLINICAL MANIFESTATIONS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H7\">",
"      Classic signs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H8\">",
"      Other signs",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H9\">",
"      DIAGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H10\">",
"      Differential diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H11\">",
"      Clinical criteria",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H12\">",
"      Laboratory testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H13\">",
"      Imaging studies",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H14\">",
"      TREATMENT",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H15\">",
"      CLINICAL COURSE AND PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H16\">",
"      PREVENTION",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#PATIENT_INFORMATION\">",
"      INFORMATION FOR PATIENTS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H17\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/4818\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/4818|DiagnosticImage\">",
"      <a href=\"#\" title=\"DIAGNOSTIC IMAGES\">",
"       DIAGNOSTIC IMAGES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?13/38/13925\" title=\"diagnostic image 1\">",
"      MRI findings Wernicke A",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_diagnosticimage\" href=\"UTD.htm?43/22/44385\" title=\"diagnostic image 2\">",
"      MRI findings Wernicke B",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/4818|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?3/43/3773\" title=\"table 1\">",
"      Causes of delirium and confusion",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?38/10/39081?source=related_link\">",
"      Diagnosis of delirium and confusional states",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?19/61/20441?source=related_link\">",
"      Management of moderate and severe alcohol withdrawal syndromes",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/24/40328?source=related_link\">",
"      Overview of the chronic neurologic complications of alcohol",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?27/62/28650?source=related_link\">",
"      Overview of water-soluble vitamins",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_patient\" href=\"UTD.htm?10/57/11155?source=related_link\">",
"      Patient information: Delirium (Beyond the Basics)",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_62_10218="Psychogenic movement disorders";
var content_f9_62_10218=[" <noscript>",
"  <div id=\"javascriptDisabled\">",
"   It seems to us that you have your JavaScript turned off on your browser. JavaScript is required in order for our site to behave correctly.  Please enable your JavaScript to continue use our site.",
"  </div>",
" </noscript>",
" <div id=\"printHeader\">",
"  <div id=\"printHeaderLogo\">",
"   <img alt=\"UpToDate\" src=\"./../images/UTD2_masthead.myextg\">",
"    <img align=\"right\" alt=\"Wolters Kluwer Health\" height=\"40\" src=\"./../images/logoWKH.myextg\" width=\"175\">",
"     <br>",
"      <div id=\"printHeaderText\">",
"       Official reprint from  UpToDate",
"       <sup>",
"        &reg;",
"       </sup>",
"       <br>",
"        <a href=\"file://www.uptodate.com\">",
"         www.uptodate.com",
"        </a>",
"        &copy;2013 UpToDate",
"        <sup>",
"         &reg;",
"        </sup>",
"       </br>",
"      </div>",
"     </br>",
"    </img>",
"   </img>",
"  </div>",
"  <div id=\"printHeaderLinks\">",
"   <a class=\"TOPIC\" href=\"#\" id=\"printHeaderPrint\" rel=\"5\" title=\"Click here to print\">",
"    Print",
"   </a>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a href=\"#\" id=\"printHeaderBack\" title=\"Back to normal view\">",
"    Back",
"   </a>",
"  </div>",
" </div>",
" <!-- TC:TOPIC_PAGE -->",
" <div id=\"topicContent\">",
"  <div id=\"topicTitle\">",
"   Psychogenic movement disorders",
"  </div>",
"  <div id=\"topicContributors\">",
"   <div>",
"    <a id=\"authors\">",
"    </a>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/62/10218/contributors\">",
"     Author",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/62/10218/contributors\">",
"     Janis M Miyasaki, MD, MEd",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/62/10218/contributors\">",
"     Section Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/62/10218/contributors\">",
"     Howard I Hurtig, MD",
"    </a>",
"    <br/>",
"   </div>",
"   <div>",
"    <a class=\"contributor contributor_credentials contributorType\" href=\"UTD.htm?9/62/10218/contributors\">",
"     Deputy Editor",
"    </a>",
"    <br/>",
"    <a class=\"contributor contributor_credentials\" href=\"UTD.htm?9/62/10218/contributors\">",
"     John F Dashe, MD, PhD",
"    </a>",
"    <br/>",
"   </div>",
"  </div>",
"  <div id=\"disclosures\">",
"   <a href=\"UTD.htm?9/62/10218/contributor-disclosure\" target=\"_blank\">",
"    Disclosures",
"   </a>",
"  </div>",
"  <div id=\"reviewProcess\">",
"   <span>",
"    All topics are updated as new evidence becomes available and our",
"   </span>",
"   <a href=\"/home/editorial-policy\" target=\"_blank\">",
"    peer review process",
"   </a>",
"   <span>",
"    is complete.",
"   </span>",
"  </div>",
"  <div id=\"literatureReviewDate\">",
"   <span class=\"emphasis\">",
"    Literature review current through:",
"   </span>",
"   Oct 2013.",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <span class=\"emphasis\">",
"    This topic last updated:",
"   </span>",
"   Jan 16, 2013.",
"  </div>",
"  <div id=\"topicText\">",
"   <p class=\"headingAnchor\" id=\"H278442959\">",
"    <span class=\"h1\">",
"     INTRODUCTION AND BACKGROUND",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychogenic movement disorder (PMD) is a clinical syndrome defined as the occurrence of abnormal movements that result from a psychiatric cause rather than a general medical or neurologic cause [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/1\">",
"     1",
"    </a>",
"    ]. Psychogenic movement disorders were first described in the late 19",
"    <sup>",
"     th",
"    </sup>",
"    and early 20",
"    <sup>",
"     th",
"    </sup>",
"    centuries and have been the subject of great interest and puzzlement ever since [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/2-4\">",
"     2-4",
"    </a>",
"    ]. Alternative terms for PMD include hysterical movement disorder, functional movement disorder, nonorganic movement disorder, and medically unexplained motor symptoms [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/5\">",
"     5",
"    </a>",
"    ]. In modern times, awareness of PMDs has increased in the movement disorder literature. However, the pathogenesis and pathophysiology of PMDs remain poorly understood [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/6-8\">",
"     6-8",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    The dangers of PMDs are manifold: excessive investigation of PMD resulting in reinforcing the sick role, misdiagnosing organic illness as psychogenic [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/9\">",
"     9",
"    </a>",
"    ], misdiagnosing PMD as organic, and failure to recognize a kernel of organic illness embedded in the symptoms of a PMD [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/10\">",
"     10",
"    </a>",
"    ]. The prevalence, poor prognosis, and intensive healthcare utilization of PMDs present a problem that has been likened to a crisis in neurology [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/11\">",
"     11",
"    </a>",
"    ]. In order to offer the best chance for remission and to use scarce resources wisely, rapid and accurate diagnosis of psychogenic movement disorders is essential.",
"   </p>",
"   <p>",
"    This topic will review clinical aspects of PMDs, including epidemiology, clinical features, diagnosis, management and prognosis.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H278442966\">",
"    <span class=\"h1\">",
"     EPIDEMIOLOGY",
"    </span>",
"    &nbsp;&mdash;&nbsp;The precise incidence and prevalence of PMD are unknown, as population-based studies are unavailable. Estimates of the prevalence of PMD among adults and children with movement disorders vary between 2 to 4 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/12-17\">",
"     12-17",
"    </a>",
"    ]. Women are affected more often than men. A retrospective chart review of our center in Toronto yielded 206 patients with a diagnosis of PMD out of 7624 records, for a prevalence of 3 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/12\">",
"     12",
"    </a>",
"    ]. Of note, our center receives referral from both primary care physicians and from other academic movement disorders centers. The prevalence of PMD among patients who present with dystonia and fixed, contracted joints may be even higher. As an example, one study of 41 such patients with prospective data reported that criteria for psychogenic dystonia were fulfilled in 15 (37 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/18\">",
"     18",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    In most reports of adults and children with PMD, psychogenic tremor is the most frequent type of involuntary movement, followed by psychogenic dystonia [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/12,19-21\">",
"     12,19-21",
"    </a>",
"    ]. Among our cohort of 206 patients with PMD, the most common psychogenic involuntary movements were tremor (33 percent), dystonia (25 percent), myoclonus (25 percent), gait disorders (11 percent), and parkinsonism (6 percent) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/12\">",
"     12",
"    </a>",
"    ]. Women comprised 77 percent of the total cohort. Although our population is culturally diverse, a formal study of transcultural differences that compared patients with PMD from the United States and Spain revealed similar frequencies of movement types, gender, anatomic distribution, and disability across ethnic groups [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/22\">",
"     22",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H303672\">",
"    <span class=\"h2\">",
"     Risk factors",
"    </span>",
"    &nbsp;&mdash;&nbsp;Based upon limited and inconsistent data, potential risk factors for PMD include a history of sexual abuse, previous surgery or other physical trauma, higher rates of childhood trauma, and major stressful life events [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/14,23-26\">",
"     14,23-26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H278442973\">",
"    <span class=\"h1\">",
"     UNDERLYING PSYCHIATRIC DISORDERS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Conversion disorder is probably the most common mechanism of PMD, and coexisting personality disorders may predispose to PMD. Other psychiatric disorders and diagnoses among patients with PMD may include somatization, factitious disorder, anxiety disorders, and depression [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/27\">",
"     27",
"    </a>",
"    ]. Malingering, though not a psychiatric disorder, is probably an uncommon cause of PMD. An awareness of these conditions is important for the clinician caring for a patient with suspected PMD.",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Conversion disorder is characterized by neurologic symptoms involving motor or sensory function that are not explained by a neurologic or medical disease, are not intentionally produced or feigned, and are temporally associated with psychologic factors such as conflict or other stressors (",
"      <a class=\"graphic graphic_table graphicRef79549 \" href=\"UTD.htm?43/46/44779\">",
"       table 1",
"      </a>",
"      ). While a psychological factor is often associated with conversion disorder, there is growing awareness that it is not necessary; a psychological factor is not always readily apparent in patients with non-physiological neurologic symptoms. There is no age restriction for onset.",
"     </li>",
"     <li>",
"      The terms &ldquo;somatization&rdquo;, &ldquo;multiple somatizations&rdquo; or &ldquo;somatoform disorders&rdquo; are used to describe a syndrome of physical symptoms that cannot be explained by a known medical disease and are associated with substantial psychosocial impairment. In one system (DSM-IV-TR), conversion disorder is considered a subtype of somatoform disorder (",
"      <a class=\"graphic graphic_table graphicRef67901 \" href=\"UTD.htm?14/20/14668\">",
"       table 2",
"      </a>",
"      ). The different terms and diagnoses used to describe somatization can be confusing, a problem discussed in detail separately. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?5/20/5450?source=see_link\">",
"       \"Somatization: Epidemiology, pathogenesis, clinical features, medical evaluation, and diagnosis\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      While factitious disorder and malingering are both intentionally feigned or deliberately induced, they are distinguished by motivation.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Factitious disorder refers to intentionally feigned or deliberately induced physical or psychological symptoms in order to assume the sick role in the absence of external rewards. That is, the motivation for factitious disorders is attention for illness. (See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?7/21/7512?source=see_link\">",
"       \"Factitious disorder and Munchausen syndrome\"",
"      </a>",
"      .)",
"     </li>",
"     <li>",
"      Malingering refers to symptoms that are intentionally feigned or deliberately induced in order to obtain external incentives such as avoiding work, gaining compensation, or obtaining more favorable living arrangements. Malingering is not a psychiatric disorder.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Personality disorders are characterized by personality traits that are inflexible and maladaptive across a wide range of situations, causing significant distress and impairment of social, occupational, and role functioning (",
"      <a class=\"graphic graphic_table graphicRef78113 \" href=\"UTD.htm?38/41/39579\">",
"       table 3",
"      </a>",
"      ). In addition, the thinking, displays of emotion, impulsivity, and interpersonal behavior of the individual deviate markedly from the expectations of the individual's culture. The most common is the histrionic personality disorder, characterized by pervasive and excessive emotionality and attention-seeking behavior. Other predisposing personality disorders include borderline personality or antisocial personality disorders. &nbsp;(See",
"      <a class=\"medical medical_review\" href=\"UTD.htm?39/55/40824?source=see_link\">",
"       \"Personality disorders\"",
"      </a>",
"      .)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The burden of psychiatric disease, psychologic factors and stressors among patients with PMD is illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In one report of 49 patients with a PMD, conversion disorder, malingering, and factitious disorder were present in 90, 8 and 2 percent, respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/13\">",
"       13",
"      </a>",
"      ]. In addition, major depression, anxiety disorder and schizophrenia were diagnosed in 33, 16, and 2 percent, respectively.",
"     </li>",
"     <li>",
"      In another study of 42 patients with documented or clinically established PMD, the lifetime prevalence rates of conversion disorder, personality disorders, anxiety disorders, and major depression were 95, 45, 62 and 43 percent respectively [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/23\">",
"       23",
"      </a>",
"      ]. Additional major psychiatric diagnoses included schizoaffective disorder, bipolar disorder, and substance abuse.",
"     </li>",
"     <li>",
"      In a case-control study, 64 adult patients with PMD reported significantly higher rates of childhood trauma (mainly emotional abuse and physical neglect), greater fear associated with traumatic events, and a greater number of traumatic episodes compared with 39 healthy controls and 39 patients with an organic movement disorder (focal hand dystonia) [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/24\">",
"       24",
"      </a>",
"      ]. In addition, patients with PMD had significantly higher scores on measures of depression and anxiety than controls and patients with focal hand dystonia. However, there was no significant difference between groups for rates of sexual or physical abuse, and no significant differences on personality scales between the PMD and healthy control groups.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H278442994\">",
"    <span class=\"h1\">",
"     CLINICAL FEATURES",
"    </span>",
"    &nbsp;&mdash;&nbsp;A number of clinical characteristics (",
"    <a class=\"graphic graphic_table graphicRef50039 \" href=\"UTD.htm?35/2/35883\">",
"     table 4",
"    </a>",
"    ) are associated with PMDs [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/6,25\">",
"     6,25",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Abrupt onset",
"     </li>",
"     <li>",
"      History of a precipitating event",
"     </li>",
"     <li>",
"      Fast progression to maximum symptom severity and disability",
"     </li>",
"     <li>",
"      Movement abnormality that is incongruent with organic disease (eg, bizarre, multiple or difficult to classify)",
"     </li>",
"     <li>",
"      Inconsistency over time with variable amplitude, frequency, or distribution of the movement",
"     </li>",
"     <li>",
"      Ability to trigger or relieve the movement with unusual or nonphysiologic intervention (eg, trigger points on the body, application of a tuning fork)",
"     </li>",
"     <li>",
"      Decreased movement of the affected body part with distraction",
"     </li>",
"     <li>",
"      Increased movement of the affected body part during observation or examination",
"     </li>",
"     <li>",
"      Entrainment of movement (eg, tremor) to the frequency of repetitive movements (see",
"      <a class=\"local\" href=\"#H313979223\">",
"       'History and examination'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Coactivation sign of antagonist muscles (see",
"      <a class=\"local\" href=\"#H398881631\">",
"       'Psychogenic tremor'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H537747505\">",
"       'Electrodiagnostic testing'",
"      </a>",
"      below)",
"     </li>",
"     <li>",
"      Deliberate slowness of movement",
"     </li>",
"     <li>",
"      Association with false weakness, sensory loss, and pain",
"     </li>",
"     <li>",
"      Functional disability out of proportion to exam findings",
"     </li>",
"     <li>",
"      Unresponsiveness to drugs for organic movement disorders",
"     </li>",
"     <li>",
"      Responsiveness to placebo drugs and suggestion",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The main PMD syndromes are psychogenic tremor, psychogenic dystonia, psychogenic gait, psychogenic myoclonus, and psychogenic parkinsonism. These are reviewed in the sections below.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H398881631\">",
"    <span class=\"h2\">",
"     Psychogenic tremor",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychogenic tremor is the most common type of PMD [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/28\">",
"     28",
"    </a>",
"    ]. (See",
"    <a class=\"local\" href=\"#H278442966\">",
"     'Epidemiology'",
"    </a>",
"    above.) Tremor associated with typical neurologic disorders is defined as a rhythmic and oscillatory movement of a body part with a relatively constant frequency (",
"    <a class=\"graphic graphic_table graphicRef68810 \" href=\"UTD.htm?29/60/30667\">",
"     table 5",
"    </a>",
"    ). Psychogenic tremor is typically a complex resting, postural, and action tremor. The only known organic tremor with such physical findings is a cerebellar outflow tremor (ie, Holmes tremor) [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/29\">",
"     29",
"    </a>",
"    ]. Any body part may be involved with psychogenic tremor, but hand tremor, leg tremor, and whole body tremor are common sites [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/30\">",
"     30",
"    </a>",
"    ]. Remarkably, the fingers are often spared with much of the upper limb tremor occurring at the wrist [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/20,31\">",
"     20,31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    A characteristic that suggests psychogenic tremor rather than organic tremors is abrupt onset with immediate maximal severity, often precipitated by trivial emotional or physical trauma [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/28\">",
"     28",
"    </a>",
"    ]. In contrast, essential tremor typically begins gradually in one or both arms, requiring years to decades to worsen sufficiently to warrant treatment (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?10/46/10984?source=see_link\">",
"     \"Overview of tremor\"",
"    </a>",
"    ). With psychogenic tremor, a classic but not universal finding is complete remission or entrainment (ie, a shift of tremor frequency to the speed of contralateral rhythmic movement) with distraction maneuvers such as repetitive tapping tasks with an uninvolved opposite hand or foot. In some patients with psychogenic tremor, restraining the affected limb may precipitate tremor in other previously unaffected body regions. Additionally, the affected limb may \"fight\" with the examiner when it is restrained. The coactivation sign describes the ongoing isometric contraction of antagonistic muscles that may be perceived on examination as increased muscle tone during passive movement [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/31\">",
"     31",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Electrophysiologic studies may be helpful in documenting the frequency of the psychogenic tremor and distractibility. (See",
"    <a class=\"local\" href=\"#H537747505\">",
"     'Electrodiagnostic testing'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H398882742\">",
"    <span class=\"h2\">",
"     Psychogenic dystonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Psychogenic dystonia is the second most common type of PMD in most series (see",
"    <a class=\"local\" href=\"#H278442966\">",
"     'Epidemiology'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    True dystonia is defined as involuntary sustained muscle contractions causing twisting and repetitive movements or abnormal postures (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?0/60/970?source=see_link\">",
"     \"Classification and evaluation of dystonia\"",
"    </a>",
"    ). Psychogenic dystonia may affect any part of the body or be generalized. Features that suggest a psychogenic etiology include inconsistent dystonic movements over time, dystonia presenting as a fixed posture or a paroxysmal disorder (not due to a known paroxysmal movement disorder), the presence of incongruous dystonic movements and postures (eg, facial grimacing with pulling of the mouth to one side), excessive slowness, marked resistance to passive movements, and multiple somatizations [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/5,32,33\">",
"     5,32,33",
"    </a>",
"    ]. Additional suggestive features include foot dystonia in an adult, the presence of other atypical movements or postures such as a bizarre gait, dystonia occurring when the affected body part is at rest, and pain as a prominent aspect. Muscle atrophy or joint contractures may be present in longstanding psychogenic dystonia due to disuse or prolonged maintenance of the tonic posture. Muscle hypertrophy may be present due to sustained contracture.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H19168773\">",
"    <span class=\"h3\">",
"     Peripherally induced dystonia",
"    </span>",
"    &nbsp;&mdash;&nbsp;Dystonia that occurs after peripheral trauma has been described in adults and children and is known by a number of terms, including fixed dystonia, traumatic or posttraumatic dystonia, posttraumatic cervical dystonia, posttraumatic painful torticollis, peripherally induced dystonia, causalgia-dystonia syndrome, and complex regional pain syndrome dystonia [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/18,34-40\">",
"     18,34-40",
"    </a>",
"    ]. The inciting injury may involve nerve root, peripheral nerve, or soft tissue. Although the mechanism of peripherally induced dystonia is controversial [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/41-47\">",
"     41-47",
"    </a>",
"    ], there is little evidence to support an organic basis, while the overlap with features suggestive of PMD is extensive [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/35\">",
"     35",
"    </a>",
"    ]. Thus, many cases are probably psychogenic.",
"   </p>",
"   <p>",
"    The following observations illustrate these points:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      One of the larger studies described 103 patients with dystonic postures and joint contractures, including 41 who were prospectively assessed [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/18\">",
"       18",
"      </a>",
"      ]. The majority were women (84 percent) and young (mean age of onset 30 years), with a mean disease duration of five years prior to evaluation. A peripheral, back or neck injury preceded onset in 63 percent, and a history of somatization disorder was noted in 22 percent. A psychologic stressor or psychiatric disorder was present at onset in 10 percent. Features of complex regional pain syndrome were present in 41 percent. Psychogenic signs on examination (including give-way weakness, nonanatomic sensory changes, and self-inflicted injuries) were present in 33 percent of the entire cohort, and in 46 percent of the prospective group. Diagnostic investigations revealed no consistent abnormalities to explain dystonia, and genetic testing conducted in 25 patients was negative for the DYT1 mutation, the most common positive genetic abnormality in patients with hereditary dystonia. Criteria for clinically definite psychogenic dystonia were fulfilled by 24 percent of the entire cohort and by 36 percent of the prospective group. Prognosis was poor, with rates of complete remission for the entire cohort and the prospective group of 8 and 10 percent, respectively, although follow-up was relatively short (mean 2.9 and 3.9 years respectively).",
"     </li>",
"     <li>",
"      In a retrospective chart review of 16 patients with posttraumatic painful dystonia, all 16 were seeking compensation through the courts [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/34\">",
"       34",
"      </a>",
"      ]. Unlike other forms of PMD, men and women were equally represented. All had a trivial motor vehicle or work-related accident with abrupt onset shortly after the injury and little or no progression after the first week of onset. All 16 patients had prominent pain. The characteristic posture, a fixed head tilt with shoulder elevation, was present in 15 patients. Nondermatomal sensory loss was present in 14. Intravenous",
"      <a class=\"drug drug_general\" href=\"UTD.htm?36/7/36982?source=see_link\">",
"       amobarbital",
"      </a>",
"      improved the posture, pain, or both in all 13 patients undergoing the procedure, and marked or complete remission of sensory deficits occurred for 7 of the 13 patients. Formal psychologic evaluation of 11 patients revealed conflict, stress, or both and a tendency to express distress through somatic complaints.",
"     </li>",
"    </ul>",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H278443023\">",
"    <span class=\"h2\">",
"     Psychogenic gait",
"    </span>",
"    &nbsp;&mdash;&nbsp;In psychogenic gait disorders, walking is often bizarre and does not conform to any of the usual patterns observed with neurologic gait disorders (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/12/9417?source=see_link&amp;anchor=H7#H7\">",
"     \"Gait disorders of elderly patients\", section on 'Neurologic causes'",
"    </a>",
"    ). There may be excessive slowness and stiffness, or maintenance of postural control on a narrow base with flailing arms and excessive trunk sway. Astasia-abasia, an inability to stand (astasia) or walk (abasia) in the absence of other neurologic abnormalities, was the term applied by investigators in the mid to late 19",
"    <sup>",
"     th",
"    </sup>",
"    century to describe certain patients with a frankly psychogenic gait [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/48,49\">",
"     48,49",
"    </a>",
"    ]. Other descriptive terms include gaits that resemble walking on ice, walking a sticky surface, walking through water (bringing to mind excessive slowness), tightrope walking, habitual limping, and bizarre, robotic, knock-kneed, trepidant, anxious, and cautious gaits [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/5,50\">",
"     5,50",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Features suggestive of a psychogenic gait disorder are illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a report that analyzed the clinical manifestations of psychogenic gait disorder in 37 patients, the following six characteristics were identified as supporting the diagnosis [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/51\">",
"       51",
"      </a>",
"      ]:",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Momentary fluctuations of stance and gait, often in response to suggestion",
"     </li>",
"     <li>",
"      Excessive slowness or hesitation of locomotion incompatible with neurologic disease",
"     </li>",
"     <li>",
"      A \"psychogenic\" response to the Romberg test, with a build-up of swaying amplitudes after a silent latency, or with improvement by distraction",
"     </li>",
"     <li>",
"      Uneconomic postures that waste muscular energy",
"     </li>",
"     <li>",
"      Walking on ice, characterized by small, cautious steps with fixed ankle joints",
"     </li>",
"     <li>",
"      Sudden buckling of the knees, usually without falls",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a retrospective review of 279 patients with various types of PMD, a psychogenic gait disturbance was paired with additional psychogenic movements in 102 patients (37 percent), and a pure psychogenic gait disturbance in 16 patients (5 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/52\">",
"       52",
"      </a>",
"      ]. Thus, a psychogenic gait was present in a total of 118 patients (42 percent). The most frequent gait patterns among all 118 patients with a psychogenic gait were excessive slowness (19 percent), dystonic gait (18 percent), bizarre gait (12 percent), astasia-abasia (12 percent) and knee buckling (8 percent). For the 16 patients with a pure psychogenic gait disturbance, the most frequent patterns were knee buckling (31 percent), astasia-abasia (19 percent) and bizarre gait (13 percent). Compared with patients who had another PMD and normal gait, those with a psychogenic gait disorder had more frequent excessive slowing of movements on finger to nose testing and finger or foot tapping.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The mere presence of a cautious gait does not confirm a psychogenic etiology. A cautious gait may be a legitimate psychological adaptation, based upon an appropriate response to real or perceived disequilibrium [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/53\">",
"     53",
"    </a>",
"    ]. This type of cautious gait is characterized by a shortened stride, a normal to mildly widened base, slow walking speed, en bloc turns, and mild disequilibrium. Other neurologic symptoms and signs are mild or absent. In contrast to an appropriately cautious gait, patients with an incapacitating fear of falling may exhibit another type of cautious gait described as \"space phobia\" and characterized by timid walking while holding on to furniture and walls [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/54\">",
"     54",
"    </a>",
"    ]. However, other psychogenic features are typically absent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/50\">",
"     50",
"    </a>",
"    ]. In addition to appropriate caution and fear of falling, the differential diagnosis of cautious gait includes higher level organic gait disorders. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?9/12/9417?source=see_link&amp;anchor=H14#H14\">",
"     \"Gait disorders of elderly patients\", section on 'Frontal lobe dysfunction'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Anxiety and depression usually have a minor effect on gait [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/49\">",
"     49",
"    </a>",
"    ]. However, severely depressed patients with psychomotor retardation may walk with reduced stride length and a lifting motion of the legs [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/55\">",
"     55",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H278443030\">",
"    <span class=\"h2\">",
"     Psychogenic myoclonus",
"    </span>",
"    &nbsp;&mdash;&nbsp;Myoclonus is a brief, shock-like muscle contraction (positive myoclonus) or a sudden lapse in tone (negative myoclonus or asterixis) of the affected body part. Patients will usually describe myoclonus as consisting of \"jerks,\" \"shakes,\" or \"spasms.\" Myoclonic movements have many possible etiologies and pathophysiologic features (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?7/32/7689?source=see_link\">",
"     \"Classification and evaluation of myoclonus\"",
"    </a>",
"    ). The characteristics of psychogenic myoclonus were described in detail by a report of 212 patients with myoclonus that included 18 patients diagnosed with psychogenic myoclonus [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/56\">",
"     56",
"    </a>",
"    ]. The characteristics of psychogenic myoclonus were the following:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Inconsistent character of the movements (amplitude, frequency, and distribution) and other features incongruous with typical \"organic\" myoclonus",
"     </li>",
"     <li>",
"      Associated psychogenic symptomatology",
"     </li>",
"     <li>",
"      Marked reduction of the myoclonus with distraction",
"     </li>",
"     <li>",
"      Exacerbation and relief with suggestion and placebo",
"     </li>",
"     <li>",
"      Spontaneous periods of remission",
"     </li>",
"     <li>",
"      Acute onset and sudden resolution",
"     </li>",
"     <li>",
"      Evidence of underlying psychopathology",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Electrodiagnostic testing can be helpful in differentiating psychogenic myoclonus from true myoclonus. (See",
"    <a class=\"local\" href=\"#H537747505\">",
"     'Electrodiagnostic testing'",
"    </a>",
"    below.)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H278443037\">",
"    <span class=\"h3\">",
"     Startle syndromes",
"    </span>",
"    &nbsp;&mdash;&nbsp;Startle is a physiologic generalized myoclonic response to an unexpected auditory, visual, somatosensory, and vestibular stimulus that occurs in normal individuals. It consists of a short latency stereotyped blink, facial grimace, or brisk flexion of the neck, trunk, and upper limbs [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/57,58\">",
"     57,58",
"    </a>",
"    ]. Normal startle is characterized by consistent latency of response after stimulation and rapid habituation to repetitive stimulation. Patients with pathologic exaggerated startle (hyperekplexia) do not habituate. Sporadic and hereditary forms of hyperekplexia are considered organic and can produce generalized myoclonus [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/58,59\">",
"     58,59",
"    </a>",
"    ]. Patients with psychogenic startle tend to have an exaggerated initial startle response that habituates to repetitive stimulation but shows inconsistent latencies [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/60\">",
"     60",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Culturally determined forms of startle presumed to be psychogenic in origin include the latah syndrome of Malaysia and Indonesia, the Jumping Frenchmen of Maine, the Ragin' Cajuns of Louisiana, and the miryachit phenomenon of eastern Siberia [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/61-63\">",
"     61-63",
"    </a>",
"    ]. A psychodynamic explanation of these forms of excessive startle is that they represent an environment-dependent behavior determined by culture, isolation, and familial behavior, particularly in the case of the orienting behaviors. These may include automatic obedience, echopraxia, perseveration of simple movements, vocalizations, and coprolalia [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/61\">",
"     61",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H278443044\">",
"    <span class=\"h2\">",
"     Psychogenic parkinsonism",
"    </span>",
"    &nbsp;&mdash;&nbsp;The motor manifestations of true parkinsonism are the presence of rest tremor, bradykinesia, rigidity, and postural instability (see",
"    <a class=\"medical medical_review\" href=\"UTD.htm?14/13/14554?source=see_link&amp;anchor=H2#H2\">",
"     \"Clinical manifestations of Parkinson disease\", section on 'Cardinal manifestations'",
"    </a>",
"    ). The manifestations of psychogenic parkinsonism can be superficially similar but have features suggesting a psychogenic origin (see",
"    <a class=\"local\" href=\"#H278442994\">",
"     'Clinical features'",
"    </a>",
"    above).",
"   </p>",
"   <p>",
"    Unlike a parkinsonian tremor, the tremor of psychogenic parkinsonism shares the characteristics of isolated psychogenic tremor (see",
"    <a class=\"local\" href=\"#H398881631\">",
"     'Psychogenic tremor'",
"    </a>",
"    above), manifesting as a complex resting, postural, and action tremor with abrupt onset, a static course, and changeable features [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/5,64-66\">",
"     5,64-66",
"    </a>",
"    ]. The tremor will typically increase with attention and decrease with distraction [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/30\">",
"     30",
"    </a>",
"    ]. With psychogenic bradykinesia, movements are slow and effortful, but usually lack the typical reduction in speed or amplitude that is observed with successive movements in true bradykinesia. Increased muscle tone is a result of voluntary opposition (ie, gegenhalten) rather than the true rigidity (ie, involuntary resistance to passive movement) seen with parkinsonism, and cogwheeling is absent. Atypical gait abnormalities and postural instability are often present, but postural stability testing may reveal bizarre responses such as arm flailing and reeling backward without falling.",
"   </p>",
"   <p>",
"    Features of psychogenic parkinsonism may coexist with organic Parkinson disease, and some evidence suggests that psychogenic parkinsonism or other somatoform disorders can be an early manifestation of Parkinson disease [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/67,68\">",
"     67,68",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      In a study of 14 patients with psychogenic parkinsonism, tremor was present in 12, balance and gait difficulties were present in 12, and rigidity with voluntary resistance was noted in 6 [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/65\">",
"       65",
"      </a>",
"      ]. Non-physiologic weakness and sensory disturbances were present in 10 patients.",
"     </li>",
"     <li>",
"      In another report of nine patients referred for suspicion of psychogenic parkinsonism who were followed for at least two years, the final diagnosis was pure psychogenic parkinsonism for four patients and a combination of psychogenic parkinsonism with Parkinson disease for five patients [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/69\">",
"       69",
"      </a>",
"      ]. Common clinical features in this group included the sudden onset of symptoms, precipitation by emotional, physical, financial or legal factors, marked disability despite short duration of symptoms, false neurologic signs, atypical tremor (violent shaking of one arm, generalized violent shaking, distractibility), gegenhalten tone, lack of response to adequate levodopa treatment trials, and psychological disturbances including depression, anxiety, personality, or bipolar disorder. For one patient who was initially misdiagnosed as having combined psychogenic parkinsonism and Parkinson disease, clinical follow-up and persistently normal single photon emission computed tomography (SPECT) scan findings excluded Parkinson disease and supported the final diagnosis of pure psychogenic parkinsonism.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A normal dopamine transporter imaging study using SPECT scan is helpful for supporting a diagnosis of psychogenic, drug-induced or vascular parkinsonism [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/70\">",
"     70",
"    </a>",
"    ]. However, change from normal to abnormal may occur over time, and, therefore, a single test should not be used to support a diagnosis of PMD. (See",
"    <a class=\"local\" href=\"#H537747554\">",
"     'Neuroimaging'",
"    </a>",
"    below and",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/30/26089?source=see_link&amp;anchor=H18#H18\">",
"     \"Diagnosis of Parkinson disease\", section on 'DaTscan'",
"    </a>",
"    .)",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H278443749\">",
"    <span class=\"h1\">",
"     DIAGNOSIS AND DIFFERENTIAL",
"    </span>",
"    &nbsp;&mdash;&nbsp;The diagnosis of a PMD is based upon clinical impression:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis of PMD requires the presence of characteristic clinical features (",
"      <a class=\"graphic graphic_table graphicRef50039 \" href=\"UTD.htm?35/2/35883\">",
"       table 4",
"      </a>",
"      ), particularly symptoms and signs that are inconsistent over time and incongruent with organic movement disorders [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/1,6\">",
"       1,6",
"      </a>",
"      ]. Thus, the diagnosis depends on positive criteria and is not merely one of exclusion.",
"     </li>",
"     <li>",
"      Coexisting psychologic factors and psychiatric disorders are supportive features for the diagnosis of PMD, but their presence is not required [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/14\">",
"       14",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      PMD can coexist with organic illness.",
"     </li>",
"     <li>",
"      There is no gold standard test for confirming the diagnosis of PMD. However, electrodiagnostic studies can provide additional supportive evidence for the diagnosis of psychogenic tremor and psychogenic myoclonus, and dopamine transporter imaging with SPECT scan can support the diagnosis of psychogenic parkinsonism by excluding organic causes of parkinsonism. (See",
"      <a class=\"local\" href=\"#H537747505\">",
"       'Electrodiagnostic testing'",
"      </a>",
"      below and",
"      <a class=\"local\" href=\"#H537747554\">",
"       'Neuroimaging'",
"      </a>",
"      below.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The diagnosis of PMD is best made by clinicians with expertise in movement disorders. An accurate diagnosis depends not only on the ability to recognize the characteristic features of PMDs, but also on a meticulous knowledge of organic movement disorders and their common and rare variants. To illustrate this point, a patient presenting with a very symmetric akinetic rigid syndrome without tremor may be erroneously diagnosed with psychogenic parkinsonism. In fact, such a presentation is common among other parkinsonian syndromes such as multiple system atrophy. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?28/49/29465?source=see_link\">",
"     \"Multiple system atrophy: Clinical features and diagnosis\"",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Among PMDs, psychogenic dystonia is particularly challenging to diagnose because it is typically a persistent, tonic condition that often manifests as a fixed posture [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/6\">",
"     6",
"    </a>",
"    ]. These features contrast with the variability that is typical of most other PMDs. In addition, they preclude assessment of certain clues that support a psychogenic etiology, such as distractibility, entrainment, and increased movement during observation or examination.",
"   </p>",
"   <p>",
"    As a note of caution, the literature documents a number of examples of mislabeling PMD [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/9,10,71\">",
"     9,10,71",
"    </a>",
"    ]. However, a systematic review published in 2005 found that the misdiagnosis rate for patients with various conversion symptoms, including some with abnormal movements, has been approximately 4 percent since the 1970s [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/72\">",
"     72",
"    </a>",
"    ]. While not specific for PMDs, this finding suggests that the misdiagnosis rate for conversion disorder is not unacceptably high compared with other psychiatric and neurologic disorders [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H313979223\">",
"    <span class=\"h2\">",
"     History and examination",
"    </span>",
"    &nbsp;&mdash;&nbsp;PMDs often begin suddenly with maximal disability at onset after a trivial provocation (eg, lifting a moderate weight, or following a non-concussive motor vehicle accident). In contrast, organic movement disorders typically begin gradually, except when the underlying cause is an acute illness such as a stroke. With time, the severity and anatomic distribution of the movements and associated disability tend to increase more or less linearly. As an example, the typical history for cervical dystonia is onset with a gradual pulling, perhaps while sitting at the computer. Over time, head turning is evident during other activities, with more extreme postures appearing. Pain is common in organic cervical dystonia but is not the dominant feature of presentation.",
"   </p>",
"   <p>",
"    Despite severe disability, PMD often has periods of \"complete remission,\" allowing the sufferer to do select activities unimpeded. Significant remission in response to psychotherapy or to treatment without a pathophysiologic rationale is also suspicious for a psychogenic etiology of a movement disorder; for example, complete remission of parkinsonian symptoms with herbal remedies [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/74\">",
"     74",
"    </a>",
"    ]. Similarly, lack of response to appropriate treatment, such as levodopa for Parkinson disease, also increases suspicion for PMD in the proper clinical context [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/64\">",
"     64",
"    </a>",
"    ]. However, this is a nonspecific finding that could also support a diagnosis of atypical parkinsonism.",
"   </p>",
"   <p>",
"    Social history may provide important clues to PMD. Familiarity with organic illness among family members, acquaintances, or due to employment as a healthcare professional, may predispose to the development of PMD. A history of sexual or physical abuse may be suppressed by patients with PMD and should be considered carefully when interviewing the patient [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/75\">",
"     75",
"    </a>",
"    ]. Collateral history from family members, other clinicians, and healthcare providers is important, especially in obtaining deeply private information such as a history of sexual and physical abuse during childhood.",
"   </p>",
"   <p>",
"    Accompanying signs or symptoms are helpful in diagnosing PMD. Nonanatomic sensory change, give-way weakness, and bizarre gaits (eg, walking on a tightrope, histrionic lurching without losing balance) are common in PMD [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/52\">",
"     52",
"    </a>",
"    ]. Patients may have nonphysiologic triggers or relieving factors (eg, tapping the patellar tendon, inducing distant myoclonus or squeezing the neck, inducing forceful neck flexion).",
"   </p>",
"   <p>",
"    One of the most important physical findings that can help differentiate PMD from organic movement disorders is distractibility, not to be confused with a sensory trick that allows near or complete normal posture in dystonia. Distracting maneuvers typically diminish the intensity of the movement in PMD. In contrast, distracting maneuvers usually increase intensity of the movement in organic movement disorders. Variation in frequency and amplitude of the movement, especially with tremor, is an additional clue that the movement is psychogenic.",
"   </p>",
"   <p>",
"    Entrainment is another feature associated with PMD, and refers to the physical examination finding of the limb taking on the same frequency of movement as an unaffected limb during a maneuver requiring concentration. In particular, psychogenic tremor will entrain (take on the distracting maneuver's frequency) with distraction, while organic tremor typically will increase in amplitude and become more evident with distraction, maintaining the original frequency. However, distracting maneuvers may not be effective in longstanding PMD [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H537747505\">",
"    <span class=\"h2\">",
"     Electrodiagnostic testing",
"    </span>",
"    &nbsp;&mdash;&nbsp;Electrodiagnostic methods can provide additional supportive evidence for the diagnosis of psychogenic tremor and psychogenic myoclonus. However, electrodiagnostic methods for analyzing tremor and myoclonus are not universally available and depend on patient effort for accuracy.",
"   </p>",
"   <p>",
"    Tremor analysis using surface electromyography (EMG) and accelerometry can identify features associated with psychogenic tremor, including entrainment, coactivation of antagonist muscles, variability in tremor frequency, and increased tremor amplitude and frequency with weight loading of the involved limb [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/25,31,76,77\">",
"     25,31,76,77",
"    </a>",
"    ]. Coherence analysis is a quantitative method to determine the similarity of tremor oscillation frequency and phase in different limbs or body parts. Psychogenic tremor typically has the same frequency in different limbs or in the shaking limb and another limb performing distracting maneuvers [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/78\">",
"     78",
"    </a>",
"    ]. Changes in frequency are simultaneous when they occur. In contrast, most organic forms of tremor, including essential tremor and parkinsonian tremor, have similar but slightly different frequencies in different body parts, consistent with the presence of multiple oscillators [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Entrainment is a property whereby a tremor synchronizes with the frequency of voluntary tapping of another body part, most often the opposite hand. The degree of similarity of tremor frequency with voluntary tapping can be assessed by coherence analysis. Lack of entrainment suggests an organic etiology of tremor, since essential tremor and parkinsonian tremor maintain their original frequencies and do not entrain. However, in some cases psychogenic tremor will stop or change frequency rather than show clear entrainment. In longstanding PMD, distracting maneuvers may not be effective, a feature that limits the utility of testing with electrodiagnostic methods such as an accelerometer [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/76\">",
"     76",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Electrodiagnostic techniques, including surface EMG, electroencephalography (EEG), back-averaged EEG, and somatosensory evoked potentials, can be helpful in differentiating psychogenic myoclonus from true myoclonus. Features associated with psychogenic myoclonus on surface EMG include abnormally long and variable latency between the stimulus and the myoclonic jerk, variable patterns of muscle recruitment with each jerk, prolonged myoclonic burst duration, a triphasic pattern of agonist and antagonist muscle activation, and habituation with repeated stimulation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/80,81\">",
"     80,81",
"    </a>",
"    ]. In organic myoclonus of cortical origin, the myoclonic jerk has a short latency of 60 to 70 ms after a stimulus-induced cortical evoked potential on EEG and consists of short duration (10 to 50 ms) burst activity in an agonist muscle on EMG accompanied by co-contraction in antagonist muscles. Brainstem myoclonus has short latencies (less than 80 ms) affecting the upper body. A pattern consistent with voluntary movement (ie, a long latency of 100 to 120 ms from stimulus to jerk) is suggestive of psychogenic myoclonus. In addition, psychogenic myoclonus is usually but not always preceded by a Bereitschaftspotential, which is a normal movement-related cognitive potential indicative of premotor activity that occurs prior to movement on back-averaged EEG [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/82\">",
"     82",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    There are no definitive electrodiagnostic tests for distinguishing psychogenic dystonia from organic dystonia [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/79\">",
"     79",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H537747554\">",
"    <span class=\"h2\">",
"     Neuroimaging",
"    </span>",
"    &nbsp;&mdash;&nbsp;A normal dopamine transporter imaging study using SPECT scan is helpful for supporting a diagnosis of psychogenic, drug-induced or vascular parkinsonism [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/70\">",
"     70",
"    </a>",
"    ]. However, change from normal to abnormal may occur over time, and, therefore, a single test should not be used to support a diagnosis of PMD. (See",
"    <a class=\"medical medical_review\" href=\"UTD.htm?25/30/26089?source=see_link&amp;anchor=H18#H18\">",
"     \"Diagnosis of Parkinson disease\", section on 'DaTscan'",
"    </a>",
"    .)",
"   </p>",
"   <p>",
"    Neuroimaging with CT and MRI scans has little utility for the diagnosis of patients with suspected PMD, except to exclude the possibility of an underlying structural abnormality that potentially contradicts the diagnosis of a PMD. However, the diagnosis of PMD depends on positive criteria (",
"    <a class=\"graphic graphic_table graphicRef50039 \" href=\"UTD.htm?35/2/35883\">",
"     table 4",
"    </a>",
"    ) and is not merely one of exclusion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H278443058\">",
"    <span class=\"h2\">",
"     Classification of diagnostic certainty",
"    </span>",
"    &nbsp;&mdash;&nbsp;Criteria for degrees of certainty in the diagnosis of PMDs were first proposed in 1988 and are well-known among specialists familiar with PMDs [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/32\">",
"     32",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Documented PMD &ndash; Consistently and persistently relieved by psychotherapy with or without psychotropic medication, or symptoms may be seen to spontaneously remit when the patient is unaware of being observed, as seen in malingering or factitious disorder. (Note that organic movement disorders may demonstrate transient improvement with psychotropic drugs).",
"     </li>",
"     <li>",
"      Clinically established PMD &ndash; Inconsistent symptoms and signs, and presentation incongruent with the typical presentation of an organic movement disorder, and presence of other psychogenic signs such as false weakness or sensory loss, multiple somatizations and obvious psychiatric diagnosis.",
"     </li>",
"     <li>",
"      Probable PMD &ndash; Inconsistent or incongruent with an organic movement disorder but lacking other features listed above, or abnormal movements that are consistent and congruent with an organic disorder and coexistent psychogenic signs such as false weakness or sensory loss, or movements consistent and congruent with an organic disorder but manifest multiple somatizations.",
"     </li>",
"     <li>",
"      Possible PMD &ndash; Movements consistent and congruent with an organic disorder, but other features are present that raise the level of suspicion that the diagnosis is psychogenic in nature. These features include inappropriate affect, a discrepancy between the movement disorder and the reported disability or the presence of secondary gain.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    A few subsequent reports have attempted to validate and revise these original criteria [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/1,14,83\">",
"     1,14,83",
"    </a>",
"    ], but the clinical value of the original and revised versions is uncertain [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/73\">",
"     73",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H278443065\">",
"    <span class=\"h1\">",
"     MANAGEMENT",
"    </span>",
"    &nbsp;&mdash;&nbsp;Optimal management of PMDs consists of early diagnosis, providing the patient a credible explanation of the diagnosis, curtailing investigations, and a multidisciplinary approach to treatment.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H623641336\">",
"    <span class=\"h2\">",
"     Explaining the diagnosis",
"    </span>",
"    &nbsp;&mdash;&nbsp;Informing the patient of the diagnosis of PMD is often problematic because most patients do not accept that the trouble may be psychiatric, and many become alienated and seek another opinion [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/11\">",
"     11",
"    </a>",
"    ]. However, it is the role of the neurologist to make and convey the diagnosis of PMD because most psychiatrists lack sufficient expertise in movement disorders. While some experts use the term &ldquo;psychogenic&rdquo; when telling the patient of the diagnosis of PMD, others suggest that the term &ldquo;functional&rdquo; movement disorder may be preferred for patient acceptance. Except for rare patients with factitious disorder or malingering, it is important to let the patient know that the condition is &ldquo;real&rdquo; and involuntary, that the main components of the neurologic examination are normal, and that there is potential for recovery [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/5,11\">",
"     5,11",
"    </a>",
"    ]. Some neurologists find it useful to review symptoms with the patient using a website &ndash;",
"    <a class=\"external\" href=\"file://www.neurosymptoms.org/\">",
"     www.neurosymptoms.org",
"    </a>",
"    &ndash; that presents balanced information about functional neurologic disorders. Showing the patient their neurologic signs may be a valuable way to help the patient accept the diagnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/84\">",
"     84",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    It is also advisable to tell the patient that the best approach to treatment involves the neurologist working with a psychiatrist or other practitioner who is skilled in psychological counselling and familiar with PMDs [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/11,85\">",
"     11,85",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H623641343\">",
"    <span class=\"h2\">",
"     Treatment options",
"    </span>",
"    &nbsp;&mdash;&nbsp;There are no proven or universally accepted treatments for PMDs. The evidence supporting available treatments mainly comes from small retrospective studies, and large randomized controlled trials are lacking [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/5\">",
"     5",
"    </a>",
"    ]. Treatments that may be helpful include psychotherapy with or without pharmacotherapy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/85\">",
"     85",
"    </a>",
"    ], cognitive behavioral therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/86\">",
"     86",
"    </a>",
"    ], physical therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/87,88\">",
"     87,88",
"    </a>",
"    ], antidepressant medications [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/89\">",
"     89",
"    </a>",
"    ], mild to moderate exercise [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/90\">",
"     90",
"    </a>",
"    ], transcranial magnetic stimulation [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/91\">",
"     91",
"    </a>",
"    ], and hypnosis [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/92\">",
"     92",
"    </a>",
"    ]. Psychiatric interventions are individualized according to the underlying psychiatric diagnosis. (See",
"    <a class=\"local\" href=\"#H278442973\">",
"     'Underlying psychiatric disorders'",
"    </a>",
"    above.)",
"   </p>",
"   <p>",
"    Multidisciplinary inpatient treatment of PMD lasting weeks to months has been employed by a few specialized centers in Canada and the United Kingdom, with one study of 32 patients reporting resolution of symptoms in 81 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/93\">",
"     93",
"    </a>",
"    ]. In an observational study that prospectively followed 42 patients with fixed dystonia, most of whom fulfilled criteria for PMD at the level of &ldquo;probable&rdquo; or higher, lasting improvement was seen for all 7 patients who received multidisciplinary inpatient treatment combining psychotherapy, cognitive behavioral therapy, physiotherapy, and occupational therapy [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/18\">",
"     18",
"    </a>",
"    ]. These uncontrolled data suggest but do not prove that a multidisciplinary inpatient treatment approach is effective for PMD. However, inpatient treatment for PMD is generally not a viable option in the United States due to insurance restrictions.",
"   </p>",
"   <p>",
"    A few small uncontrolled prospective studies have evaluated the treatment of PMD, as illustrated by the following observations:",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      An assessor-blinded study of nine patients with PMD reported that 12 weeks of psychotherapy was associated with a statistically significant improvement in movement disorder severity compared with baseline [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/85\">",
"       85",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In an uncontrolled study of 15 patients with chronic PMD and recent or current depression or anxiety, antidepressant treatment was associated with improvement in most patients [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/89\">",
"       89",
"      </a>",
"      ].",
"     </li>",
"     <li>",
"      In another assessor-blinded study of 16 sedentary patients with PMD who were treated with a 12 week program of exercise (low intensity walking three times a week), a statistically significant improvement in movement disorder severity was reported for 10 patients (63 percent) [",
"      <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/90\">",
"       90",
"      </a>",
"      ].",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    However, the strength of these studies is limited by the small size and lack of control groups.",
"   </p>",
"   <p>",
"    Given the available data and our clinical experience, we suggest multidisciplinary inpatient treatment (where available) combining psychotherapy, cognitive behavioral therapy, physical therapy, and occupational therapy for patients with PMD rather than outpatient treatment. We suggest multidisciplinary outpatient treatment using the same modalities when inpatient treatment is not an option.",
"   </p>",
"   <p>",
"    In our clinical experience, treatment includes disclosing the diagnosis (see",
"    <a class=\"local\" href=\"#H623641336\">",
"     'Explaining the diagnosis'",
"    </a>",
"    above) to the patient with emphasis that the problem is not &ldquo;made up&rdquo; by the patient or &ldquo;in their head&rdquo;. PMDs represent the complex interaction of mind and physical expression. Involvement with a psychiatrist or psychologist who is familiar with PMDs and treatment of underlying anxiety and depression are useful. Engaging physiotherapy to improve function gradually in a safe environment can be helpful. Finally, spiritual counselling may be helpful for some individuals. The opportunity to &ldquo;save face&rdquo; is important for patients. Clinicians must be inventive to give patients an &ldquo;out&rdquo; from their PMD. Some patients have responded to light physical pressure or touch, suggestion, prayer and other nonconventional interventions. As an example, applying minimal finger pressure on the patient&rsquo;s chest, along with the suggestion that this maneuver will make the movement stop, has been successful on occasion.",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H873058793\">",
"    <span class=\"h1\">",
"     PROGNOSIS",
"    </span>",
"    &nbsp;&mdash;&nbsp;Prognosis for complete remission with longstanding PMD is generally poor [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/11,23,94\">",
"     11,23,94",
"    </a>",
"    ]. In one prospective study of 42 subjects with PMD who were followed for a mean of three years, abnormal movements persisted in 90 percent [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/23\">",
"     23",
"    </a>",
"    ]. In a retrospective study with self-reported outcome data for 122 patients with PMD who had a mean duration of symptoms of 4.7 years and a mean follow-up of 3.4 years, there was improvement, no change, or worsening in 57, 21 and 22 percent, respectively [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/26\">",
"     26",
"    </a>",
"    ].",
"   </p>",
"   <p>",
"    Although data are limited, the following factors have been associated with a poor prognosis for PMD [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/23,26\">",
"     23,26",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Long duration of illness",
"     </li>",
"     <li>",
"      Insidious onset of symptoms",
"     </li>",
"     <li>",
"      Inconsistency of movements",
"     </li>",
"     <li>",
"      Psychiatric comorbidity",
"     </li>",
"     <li>",
"      Smoking",
"     </li>",
"     <li>",
"      Suggestibility",
"     </li>",
"     <li>",
"      Dissatisfaction with physician",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    Factors associated with a more favorable PMD prognosis include the following [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/23,26\">",
"     23,26",
"    </a>",
"    ]:",
"   </p>",
"   <p>",
"    <ul class=\"bulletCompact-block\">",
"     <li>",
"      Short duration of symptoms (&lt;1 year)",
"     </li>",
"     <li>",
"      Good physical health",
"     </li>",
"     <li>",
"      Positive social life perception",
"     </li>",
"     <li>",
"      Elimination of stressors",
"     </li>",
"     <li>",
"      Patient perception of receiving effective treatment",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    The presence of litigation did not correlate significantly with prognosis in these studies [",
"    <a class=\"abstract\" href=\"UTD.htm?9/62/10218/abstract/23,26\">",
"     23,26",
"    </a>",
"    ].",
"   </p>",
"   <p class=\"headingAnchor\" id=\"H873058801\">",
"    <span class=\"h1\">",
"     SUMMARY AND RECOMMENDATIONS",
"    </span>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      Psychogenic movement disorder (PMD) is a clinical syndrome defined as the occurrence of abnormal movements that result from a psychologic or psychiatric cause rather than a medical or neurologic cause. Alternative terms for PMD include hysterical movement disorder, functional movement disorder, nonorganic movement disorder, and medically unexplained motor symptoms. (See",
"      <a class=\"local\" href=\"#H278442959\">",
"       'Introduction and background'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prevalence estimates among adults and children suggest that PMDs account for 2 to 4 percent of all movement disorders. Psychogenic tremor is the most frequent type of involuntary movement with PMD, followed by psychogenic dystonia. (See",
"      <a class=\"local\" href=\"#H278442966\">",
"       'Epidemiology'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Conversion disorder (",
"      <a class=\"graphic graphic_table graphicRef79549 \" href=\"UTD.htm?43/46/44779\">",
"       table 1",
"      </a>",
"      ) is probably the most common mechanism of PMD. (See",
"      <a class=\"local\" href=\"#H278442973\">",
"       'Underlying psychiatric disorders'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      A number of clinical characteristics (",
"      <a class=\"graphic graphic_table graphicRef50039 \" href=\"UTD.htm?35/2/35883\">",
"       table 4",
"      </a>",
"      ) are associated with PMDs. The main PMD syndromes are psychogenic tremor, psychogenic dystonia, psychogenic gait, psychogenic myoclonus, and psychogenic parkinsonism.",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"hyphen-block\">",
"     <li>",
"      Psychogenic tremor is typically a complex resting, postural, and action tremor of abrupt onset. Any body part may be involved although the fingers are often spared. (See",
"      <a class=\"local\" href=\"#H398881631\">",
"       'Psychogenic tremor'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Psychogenic dystonia may affect any part of the body or be generalized. Features include inconsistent dystonic movements over time, dystonia presenting as a fixed posture or a paroxysmal disorder, the presence of incongruous dystonic movements and postures, excessive slowness, marked resistance to passive movements, multiple somatizations, foot dystonia in an adult, and pain as a prominent aspect. (See",
"      <a class=\"local\" href=\"#H398882742\">",
"       'Psychogenic dystonia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Dystonia that occurs after peripheral trauma is known by a number of terms, including fixed dystonia, traumatic or posttraumatic dystonia, posttraumatic cervical dystonia, posttraumatic painful torticollis, peripherally induced dystonia, causalgia-dystonia syndrome, and complex regional pain syndrome dystonia. Although controversial, many cases are probably psychogenic. (See",
"      <a class=\"local\" href=\"#H19168773\">",
"       'Peripherally induced dystonia'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      In psychogenic gait disorders, walking is often bizarre and does not conform to any of the usual patterns observed with neurologic gait disorders. (See",
"      <a class=\"local\" href=\"#H278443023\">",
"       'Psychogenic gait'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The characteristics of psychogenic myoclonus include features similar to other PMDs such as acute onset, spontaneous periods of remission, inconsistent character of the movements in terms of amplitude, frequency, and distribution, and marked reduction with distraction. (See",
"      <a class=\"local\" href=\"#H278443030\">",
"       'Psychogenic myoclonus'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      The tremor of psychogenic parkinsonism shares the characteristics of isolated psychogenic tremor, manifesting as a complex resting, postural, and action tremor with abrupt onset, a static course, and changeable features. With psychogenic bradykinesia, movements are slow and effortful, but usually lack the typical reduction in speed or amplitude that is observed with successive movements in true bradykinesia. Increased muscle tone is a result of voluntary opposition rather than true rigidity seen with parkinsonism, and cogwheeling is absent. Atypical gait abnormalities and postural instability are often present, but postural stability testing may reveal bizarre responses. (See",
"      <a class=\"local\" href=\"#H278443044\">",
"       'Psychogenic parkinsonism'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"   <p>",
"    <ul class=\"bullet-block\">",
"     <li>",
"      The diagnosis of PMD requires the presence of characteristic clinical features, particularly symptoms and signs that are inconsistent over time and incongruent with organic movement disorders (",
"      <a class=\"graphic graphic_table graphicRef50039 \" href=\"UTD.htm?35/2/35883\">",
"       table 4",
"      </a>",
"      ). Thus, the diagnosis depends on positive criteria and is not merely one of exclusion. Coexisting psychologic factors and psychiatric disorders are supportive features for the diagnosis, but their presence is not required. Electrodiagnostic studies can provide additional supportive evidence for the diagnosis of psychogenic tremor and psychogenic myoclonus, and dopamine transporter imaging with SPECT scan can support the diagnosis of psychogenic parkinsonism by excluding organic causes of parkinsonism. (See",
"      <a class=\"local\" href=\"#H278443749\">",
"       'Diagnosis and differential'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      There is no proven or universally accepted treatment for PMDs. Optimal management consists of early diagnosis, providing the patient a credible explanation of the diagnosis, and a multidisciplinary approach to treatment that combines psychotherapy, cognitive behavioral therapy, physical therapy, and occupational therapy. Some patients respond to pressure, suggestion, prayer and other nonconventional interventions. (See",
"      <a class=\"local\" href=\"#H278443065\">",
"       'Management'",
"      </a>",
"      above.)",
"     </li>",
"     <li>",
"      Prognosis for complete remission with longstanding PMD is generally poor. However, a number of factors are associated with a more favorable prognosis, including short duration of symptoms, good physical health, positive social life perception, elimination of stressors, and patient perception of receiving effective treatment. (See",
"      <a class=\"local\" href=\"#H873058793\">",
"       'Prognosis'",
"      </a>",
"      above.)",
"     </li>",
"    </ul>",
"   </p>",
"  </div>",
"  <div id=\"topicAgreement\">",
"   Use of UpToDate is subject to the",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_in_page\" target=\"_blank\">",
"    Subscription and License Agreement",
"   </a>",
"   .",
"  </div>",
"  <div class=\"headingAnchor\" id=\"references\">",
"   <h1>",
"    REFERENCES",
"   </h1>",
"   <ol id=\"reference\">",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/1\">",
"      Gupta A, Lang AE. Psychogenic movement disorders. Curr Opin Neurol 2009; 22:430.",
"     </a>",
"    </li>",
"    <li>",
"     Charcot JM. Hystero-epilepsy: A young woman with a convulsive attack in the auditorium. In: Charcot, the clinician: The Tuesday lessons: Excerpts from nine case presentations on general neurology delivered at the Salp&ecirc;tri&egrave;re hospital in 1887&ndash;88, Goetz CG (Ed), Raven Press, New York 1987. p.102.",
"    </li>",
"    <li>",
"     Gowers WR. A Manual of Diseases of the Nervous System, P Blakiston Son &amp; Co, Philadelphia 1886.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/4\">",
"      Head H. An Address ON THE DIAGNOSIS OF HYSTERIA. Br Med J 1922; 1:827.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/5\">",
"      Peckham EL, Hallett M. Psychogenic movement disorders. Neurol Clin 2009; 27:801.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/6\">",
"      Lang AE, Voon V. Psychogenic movement disorders: past developments, current status, and future directions. Mov Disord 2011; 26:1175.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/7\">",
"      Carson AJ, Brown R, David AS, et al. Functional (conversion) neurological symptoms: research since the millennium. J Neurol Neurosurg Psychiatry 2012; 83:842.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/8\">",
"      Edwards MJ, Adams RA, Brown H, et al. A Bayesian account of 'hysteria'. Brain 2012; 135:3495.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/9\">",
"      Simon DK, Nishino S, Scammell TE. Mistaken diagnosis of psychogenic gait disorder in a man with status cataplecticus (\"limp man syndrome\"). Mov Disord 2004; 19:838.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/10\">",
"      Bentivoglio AR, Loi M, Valente EM, et al. Phenotypic variability of DYT1-PTD: does the clinical spectrum include psychogenic dystonia? Mov Disord 2002; 17:1058.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/11\">",
"      Hallett M. Psychogenic movement disorders: a crisis for neurology. Curr Neurol Neurosci Rep 2006; 6:269.",
"     </a>",
"    </li>",
"    <li>",
"     Miyasaki J. Unpublished data, Morton and Gloria Shulman Movement Disorders Centre, Toronto Western Hospital, Univeristy of Toronto.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/13\">",
"      Ertan S, Uluduz D, Ozekmek&ccedil;i S, et al. Clinical characteristics of 49 patients with psychogenic movement disorders in a tertiary clinic in Turkey. Mov Disord 2009; 24:759.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/14\">",
"      Williams DT, Ford B, Fahn S. Phenomenology and psychopathology related to psychogenic movement disorders. Adv Neurol 1995; 65:231.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/15\">",
"      Factor SA, Podskalny GD, Molho ES. Psychogenic movement disorders: frequency, clinical profile, and characteristics. J Neurol Neurosurg Psychiatry 1995; 59:406.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/16\">",
"      Portera-Cailliau C, Victor D, Frucht S, Fahn S. Movement disorders fellowship training program at Columbia University Medical Center in 2001-2002. Mov Disord 2006; 21:479.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/17\">",
"      Schwingenschuh P, Pont-Sunyer C, Surtees R, et al. Psychogenic movement disorders in children: a report of 15 cases and a review of the literature. Mov Disord 2008; 23:1882.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/18\">",
"      Schrag A, Trimble M, Quinn N, Bhatia K. The syndrome of fixed dystonia: an evaluation of 103 patients. Brain 2004; 127:2360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/19\">",
"      Kirsch DB, Mink JW. Psychogenic movement disorders in children. Pediatr Neurol 2004; 30:1.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/20\">",
"      Bhatia KP, Schneider SA. Psychogenic tremor and related disorders. J Neurol 2007; 254:569.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/21\">",
"      McKeon A, Ahlskog JE, Bower JH, et al. Psychogenic tremor: long-term prognosis in patients with electrophysiologically confirmed disease. Mov Disord 2009; 24:72.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/22\">",
"      Cubo E, Hinson VK, Goetz CG, et al. Transcultural comparison of psychogenic movement disorders. Mov Disord 2005; 20:1343.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/23\">",
"      Feinstein A, Stergiopoulos V, Fine J, Lang AE. Psychiatric outcome in patients with a psychogenic movement disorder: a prospective study. Neuropsychiatry Neuropsychol Behav Neurol 2001; 14:169.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/24\">",
"      Kranick S, Ekanayake V, Martinez V, et al. Psychopathology and psychogenic movement disorders. Mov Disord 2011; 26:1844.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/25\">",
"      Hinson VK, Haren WB. Psychogenic movement disorders. Lancet Neurol 2006; 5:695.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/26\">",
"      Thomas M, Vuong KD, Jankovic J. Long-term prognosis of patients with psychogenic movement disorders. Parkinsonism Relat Disord 2006; 12:382.",
"     </a>",
"    </li>",
"    <li>",
"     American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, 4th, text revision, American Psychiatric Association, Washington, DC 2000.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/28\">",
"      Kim YJ, Pakiam AS, Lang AE. Historical and clinical features of psychogenic tremor: a review of 70 cases. Can J Neurol Sci 1999; 26:190.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/29\">",
"      Gajos A, Bogucki A, Schinwelski M, et al. The clinical and neuroimaging studies in Holmes tremor. Acta Neurol Scand 2010; 122:360.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/30\">",
"      Thomas M, Jankovic J. Psychogenic movement disorders: diagnosis and management. CNS Drugs 2004; 18:437.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/31\">",
"      Deuschl G, K&ouml;ster B, L&uuml;cking CH, Scheidt C. Diagnostic and pathophysiological aspects of psychogenic tremors. Mov Disord 1998; 13:294.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/32\">",
"      Fahn S, Williams DT. Psychogenic dystonia. Adv Neurol 1988; 50:431.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/33\">",
"      Lang AE. Psychogenic dystonia: a review of 18 cases. Can J Neurol Sci 1995; 22:136.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/34\">",
"      Sa DS, Mailis-Gagnon A, Nicholson K, Lang AE. Posttraumatic painful torticollis. Mov Disord 2003; 18:1482.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/35\">",
"      Hawley JS, Weiner WJ. Psychogenic dystonia and peripheral trauma. Neurology 2011; 77:496.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/36\">",
"      Tarsy D. Comparison of acute- and delayed-onset posttraumatic cervical dystonia. Mov Disord 1998; 13:481.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/37\">",
"      Bhatia KP, Bhatt MH, Marsden CD. The causalgia-dystonia syndrome. Brain 1993; 116 ( Pt 4):843.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/38\">",
"      Lang AE, Chen R. Dystonia in complex regional pain syndrome type I. Ann Neurol 2010; 67:412.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/39\">",
"      Majumdar A, L&oacute;pez-Casas J, Poo P, et al. Syndrome of fixed dystonia in adolescents--short term outcome in 4 cases. Eur J Paediatr Neurol 2009; 13:466.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/40\">",
"      Sankhla C, Lai EC, Jankovic J. Peripherally induced oromandibular dystonia. J Neurol Neurosurg Psychiatry 1998; 65:722.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/41\">",
"      Jankovic J. Can peripheral trauma induce dystonia and other movement disorders? Yes! Mov Disord 2001; 16:7.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/42\">",
"      Weiner WJ. Can peripheral trauma induce dystonia? No! Mov Disord 2001; 16:13.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/43\">",
"      Carroll CG, Hawley JS, Ney JP. Post-traumatic shoulder dystonia in an active duty soldier. Mil Med 2006; 171:494.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/44\">",
"      Bohlhalter S, Leon-Sarmiento FE, Hallett M. Abnormality of motor cortex excitability in peripherally induced dystonia. Mov Disord 2007; 22:1186.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/45\">",
"      Kumar H, Jog M. Peripheral trauma induced dystonia or post-traumatic syndrome? Can J Neurol Sci 2011; 38:22.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/46\">",
"      Munts AG, Koehler PJ. How psychogenic is dystonia? Views from past to present. Brain 2010; 133:1552.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/47\">",
"      van Rooijen DE, Geraedts EJ, Marinus J, et al. Peripheral trauma and movement disorders: a systematic review of reported cases. J Neurol Neurosurg Psychiatry 2011; 82:892.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/48\">",
"      Okun MS, Koehler PJ. Paul Blocq and (psychogenic) astasia abasia. Mov Disord 2007; 22:1373.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/49\">",
"      Sudarsky L. Psychogenic gait disorders. Semin Neurol 2006; 26:351.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/50\">",
"      Keane JR. Hysterical gait disorders: 60 cases. Neurology 1989; 39:586.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/51\">",
"      Lempert T, Brandt T, Dieterich M, Huppert D. How to identify psychogenic disorders of stance and gait. A video study in 37 patients. J Neurol 1991; 238:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/52\">",
"      Baik JS, Lang AE. Gait abnormalities in psychogenic movement disorders. Mov Disord 2007; 22:395.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/53\">",
"      Nutt JG, Marsden CD, Thompson PD. Human walking and higher-level gait disorders, particularly in the elderly. Neurology 1993; 43:268.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/54\">",
"      Marks I. Space \"phobia\": a pseudo-agoraphobic syndrome. J Neurol Neurosurg Psychiatry 1981; 44:387.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/55\">",
"      Sloman L, Berridge M, Homatidis S, et al. Gait patterns of depressed patients and normal subjects. Am J Psychiatry 1982; 139:94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/56\">",
"      Monday K, Jankovic J. Psychogenic myoclonus. Neurology 1993; 43:349.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/57\">",
"      Brown P, Rothwell JC, Thompson PD, et al. The hyperekplexias and their relationship to the normal startle reflex. Brain 1991; 114 ( Pt 4):1903.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/58\">",
"      Bhidayasiri R, Truong DD. Startle syndromes. Handb Clin Neurol 2011; 100:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/59\">",
"      Harvey RJ, Topf M, Harvey K, Rees MI. The genetics of hyperekplexia: more than startle! Trends Genet 2008; 24:439.",
"     </a>",
"    </li>",
"    <li>",
"     Sa DS, Galvez-Jimenez N, Lang AE. Psychogenic movement disorders. In: Movement Disorders, 3rd ed, Watts RL, Standaert DG, Obeso JA (Eds), McGraw-Hill, New York 2012. p.975.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/61\">",
"      Simons RC. The resolution of the Latah paradox. J Nerv Ment Dis 1980; 168:195.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/62\">",
"      Saint-Hilaire MH, Saint-Hilaire JM, Granger L. Jumping Frenchmen of Maine. Neurology 1986; 36:1269.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/63\">",
"      McFarling DA. The \"Ragin' Cajuns\" of Louisiana. Mov Disord 2001; 16:531.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/64\">",
"      Miyasaki JM, Sa DS, Galvez-Jimenez N, Lang AE. Psychogenic movement disorders. Can J Neurol Sci 2003; 30 Suppl 1:S94.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/65\">",
"      Lang AE, Koller WC, Fahn S. Psychogenic parkinsonism. Arch Neurol 1995; 52:802.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/66\">",
"      Jankovic J. Diagnosis and treatment of psychogenic parkinsonism. J Neurol Neurosurg Psychiatry 2011; 82:1300.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/67\">",
"      Onofrj M, Bonanni L, Manzoli L, Thomas A. Cohort study on somatoform disorders in Parkinson disease and dementia with Lewy bodies. Neurology 2010; 74:1598.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/68\">",
"      Hallett M. Psychogenic parkinsonism. J Neurol Sci 2011; 310:163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/69\">",
"      Benaderette S, Zanotti Fregonara P, Apartis E, et al. Psychogenic parkinsonism: a combination of clinical, electrophysiological, and [(123)I]-FP-CIT SPECT scan explorations improves diagnostic accuracy. Mov Disord 2006; 21:310.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/70\">",
"      K&auml;gi G, Bhatia KP, Tolosa E. The role of DAT-SPECT in movement disorders. J Neurol Neurosurg Psychiatry 2010; 81:5.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/71\">",
"      Ranawaya R, Riley D, Lang A. Psychogenic dyskinesias in patients with organic movement disorders. Mov Disord 1990; 5:127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/72\">",
"      Stone J, Smyth R, Carson A, et al. Systematic review of misdiagnosis of conversion symptoms and \"hysteria\". BMJ 2005; 331:989.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/73\">",
"      Voon V, Lang AE, Hallett M. Diagnosing psychogenic movement disorders-which criteria should be used in clinical practice? Nat Clin Pract Neurol 2007; 3:134.",
"     </a>",
"    </li>",
"    <li>",
"     Suchowersky O. Personal communication. 2006.",
"    </li>",
"    <li>",
"     Glosser DS, Stern, MB. Psychogenic movement disorders: Theoretical and clinical considerations. In: Parkinson's disease and movement disorders: Diagnosis and treatment guidelines for the practicing physician, Adler CH, Ahlskog JE.  (Eds), Humana Press, Totowa, NJ 2000. p.435.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/76\">",
"      McAuley J, Rothwell J. Identification of psychogenic, dystonic, and other organic tremors by a coherence entrainment test. Mov Disord 2004; 19:253.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/77\">",
"      Raethjen J, Kopper F, Govindan RB, et al. Two different pathogenetic mechanisms in psychogenic tremor. Neurology 2004; 63:812.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/78\">",
"      O'Suilleabhain PE, Matsumoto JY. Time-frequency analysis of tremors. Brain 1998; 121 ( Pt 11):2127.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/79\">",
"      Hallett M. Physiology of psychogenic movement disorders. J Clin Neurosci 2010; 17:959.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/80\">",
"      Thompson PD, Colebatch JG, Brown P, et al. Voluntary stimulus-sensitive jerks and jumps mimicking myoclonus or pathological startle syndromes. Mov Disord 1992; 7:257.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/81\">",
"      Brown P, Thompson PD. Electrophysiological aids to the diagnosis of psychogenic jerks, spasms, and tremor. Mov Disord 2001; 16:595.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/82\">",
"      Shibasaki H, Hallett M. What is the Bereitschaftspotential? Clin Neurophysiol 2006; 117:2341.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/83\">",
"      Shill H, Gerber P. Evaluation of clinical diagnostic criteria for psychogenic movement disorders. Mov Disord 2006; 21:1163.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/84\">",
"      Stone J, Edwards M. Trick or treat? Showing patients with functional (psychogenic) motor symptoms their physical signs. Neurology 2012; 79:282.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/85\">",
"      Hinson VK, Weinstein S, Bernard B, et al. Single-blind clinical trial of psychotherapy for treatment of psychogenic movement disorders. Parkinsonism Relat Disord 2006; 12:177.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/86\">",
"      Shapiro AP, Teasell RW. Behavioural interventions in the rehabilitation of acute v. chronic non-organic (conversion/factitious) motor disorders. Br J Psychiatry 2004; 185:140.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/87\">",
"      Ness D. Physical therapy management for conversion disorder: case series. J Neurol Phys Ther 2007; 31:30.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/88\">",
"      Speed J. Behavioral management of conversion disorder: retrospective study. Arch Phys Med Rehabil 1996; 77:147.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/89\">",
"      Voon V, Lang AE. Antidepressant treatment outcomes of psychogenic movement disorder. J Clin Psychiatry 2005; 66:1529.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/90\">",
"      Dallocchio C, Arbasino C, Klersy C, Marchioni E. The effects of physical activity on psychogenic movement disorders. Mov Disord 2010; 25:421.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/91\">",
"      Dafotakis M, Ameli M, Vitinius F, et al. [Transcranial magnetic stimulation for psychogenic tremor - a pilot study]. Fortschr Neurol Psychiatr 2011; 79:226.",
"     </a>",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/92\">",
"      Moene FC, Spinhoven P, Hoogduin KA, van Dyck R. A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. Int J Clin Exp Hypn 2003; 51:29.",
"     </a>",
"    </li>",
"    <li>",
"     Rosebush P, Mazurek M. Treatment of conversion disorder. In: Psychogenic movement disorders, Hallett M, Fahn S, Jankovic J, et al.  (Eds), Lippincott Williams &amp; Wilkins, Philadelphia 2006. p.289.",
"    </li>",
"    <li>",
"     <a class=\"nounderline abstract\" href=\"UTD.htm?9/62/10218/abstract/94\">",
"      Crimlisk HL, Bhatia K, Cope H, et al. Slater revisited: 6 year follow up study of patients with medically unexplained motor symptoms. BMJ 1998; 316:582.",
"     </a>",
"    </li>",
"   </ol>",
"  </div>",
"  <div id=\"topicVersionRevision\">",
"   Topic 14132 Version 8.0",
"  </div>",
" </div>",
" <div id=\"footer\">",
"  <div id=\"supportFooter\">",
"   <span class=\"sfInfo\">",
"    &copy; 2013 UpToDate, Inc. All rights reserved.",
"   </span>",
"   <span class=\"pipeSpace\">",
"    |",
"   </span>",
"   <a class=\"licenseLink\" href=\"./license\" id=\"sla_footer\">",
"    Subscription and License Agreement",
"   </a>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Release: 21.6- C21.56",
"   </span>",
"   <br/>",
"   <span class=\"sfInfo\">",
"    Licensed to:",
"    <span class=\"emphasis\">",
"     AsanBook Dig. Med. Lib.",
"    </span>",
"   </span>",
"   <span class=\"sfInfo\">",
"    <span class=\"pipeSpace\">",
"     |",
"    </span>",
"    Support Tag: [1003-190.111.122.2-0C8C6D5D65-S244013.14]",
"    <br/>",
"   </span>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_62_10218=[""].join("\n");
var outline_f9_62_10218=[" <div id=\"toggleOutline\">",
"  <a href=\"#\" title=\"Collapse Topic Outline\">",
"   <img alt=\"\" src=\"./../images/orange_arrow_left.myextg\"/>",
"  </a>",
" </div>",
" <div id=\"innerOutline\">",
"  <h1>",
"   TOPIC OUTLINE",
"  </h1>",
"  <div id=\"outline\">",
"   <ul>",
"    <li>",
"     <a class=\"sr_button\" href=\"#H873058801\" id=\"summRecButton\">",
"      <span>",
"       SUMMARY &amp; RECOMMENDATIONS",
"      </span>",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H278442959\">",
"      INTRODUCTION AND BACKGROUND",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H278442966\">",
"      EPIDEMIOLOGY",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H303672\">",
"      Risk factors",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H278442973\">",
"      UNDERLYING PSYCHIATRIC DISORDERS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H278442994\">",
"      CLINICAL FEATURES",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H398881631\">",
"      Psychogenic tremor",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H398882742\">",
"      Psychogenic dystonia",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H19168773\">",
"      - Peripherally induced dystonia",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H278443023\">",
"      Psychogenic gait",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H278443030\">",
"      Psychogenic myoclonus",
"     </a>",
"    </li>",
"    <li class=\"dashItem\">",
"     <a class=\"outlineLink\" href=\"#H278443037\">",
"      - Startle syndromes",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H278443044\">",
"      Psychogenic parkinsonism",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H278443749\">",
"      DIAGNOSIS AND DIFFERENTIAL",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H313979223\">",
"      History and examination",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H537747505\">",
"      Electrodiagnostic testing",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H537747554\">",
"      Neuroimaging",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H278443058\">",
"      Classification of diagnostic certainty",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H278443065\">",
"      MANAGEMENT",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H623641336\">",
"      Explaining the diagnosis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"outlineLink\" href=\"#H623641343\">",
"      Treatment options",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H873058793\">",
"      PROGNOSIS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"outlineLink\" href=\"#H873058801\">",
"      SUMMARY AND RECOMMENDATIONS",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a href=\"#references\">",
"      REFERENCES",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   <div class=\"openRelatedGraphics\" id=\"NEURO/14132\" rel=\"outline_link\">",
"    GRAPHICS",
"    <a class=\"graphics_icon\" href=\"#\" title=\"View All Related Graphics\">",
"     View All",
"    </a>",
"   </div>",
"  </h1>",
"  <div id=\"relatedGraphics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <div class=\"openRelatedGraphics\" id=\"NEURO/14132|TAB\">",
"      <a href=\"#\" title=\"TABLES\">",
"       TABLES",
"      </a>",
"     </div>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?43/46/44779\" title=\"table 1\">",
"      Dx criteria conversion dis",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?14/20/14668\" title=\"table 2\">",
"      Somatization",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?38/41/39579\" title=\"table 3\">",
"      Criteria personality disorder",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?35/2/35883\" title=\"table 4\">",
"      Clinical characteristics of PMDs",
"     </a>",
"    </li>",
"    <li class=\"bulletItem\">",
"     <a class=\"graphic graphic_table\" href=\"UTD.htm?29/60/30667\" title=\"table 5\">",
"      Common tremors",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
"  <h1>",
"   RELATED TOPICS",
"  </h1>",
"  <div id=\"relatedTopics\">",
"   <ul>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?0/60/970?source=related_link\">",
"      Classification and evaluation of dystonia",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/32/7689?source=related_link\">",
"      Classification and evaluation of myoclonus",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?14/13/14554?source=related_link\">",
"      Clinical manifestations of Parkinson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?25/30/26089?source=related_link\">",
"      Diagnosis of Parkinson disease",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?7/21/7512?source=related_link\">",
"      Factitious disorder and Munchausen syndrome",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?9/12/9417?source=related_link\">",
"      Gait disorders of elderly patients",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?28/49/29465?source=related_link\">",
"      Multiple system atrophy: Clinical features and diagnosis",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?10/46/10984?source=related_link\">",
"      Overview of tremor",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?39/55/40824?source=related_link\">",
"      Personality disorders",
"     </a>",
"    </li>",
"    <li class=\"plainItem\">",
"     <a class=\"medical medical_review\" href=\"UTD.htm?5/20/5450?source=related_link\">",
"      Somatization: Epidemiology, pathogenesis, clinical features, medical evaluation, and diagnosis",
"     </a>",
"    </li>",
"   </ul>",
"  </div>",
" </div>"].join("\n");
var title_f9_62_10219="Pompe resources";
var content_f9_62_10219=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F69680&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F69680&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Internet resources for patients with acid maltase deficiency and their families",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Acid Maltase Deficiency Association (AMDA)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       www.amda-pompe.org",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Association for Glycogen Storage Disease",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       www.agsdus.org",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Association for Glycogen Storage Disease, United Kingdom",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       www.pompe.org.uk",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       Glycogen Storage Disease Network (GSDNet)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       www.pompe.org.uk/agsdnet.html",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       United Pompe Foundation",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       www.unitedpompe.com",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_single\">",
"       International Pompe Association (IPA)",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       worldpompe.org",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Adapted from Kishnani, PS, Howell, RR. Pompe disease in infants and children. J Pediatr 2004; 144:S35.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_62_10219=[""].join("\n");
var outline_f9_62_10219=null;
var title_f9_62_10220="Parent rx renal abscess";
var content_f9_62_10220=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ID%2F74492&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ID%2F74492&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Parenteral antibiotic therapy of renal or perinephric abscess",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tr>",
"      <td class=\"subtitle1_left\" colspan=\"3\">",
"       Regimens for empiric therapy",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" colspan=\"2\">",
"       Piperacillin-tazobactam",
"      </td>",
"      <td>",
"       3.375 g every 6 hours",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" colspan=\"2\">",
"       Ticarcillin-clavulanate",
"      </td>",
"      <td>",
"       3.1 g every 6 hours",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" colspan=\"2\">",
"       Cefepime",
"      </td>",
"      <td>",
"       1 g every 12 hours",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" colspan=\"2\">",
"       Meropenem",
"      </td>",
"      <td>",
"       1 g every 8 hours",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" colspan=\"2\">",
"       Imipenem",
"      </td>",
"      <td>",
"       500 mg every 6 hours",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_left\" colspan=\"3\">",
"       Regimens for therapy when susceptibility data is available",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" colspan=\"2\">",
"       Ceftriaxone",
"      </td>",
"      <td>",
"       1 g every 24 hours",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" colspan=\"2\">",
"       Ciprofloxacin",
"      </td>",
"      <td>",
"       400 mg every 12 hours",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" colspan=\"2\">",
"       Levofloxacin",
"      </td>",
"      <td>",
"       500 to 750 mg every 24 hours",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" colspan=\"2\">",
"       Aztreonam",
"      </td>",
"      <td>",
"       1 g every 8 to 12 hours",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"subtitle1_left\" colspan=\"3\">",
"       Regimens for empiric therapy in the setting of S. aureus bacteremia",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\" rowspan=\"3\">",
"       MSSA",
"      </td>",
"      <td>",
"       Nafcillin",
"      </td>",
"      <td>",
"       1-2 g every 6 hours",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Oxacillin",
"      </td>",
"      <td>",
"       1-2 g every 6 hours",
"      </td>",
"     </tr>",
"     <tr>",
"      <td>",
"       Cefazolin",
"      </td>",
"      <td>",
"       1 g every 8 hours",
"      </td>",
"     </tr>",
"     <tr>",
"      <td class=\"indent1\">",
"       MRSA*",
"      </td>",
"      <td>",
"       Vancomycin",
"      </td>",
"      <td>",
"       30 mg/kg intravenously every 24 hours in 2 equally divided doses",
"      </td>",
"     </tr>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <div class=\"footnotes\">",
"     MSSA: methicillin-susceptible Staphylococcus aureus; MRSA: methicillin-resistant Staphylococcus aureus.",
"     <br>",
"      * For alternative agents with activity against MRSA, see \"Treatment of invasive methicillin-resistant Staphylococcus aureus infections in adults\".",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_62_10220=[""].join("\n");
var outline_f9_62_10220=null;
var title_f9_62_10221="Cetuximab for recurrent and-or metastatic head and neck cancer";
var content_f9_62_10221=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=ONC%2F56253&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=ONC%2F56253&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=5\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Cetuximab for recurrent and/or metastatic head and neck cancer",
"    <sup>",
"     [1]",
"    </sup>",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <colgroup span=\"4\" width=\"25%\">",
"     </colgroup>",
"     <tbody>",
"      <tr class=\"divider_bottom\">",
"       <td colspan=\"4\">",
"        Cycle length: Weekly.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1\">",
"        Drug",
"       </td>",
"       <td class=\"subtitle1\">",
"        Dose and route",
"       </td>",
"       <td class=\"subtitle1\">",
"        Administration",
"       </td>",
"       <td class=\"subtitle1\">",
"        Given on days",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Cetuximab",
"        </strong>",
"       </td>",
"       <td>",
"        400 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV",
"       </td>",
"       <td>",
"        The appropriate dose should be withdrawn from the vials (supplied in a concentration of 2 mg/mL) and aseptically transferred into an empty sterile IV bag without further dilution. The initial dose should be infused over 120 minutes*",
"        <sup>",
"         &Delta;",
"        </sup>",
"        .",
"       </td>",
"       <td>",
"        Day 1",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        <strong>",
"         Cetuximab",
"        </strong>",
"       </td>",
"       <td>",
"        250 mg/m",
"        <sup>",
"         2",
"        </sup>",
"        IV",
"       </td>",
"       <td>",
"        If Day 1 is tolerated, subsequent doses may be administered over 60 minutes.",
"       </td>",
"       <td>",
"        Weekly, beginning Day 8",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Pretreatment considerations:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Emesis risk:",
"        </strong>",
"        LOW. Refer to UpToDate topic on \"Prevention and treatment of chemotherapy-induced nausea and vomiting\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Prophylaxis for infusion reactions:",
"        </strong>",
"        Premedication with diphenhydramine with or without a glucocorticoid at least prior to the first infusion",
"        <sup>",
"         [2]",
"        </sup>",
"        . Refer to UpToDate topic on \"Infusion reactions to therapeutic monoclonal antibodies used for cancer therapy\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Monitoring parameters:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Assess basic metabolic panel (including creatinine, magnesium, calcium, and potassium) prior to each dose. Monitor serum calcium, magnesium, and potassium levels weekly for eight weeks after completion of therapy",
"        <sup>",
"         [2]",
"        </sup>",
"        .",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull; Monitor for skin rash.",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle1_single\" colspan=\"4\">",
"        Suggested dose alterations for toxicity:",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"indent1\" colspan=\"4\">",
"        &bull;",
"        <strong>",
"         Dermatologic toxicity:",
"        </strong>",
"        Severe dermatologic reactions, such as acneiform rash, require delayed administration of cetuximab and/or dose reduction. Refer to UpToDate topic on \"Cutaneous complications of molecularly targeted therapy and other biologic agents used for cancer therapy\".",
"       </td>",
"      </tr>",
"      <tr>",
"       <td colspan=\"4\">",
"        <strong>",
"         If there is a change in body weight of at least 10 percent, dose should be recalculated for all drugs.",
"        </strong>",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    <strong>",
"     This table is provided as an example of how to administer this regimen; there may be other acceptable methods. This regimen must be administered by a clinician trained in the use of chemotherapy. The clinician is expected to use his or her independent medical judgment in the context of individual circumstances to make adjustments, as necessary.",
"    </strong>",
"    <div class=\"footnotes\">",
"     * Cetuximab should be administered with an infusion or syringe pump, using a low protein-binding 0.22 micron in line filter. Do not shake or dilute. Flush line with normal saline.",
"     <br/>",
"     &Delta; A slower infusion rate should be considered in areas with a high incidence of infusion reactions (such as the Southeast United States). Refer to UpToDate topic on \"Infusion reactions to the therapeutic monoclonal antibodies used in cancer therapy\".",
"    </div>",
"    <div class=\"reference\">",
"     References:",
"     <br/>",
"     <ol>",
"      <li>",
"       Vermorken JB, et al. J Clin Oncol 2007; 25:2171.",
"      </li>",
"      <li>",
"       Erbitux (cetuximab) injection. US FDA-approved manufacturer's package insert. US National Library of Medicine. (Available online at dailymed.nlm.nih.gov, accessed on December 9, 2011).",
"      </li>",
"     </ol>",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_62_10221=[""].join("\n");
var outline_f9_62_10221=null;
var title_f9_62_10222="Oral aphthae in Behcets";
var content_f9_62_10222=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=RHEUM%2F76223&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=RHEUM%2F76223&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=1\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\" style=\"width: 470px\">",
"   <div class=\"ttl\">",
"    Oral aphthae in Behcet's disease",
"   </div>",
"   <div class=\"cntnt\" style=\"width: 233px; height: 155px; background-image: url(data:image/jpeg;base64,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);\">",
"   </div>",
"   <div class=\"lgnd\">",
"    Multiple painful oral aphthae in a patient with Behcet's disease.",
"    <div class=\"footnotes\">",
"    </div>",
"    <div class=\"reference\">",
"     Courtesy of Samuel Moschella, MD.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_62_10222=[""].join("\n");
var outline_f9_62_10222=null;
var title_f9_62_10223="Coagulation test Preterm NB";
var content_f9_62_10223=[" <div id=\"graphicsToolbar\">",
"  <div id=\"graphicsCopy\">",
"   &copy;2013 UpToDate",
"   <sup>",
"    &reg;",
"   </sup>",
"  </div>",
"  <div id=\"graphicsLinks\">",
"   <a href=\"?imageKey=PEDS%2F65080&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\">",
"    <img alt=\"Print this page\" src=\"./../images/icn_print.myextg\" title=\"Print this page\"/>",
"   </a>",
"   <a class=\"icontxt textLink\" href=\"?imageKey=PEDS%2F65080&amp;source=image_view&amp;view=print&amp;elapsedTimeMs=2\" onclick=\"\" title=\"Print this page\">",
"    Print",
"   </a>",
"   <a class=\"etacLink\" href=\"#\">",
"    <img alt=\"Email graphic(s)\" src=\"./../images/icn_email.myextg\" title=\"Email graphic(s)\"/>",
"   </a>",
"   <a class=\"icontxt textLink etacLink\" href=\"#\" title=\"Email graphic(s)\">",
"    Email",
"   </a>",
"  </div>",
" </div>",
" <div class=\"graphic\">",
"  <div class=\"figure\">",
"   <div class=\"ttl\">",
"    Reference values for coagulation tests in healthy premature infants (30 to 36 weeks gestation) during first 6 months of life",
"   </div>",
"   <div class=\"cntnt\">",
"    <table cellspacing=\"0\">",
"     <tbody>",
"      <tr>",
"       <td class=\"subtitle1\" rowspan=\"2\">",
"        Tests",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Day 1",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Day 5",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Day 30",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Day 90",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Day 180",
"       </td>",
"       <td class=\"subtitle1\" colspan=\"2\">",
"        Adult",
"       </td>",
"      </tr>",
"      <tr>",
"       <td class=\"subtitle2\">",
"        M",
"       </td>",
"       <td class=\"subtitle2\">",
"        B",
"       </td>",
"       <td class=\"subtitle2\">",
"        M",
"       </td>",
"       <td class=\"subtitle2\">",
"        B",
"       </td>",
"       <td class=\"subtitle2\">",
"        M",
"       </td>",
"       <td class=\"subtitle2\">",
"        B",
"       </td>",
"       <td class=\"subtitle2\">",
"        M",
"       </td>",
"       <td class=\"subtitle2\">",
"        B",
"       </td>",
"       <td class=\"subtitle2\">",
"        M",
"       </td>",
"       <td class=\"subtitle2\">",
"        B",
"       </td>",
"       <td class=\"subtitle2\">",
"        M",
"       </td>",
"       <td class=\"subtitle2\">",
"        B",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        PT (s)",
"       </td>",
"       <td>",
"        13.0",
"       </td>",
"       <td>",
"        (10.6-16.2)*",
"       </td>",
"       <td>",
"        12.5",
"       </td>",
"       <td>",
"        (10.0-15.3)*",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        11.8",
"       </td>",
"       <td>",
"        (10.0-13.6)*",
"       </td>",
"       <td>",
"        12.3",
"       </td>",
"       <td>",
"        (10.0-14.6)*",
"       </td>",
"       <td>",
"        12.5",
"       </td>",
"       <td>",
"        (10.0-15.0)*",
"       </td>",
"       <td>",
"        12.4",
"       </td>",
"       <td>",
"        (10.8-13.9)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        APTT (s)",
"       </td>",
"       <td>",
"        53.6",
"       </td>",
"       <td>",
"        (27.5-79.4)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        50.5",
"       </td>",
"       <td>",
"        (26.9-74.1)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        44.7",
"       </td>",
"       <td>",
"        (26.9-62.5)",
"       </td>",
"       <td>",
"        39.5",
"       </td>",
"       <td>",
"        (28.3-50.7)",
"       </td>",
"       <td>",
"        37.5",
"       </td>",
"       <td>",
"        (21.7-53.3)*",
"       </td>",
"       <td>",
"        33.5",
"       </td>",
"       <td>",
"        (26.6-40.3)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        TCT (s)",
"       </td>",
"       <td>",
"        24.8",
"       </td>",
"       <td>",
"        (19.2-30.4)*",
"       </td>",
"       <td>",
"        24.1",
"       </td>",
"       <td>",
"        (18.8-29.4)*",
"       </td>",
"       <td>",
"        24.4",
"       </td>",
"       <td>",
"        (18.8-29.9)*",
"       </td>",
"       <td>",
"        25.1",
"       </td>",
"       <td>",
"        (19.4-30.8)*",
"       </td>",
"       <td>",
"        25.2",
"       </td>",
"       <td>",
"        (18.9-31.5)*",
"       </td>",
"       <td>",
"        25.0",
"       </td>",
"       <td>",
"        (19.7-30.3)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Fibrinogen (g/L)",
"       </td>",
"       <td>",
"        2.43",
"       </td>",
"       <td>",
"        (1.50-3.73)*",
"        <sup>",
"         &bull;&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        2.80",
"       </td>",
"       <td>",
"        (1.60-4.18)*",
"        <sup>",
"         &bull;&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        2.54",
"       </td>",
"       <td>",
"        (1.50-4.14)*",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        2.46",
"       </td>",
"       <td>",
"        (1.50-3.52)*",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        2.28",
"       </td>",
"       <td>",
"        (1.50-3.60)",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        2.78",
"       </td>",
"       <td>",
"        (1.56-4.00)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        II (u/mL)",
"       </td>",
"       <td>",
"        0.45",
"       </td>",
"       <td>",
"        (0.20-0.77)",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        0.57",
"       </td>",
"       <td>",
"        (0.29-0.85)&Delta;",
"       </td>",
"       <td>",
"        0.57",
"       </td>",
"       <td>",
"        (0.36-0.95)",
"        <sup>",
"         &bull;&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.68",
"       </td>",
"       <td>",
"        (0.30-1.06)",
"       </td>",
"       <td>",
"        0.87",
"       </td>",
"       <td>",
"        (0.51-1.23)",
"       </td>",
"       <td>",
"        1.08",
"       </td>",
"       <td>",
"        (0.70-1.46)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        V (U/mL)",
"       </td>",
"       <td>",
"        0.88",
"       </td>",
"       <td>",
"        (0.41-1.44)*",
"        <sup>",
"         &bull;&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        1.00",
"       </td>",
"       <td>",
"        (0.46-1.54)",
"       </td>",
"       <td>",
"        1.02",
"       </td>",
"       <td>",
"        (0.48-1.56)",
"       </td>",
"       <td>",
"        0.99",
"       </td>",
"       <td>",
"        (0.59-1.39)",
"       </td>",
"       <td>",
"        1.02",
"       </td>",
"       <td>",
"        (0.58-1.46)",
"       </td>",
"       <td>",
"        1.06",
"       </td>",
"       <td>",
"        (0.62-1.50)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        VII (U/mL)",
"       </td>",
"       <td>",
"        0.67",
"       </td>",
"       <td>",
"        (0.21-1.13)",
"       </td>",
"       <td>",
"        0.84",
"       </td>",
"       <td>",
"        (0.30-1.38)",
"       </td>",
"       <td>",
"        0.83",
"       </td>",
"       <td>",
"        (0.21-1.45)",
"       </td>",
"       <td>",
"        0.87",
"       </td>",
"       <td>",
"        (0.31-1.43)",
"       </td>",
"       <td>",
"        0.99",
"       </td>",
"       <td>",
"        (0.47-1.51)*",
"       </td>",
"       <td>",
"        1.05",
"       </td>",
"       <td>",
"        (0.67-1.43)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        VIII (U/mL)",
"       </td>",
"       <td>",
"        1.11",
"       </td>",
"       <td>",
"        (0.50-2.13)*",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        1.15",
"       </td>",
"       <td>",
"        (0.53-2.05)*",
"        <sup>",
"         &bull;&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        1.11",
"       </td>",
"       <td>",
"        (O.50-l.99)*",
"        <sup>",
"         &bull;&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        1.06",
"       </td>",
"       <td>",
"        (0.58-1.88)*",
"        <sup>",
"         &bull;&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.99",
"       </td>",
"       <td>",
"        (0.50-1.87)*",
"        <sup>",
"         &bull;&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.99",
"       </td>",
"       <td>",
"        (0.50-1.49)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        vWF (U/mL)",
"       </td>",
"       <td>",
"        1.36",
"       </td>",
"       <td>",
"        (0.78-2.10)",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        1.33",
"       </td>",
"       <td>",
"        (0.72-2.19)",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        1.36",
"       </td>",
"       <td>",
"        (0.66-2.16)",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        1.12",
"       </td>",
"       <td>",
"        (0.75-l.84)*",
"       </td>",
"       <td>",
"        0.98",
"       </td>",
"       <td>",
"        (0.54-1.58)*",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        0.92",
"       </td>",
"       <td>",
"        (0.50-1.58)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        IX (U/mL)",
"       </td>",
"       <td>",
"        0.35",
"       </td>",
"       <td>",
"        (0.19-0.65)",
"        <sup>",
"         &bull;&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.42",
"       </td>",
"       <td>",
"        (0.14-0.74)",
"        <sup>",
"         &bull;&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.44",
"       </td>",
"       <td>",
"        (0.13-0.80)",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        0.59",
"       </td>",
"       <td>",
"        (0.25-0.93)",
"       </td>",
"       <td>",
"        0.81",
"       </td>",
"       <td>",
"        (0.50-1.20)",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        1.09",
"       </td>",
"       <td>",
"        (0.55-1.63)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        X (U/mL)",
"       </td>",
"       <td>",
"        0.41",
"       </td>",
"       <td>",
"        (0.11-0.71)",
"       </td>",
"       <td>",
"        0.51",
"       </td>",
"       <td>",
"        (0.19-0.83)",
"       </td>",
"       <td>",
"        0.56",
"       </td>",
"       <td>",
"        (0.20-0.92)",
"       </td>",
"       <td>",
"        0.67",
"       </td>",
"       <td>",
"        (0.35-0.99)",
"       </td>",
"       <td>",
"        0.77",
"       </td>",
"       <td>",
"        (0.35-1.19)",
"       </td>",
"       <td>",
"        1.06",
"       </td>",
"       <td>",
"        (0.70-1.52)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        XI (U/mL)",
"       </td>",
"       <td>",
"        0.30",
"       </td>",
"       <td>",
"        (0.08-0.52)",
"        <sup>",
"         &bull;&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.41",
"       </td>",
"       <td>",
"        (0.13-0.69)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.43",
"       </td>",
"       <td>",
"        (0.15-0.71)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.59",
"       </td>",
"       <td>",
"        (0.25-0.93)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.78",
"       </td>",
"       <td>",
"        (0.46-1.10)",
"       </td>",
"       <td>",
"        0.97",
"       </td>",
"       <td>",
"        (0.67-1.27)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        XII (U/mL)",
"       </td>",
"       <td>",
"        0.38",
"       </td>",
"       <td>",
"        (0.10-0.66)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.39",
"       </td>",
"       <td>",
"        (0.09-0.69)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.43",
"       </td>",
"       <td>",
"        (0.11-0.75)",
"       </td>",
"       <td>",
"        0.61",
"       </td>",
"       <td>",
"        (0.15-1.07)",
"       </td>",
"       <td>",
"        0.82",
"       </td>",
"       <td>",
"        (0.22-1.42)",
"       </td>",
"       <td>",
"        1.08",
"       </td>",
"       <td>",
"        (0.52-1.64)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        PK (U/mL)",
"       </td>",
"       <td>",
"        0.33",
"       </td>",
"       <td>",
"        (0.09-0.57)",
"       </td>",
"       <td>",
"        0.45",
"       </td>",
"       <td>",
"        (0.26-0.75)",
"        <sup>",
"         &bull;",
"        </sup>",
"       </td>",
"       <td>",
"        0.59",
"       </td>",
"       <td>",
"        (0.31-0.87)",
"       </td>",
"       <td>",
"        0.79",
"       </td>",
"       <td>",
"        (0.37-1.21)",
"       </td>",
"       <td>",
"        0.78",
"       </td>",
"       <td>",
"        (0.40-1.16)",
"       </td>",
"       <td>",
"        1.12",
"       </td>",
"       <td>",
"        (0.62-1.62)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        HMWK (U/mL)",
"       </td>",
"       <td>",
"        0.49",
"       </td>",
"       <td>",
"        (0.09-0.89)",
"       </td>",
"       <td>",
"        0.62",
"       </td>",
"       <td>",
"        (0.24-1.00)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.64",
"       </td>",
"       <td>",
"        (0.16-1.12)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        0.78",
"       </td>",
"       <td>",
"        (0.32-1.24)",
"       </td>",
"       <td>",
"        0.83",
"       </td>",
"       <td>",
"        (0.41-1.25)*",
"       </td>",
"       <td>",
"        0.92",
"       </td>",
"       <td>",
"        (0.50-1.36)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        XIIIa (U/mL)",
"       </td>",
"       <td>",
"        0.70",
"       </td>",
"       <td>",
"        (0.32-1.08)",
"       </td>",
"       <td>",
"        1.01",
"       </td>",
"       <td>",
"        (0.57-1.45)*",
"       </td>",
"       <td>",
"        0.99",
"       </td>",
"       <td>",
"        (0.51-1.47)*",
"       </td>",
"       <td>",
"        1.13",
"       </td>",
"       <td>",
"        (0.71-1.55)*",
"       </td>",
"       <td>",
"        1.13",
"       </td>",
"       <td>",
"        (0.65-1.61)*",
"       </td>",
"       <td>",
"        1.05",
"       </td>",
"       <td>",
"        (0.55-1.55)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        XIIIb (U/mL)",
"       </td>",
"       <td>",
"        0.81",
"       </td>",
"       <td>",
"        (0.35-1.27)",
"       </td>",
"       <td>",
"        1.10",
"       </td>",
"       <td>",
"        (0.68-1.58)*",
"       </td>",
"       <td>",
"        1.07",
"       </td>",
"       <td>",
"        (0.57-1.57)*",
"       </td>",
"       <td>",
"        1.21",
"       </td>",
"       <td>",
"        (0.75-1.67)",
"       </td>",
"       <td>",
"        1.15",
"       </td>",
"       <td>",
"        (0.67-1.63)",
"       </td>",
"       <td>",
"        0.97",
"       </td>",
"       <td>",
"        (0.57-1.37)",
"       </td>",
"      </tr>",
"      <tr>",
"       <td>",
"        Plasminogen (CTA, U/mL)",
"       </td>",
"       <td>",
"        1.70",
"       </td>",
"       <td>",
"        (1.12-2.48)",
"        <sup>",
"         &bull;&Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        1.91",
"       </td>",
"       <td>",
"        (1.21-2.61)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        1.81",
"       </td>",
"       <td>",
"        (1.09-2.53)",
"       </td>",
"       <td>",
"        2.38",
"       </td>",
"       <td>",
"        (1.58-3.18)",
"       </td>",
"       <td>",
"        2.75",
"       </td>",
"       <td>",
"        (1.91-3.59)",
"        <sup>",
"         &Delta;",
"        </sup>",
"       </td>",
"       <td>",
"        3.36",
"       </td>",
"       <td>",
"        (2.48-4.24)",
"       </td>",
"      </tr>",
"     </tbody>",
"    </table>",
"   </div>",
"   <div class=\"lgnd\">",
"    All factors except fibrinogen and plasminogen are expressed as U/mL, where pooled plasma contains 1.0 U/mL. Plasminogen units are those recommended by the Committee on Thrombolytic Agents (CTA). All values are given as a mean (m) followed by lower and upper boundary encompassing 95 percent of the population (B). Between 40 and 96 samples were assayed for each value for newborns.",
"    <div class=\"footnotes\">",
"     PT: prothrombin time; APTT: activated partial thromboplastin time; TCT: thrombin clotting time; vWF: von Willebrand factor; PK: prekallikrein; HMWK: high molecular weight kininogen.",
"     <br>",
"      * Values indistinguishable from those of adults.",
"      <br>",
"       &bull; Measurements are skewed owing to a disproportionate number of high values. Lower limit which excludes the lower 2.5 percent of the population is given (B).",
"       <br>",
"        &Delta; Values different from those of full term infants.",
"       </br>",
"      </br>",
"     </br>",
"    </div>",
"    <div class=\"reference\">",
"     Reprinted from: Andrew M, Paes B, Milner R, et al. Development of the Human Coagulation System in the Healthy Premature Infant. Blood 1988; 72:1651. Copyright &copy;1988 The American Society of Hematology.",
"    </div>",
"   </div>",
"  </div>",
" </div>",
"</div>"].join("\n");
var script_f9_62_10223=[""].join("\n");
var outline_f9_62_10223=null;
